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Microdialysis is the most widely used technique for intracranial sampling. Its versatility 
prompts important applications, from bedside traumatic brain injury monitoring to psychological 
disorder treatment. However, historically microdialysis methods have a time resolution of 5-30 
mins, and thus are not well suited to obtain physiological information, such as rates of extracellular 
processes or the relationship between neurochemical levels and behavior. Building from recent 
work in our laboratory, we developed instrumentation for making dopamine measurements in 
awake and freely moving rats over extended periods at one-minute time resolution using 
microdialysis sampling analyzed with online HPLC (Fast Microdialysis). 
Fast Microdialysis was used to investigate the beneficial effects of the anti-inflammatory 
drug dexamethasone (DEX) to penetration injury caused by dialysis probe implantation. 
Retrodialysis of DEX was found to potentiate both basal levels and stimulated release of striatal 
DA. Applying Fast Microdialysis to behavioral studies necessitated creation of a rotating operant 
chamber. Using this device, both trained- and untrained- animal’s behavior correlated with DA 
release, however with different characteristics. Robust and fast determination of DA allowed for 
creation of new microdialysis techniques in the non-steady state regime to investigate morphology 
and neurotransmitter regulation. Thus, a comprehensive mathematical model was created to 
analyze transient responses measured by Fast Microdialysis. A robust, adaptive random sampling 
simplex approach was used to fit the model to transient data. Striatal tissue tortuosity, porosity and 
the reuptake rate constant of DA were determined from a single transient response on awake and 
freely moving rats.   
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1.1 Fundamentals of Brain Microdialysis 
The study of neurochemistry is vital to our continual quest for a better understanding of 
the nervous system. Within this vast field, in vivo measurements of neurotransmitters has shed 
light to the neurochemical processes behind learning and memory (dopamine, glutamate1,2), 
neurodegenerative disorders (dopamine3, glutamate4,5, serotonin6), and immune response 
(histamine7, acetylcholine8), to name a very select few. These in vivo measurements are typically 
made with sensors that measure solutes directly in the brain tissue9,10, probes that obtain a sample 
from the brain11,12, or imaging techniques that measure a neurotransmitter’s activities via a 
radioactive ligand13,14. Particularly, microdialysis has become the most extensively used 
technique15,16 in the last two decades. The research described in this dissertation focuses on 
improving in vivo microdialysis measurements of dopamine (DA) in the rat striatum or nucleus 
accumbens, both of which have been the subject of numerous investigations to behavior17-21, 
diseases22-26 and related pharmacology27-29.  
Microdialysis is a solute sampling and delivery technique. The principle element of the 
microdialysis technique12,15,30-35 is the microdialysis probe, the object that when inserted into a 
medium (e.g., brain tissue or agar gel) and perfused, enables sampling of and/or delivery to a small 
region of medium around the probe. The microdialysis probe consists of an inlet, an outlet, a 
cannula which houses the inlet and outlet, and a porous, semi-permeable dialysis membrane at end 
of the cannula (Figure 4.2-1). The probe is perfused typically with a solution that is isosmotic to 
and mimics the electrolyte balance of the external medium (e.g., artificial cerebral spinal fluid 
 2 
when sampling from brain). The porous membrane allows solutes of molecular weight defined by 
the membrane’s characteristic molecular weight cut-off (MWCO) to diffuse from the external 
medium through the membrane into the probe lumen (i.e. microdialysis sampling) or vice versa 
(i.e. retrodialysis). The solution, now called dialysate, passes out of the probe to an outlet, where 
is it collected for analysis. 
1.2 Microdialysis’ Time Resolution and Quantitative Analysis Problems  
Microdialysis is typically coupled with analytical techniques for separation (e.g. liquid 
chromatography36-38, electrophoresis39-41) and detection of analytes (e.g. amperometry36,37,42, mass 
spectrometry43-45). The experiment can be online, where the probe outlet is connected directly to 
the analytical instrument for immediate analysis, or offline, where dialysate is collected and stored 
frozen prior to analysis. Naturally, microdialysis’ distinguishing feature is its superior versatility 
in both sampling and detection, which has helped microdialysis to become the most popular in 
vivo analysis technique. To date, there are nearly 35,000 articles within the microdialysis topic on 
SciFinder compared to about 2,500 for the second most popular technique, Fast-Scan Cyclic 
Voltammetry (FSCV).  
However, microdialysis suffers from two problems. One is speed. It is a relatively slow 
technique, where the typical sampling interval is on the order of 5-30 min 12,46,47 which contrasts 
with FSCV where sub-second measurements are routine48. Better time resolution for microdialysis 
is therefore highly desirable. The other problem is inferring solute concentrations in the brain 
extracellular space from the concentrations measured in the dialysate. Classical FSCV lacks the 
capability to directly determine basal level concentrations of neurotransmitters, but recently 
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developed related techniques49-53 are potentially capable of estimating basal concentrations in the 
minute or less time regime. Microdialysis employs an experimental protocol12,54,55 to obtain 
quantitative estimates of the solute concentrations in the brain. The experimental protocol is based 
on a mathematical model56-66 with a set of assumptions and accuracy limitations stemming from 
these assumptions. Therefore, there are opportunities to create quantitative methods based on 
microdialysis that can improve the accuracy of estimates of solute concentrations in the brain and 
do so with a faster timescale than currently possible. This will lead to insights into biological 
processes that govern such concentrations. 
1.3 Evolution of Fast Microdialysis 
1.3.1 Pioneering Period of High Time Resolution Analysis for Fast Microdialysis 
Efforts were made early on (1980s) in the development of the microdialysis technique to 
improve not only the dialysate analysis time but also sample dispersion during fluidic transport67. 
Justice and colleagues leveraged the then recent advancements in smallbore packed 
chromatographic columns and high-performance liquid chromatography to create a method for 
online in vivo microdialysis determination of DA at 5-min time resolution68. The importance of a 
faster time resolution needed to infer biological information was recognized, and offline 
measurements with 1-min sampling followed shortly69-71. Justice and colleagues established the 
technical feasibility and possibility to observe rapid fluctuations in neurotransmitter concentrations 
using microdialysis. However, technological challenges in separation and detection of low level 
neurotransmitters hindered adoption of high time-resolution microdialysis well into the 2000s. 
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Andrews et al.72 found that 82% of microdialysis publications in 2012 were at 20-min time 
resolution and none was faster than 5-min. The opportunity to infer biological information from 
rapid fluctuations was unfortunately overlooked in favor of pharmacological and toxicological 
applications73 where time resolution is generally not a pressing need72.  
1.3.2 Renewed Interest to High Time Resolution 
With the maturity of high-performance liquid chromatography instrumentation, 
particularly the availability of sub 2 m porous stationary phase particles, efforts74,75 were renewed 
late in the 2000s to develop an online, in vivo microdialysis technique that is capable of continuous, 
hours long determination of low level (nM) neurotransmitters (Fast Microdialysis). Andrews and 
colleagues optimized their separation on commercially available HPLC instrument and analytical 
scale columns to achieve a 2-3 min time resolution online detection of serotonin (5-HT)47,72. 
Within the Weber group, prior the research described in this dissertation, capillary liquid 
chromatography systems were designed and optimized to demonstrate technical feasibility of a 1-
min time resolution online detection of 5-HT74,76,77 and dopamine78 (DA), separately. Significant 
progress was also made with offline analysis. Kennedy and colleagues developed a segmented 
flow microdialysis technique that when coupled with mass spectrometry was capable of 2 s 
determination of neurotransmitters and metabolites79-81. These works presented experimental 
evidence validating the hypothesis that Justice had made three decades prior: there is biological 




Figure 1.3-1. Seconds regime determination of (A) glutamate (B) aspartate (C) GABA (D) taurine (E) glycine 
using microdialysis sampling with segmented flow.  
Reprinted with permission with permission from Wang, M.; Hershey, N. D.; Mabrouk, O. S.; Kennedy, R. T. 
Anal Bioanal Chem 2011, 400, 2013-2023.  
1.4 Development of Microdialysis Theories 
Microdialysis theories describe the mass transport of solute across the tissue to the probe, 
driven by diffusive flux resulting from solute concentration gradients between the tissue and the 
probe. Early work in microdialysis theory only considered this mass transport process31,56,57, and 
did not considered other processes in the brain. The microdialysis probe is cylindrical, thus mass 
transport solutions in the cylindrical coordinates is most appropriate. Nevertheless, there are also 
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approximations62,82,83 in the Cartesian coordinates to simplify the calculations. Bungay, Chen and 
Morrison have provided the most comprehensive discussion of mass transport in microdialysis in 
the cylindrical coordinates. Bungay et al. (1990)84 used the concept of resistance/permeability to 
account for individual contribution of each transport layer (probe, probe membrane, and tissue) to 
the overall mass transport. He also considered biological processes that remove solute from the 
extracellular space and created a simple steady-state formulation for quantitative microdialysis 
that has been widely adopted. Bungay (2003)65 later revised his steady-state model to include the 
trauma layer resulting from penetration injury during probe implantation85-87. Another solution for 
steady-state mass transport that incorporates a trauma layer was obtained by Chen (2006)88. 
Morrison et al. (1991)60 developed the model with the fewest assumptions, as far as we are aware. 
It includes two source and uptake terms, for ‘metabolism’ and for exchange between brain tissue 
and capillary blood. The solution describes mass transport in the transient state. The mathematical 
expressions from Morrison’s solution are very complex. Over the years, Bungay and colleagues 
simplified the mathematics of mass transport, and published (2011)61 the most up-to-date model 
for transient microdialysis mass transport. He adapted an earlier solution by Chen (2002)58,59 to 
create one-dimensional (1D) and two-dimensional (2D) mass transport models. The many models 
developed over the years, however, create confusion as to which model is most appropriate for 
experimental use. Furthermore, we note that none of these models involves the analytical system 
that follows microdialysis sampling. They only describe mass transport across the probe. The few 
models77,89 that describe solute concentration in the dialysate as observed by the analytical system, 
on the other hand, do not involve microdialysis sampling. The research described in this 
dissertation, introduced below, sought to rectify both these issues.  
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1.5 Theoretical and Experimental Improvements for Fast Microdialysis 
Prior the research described in this dissertation, the Weber group had developed one-
minute in vivo measurements of neurotransmitters by microdialysis with online capillary HPLC, 
first for serotonin74,76,77 and later for dopamine78 (DA). This work was primarily a technical 
demonstration for online in vivo measurements with Fast Microdialysis to establish its feasibility. 
The instrumentation and data analysis were not capable of long-term studies, of correlating 
measurements of DA with learned behavior, or of using the improved time resolution to understand 
physiological processes in the brain. Furthermore, there were technical hurdles to significantly 
improving the time resolution of these measurements. The subsequent research, summarized 
below, addressed these issues, and established novel applications for brain microdialysis. 
1.5.1 Investigating the Effects of a Drug Treatment 
Michael and colleagues through a series of elegant works have found that microdialysis 
probe implantation causes trauma in the brain tissue surrounding the probe. This triggers an 
immune response adverse to good microdialysis measurements62,63,65,88,90,91. Their histology and 
FSCV studies found that this immune response can be mitigated with an anti-inflammatory 
drug86,87,92,93 (e.g. Dexamethasone, DEX). The DEX treatment restored evoked DA response in 
injured tissue, however, tissue viability could not be conclusively determined86,87. Thus, we used 
Fast Microdialysis to investigate the effects of DEX treatment to basal concentrations and evoked 
DA responses in the rat striatum. A simultaneous Fast Microdialysis and local field potential 
measurement was used to elucidate tissue viability. We also made improvements in Fast 
Microdialysis instrumentation and data analysis to accommodate these experiments.   
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1.5.2 Rotating Operant Chamber for Fast Microdialysis 
The improved Fast Microdialysis has a limit of quantitation of 1 nM, which is sufficient 
for DA determination in the nucleus accumbens94, the brain region that is responsible for reward 
and reinforcement95. At the time resolution of one minute, the rapid fluctuation of DA 
concentrations could encode information related to the animal’s behavior69-71. Existing behavioral 
instrumentation was not suitable for Fast Microdialysis. Thus, a rotating operant chamber was 
created to implement Fast Microdialysis to behavioral studies. The rotating operant chamber 
eliminates the need for use of a liquid swivel that adds band broadening and reduces time resolution 
of the analysis; while it also allows the animal to move freely and respond to stimuli without 
twisting of the capillaries supporting the dialysate flow. This was accomplished by modifying a 
BASi raturn with an on-board controller and adding operant behavior components that rotate with 
the raturn. Using the rotating operant chamber, rats were trained to perform learned tasks, while 
DA concentrations were determined with Fast Microdialysis. Correlation between the animal’s 
behavior and rapid releases of DA were interpreted using Short Time Fourier Transform96. 
1.5.3 Theoretical and Experimental Framework for Analysis of Transient Response 
From the two prior works97,98, it was established definitively that there is biologically 
relevant information encoded in DA changes measured at one-minute time resolution. Together 
with the much-needed experimental work to increase the time resolution of the microdialysis 
measurements, theorical improvement is also necessary to describe the relationship between 
measured solute concentration at the detector and the neurochemical environment outside the 
probe. Theories exist32,56-64,83,84,89,99-102 to describe the effects of tissue morphology and solute 
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uptake rate on the relationship between the concentration of a solute added to the perfusate going 
into the probe and the measured solute concentration coming out of the probe. However, there is 
no coherent and comprehensive mathematical description of how solute concentration, tissue 
morphology, and uptake rate govern the solute concentration profile at the detector measured by 
Fast Microdialysis in the non-steady state regime (“transient response”) that is not in differential 
equations form. Thus, a new microdialysis technique (Comprehensive Quantitative Microdialysis, 
CQM) was developed to analyze transient responses measured with Fast Microdialysis and 
elucidate the relevant biological and systemic factors that affect the transient response.   
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2.0 Monitoring Dopamine Responses to Potassium Ion and Nomifensine by in vivo 
Microdialysis with Online Liquid Chromatography at One-Minute Resolution 
The following chapter is reprinted (adapted) with permission from Ngo, K. T.; Varner, E. 
L.; Michael, A. C.; Weber, S. G. ACS Chem Neurosci 2017, 8, 329-338. Copyright© 2020 
American Chemical Society.  
2.1 Chapter Summary 
Recently, our laboratory has demonstrated the technical feasibility of monitoring dopamine 
at one-min temporal resolution with microdialysis and online liquid chromatography.  Here, we 
monitor dopamine in the rat striatum during local delivery of high potassium/low sodium or 
nomifensine in awake-behaving rats.  Microdialysis probes were implanted and perfused 
continuously with or without dexamethasone in the perfusion fluid for four days. Dexamethasone 
is an anti-inflammatory agent that exhibits several positive effects on the apparent health of the 
brain tissue surrounding microdialysis probes.  Dopamine was monitored one or four days after 
implantation under basal conditions, during 10-min applications of 60 mM or 100 mM K+, and 
during 15-min applications of 10 µM nomifensine. High K+ or nomifensine were delivered locally 
by adding them to the microdialysis perfusion fluid using a computer-controlled, low-dead-volume 
six-port valve. Each day/K+/dexamethasone combination elicited specific dopamine responses. 
Dexamethasone treatment increased dopamine levels in basal dialysates (i.e., in the absence of K+ 
or nomifensine). Applications of 60 mM K+ evoked distinct responses on days one and four after 
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probe implantation, depending upon the presence or absence of dexamethasone, consistent with 
dexamethasone’s ability to mitigate the traumatic effect of probe implantation.  Applications of 
100 mM K+ evoked dramatic oscillations in dopamine levels that correlated with changes in the 
field potential at a metal electrode implanted adjacent to the microdialysis probe.  This 
combination of results indicates the role of spreading depolarization in response to 100 mM K+.  
With one-min temporal resolution we find that it is possible to characterize the pharmacokinetics 
of the response to the local delivery of nomifensine.  Overall, the findings reported here confirm 
the benefits arising from the ability to monitor dopamine via microdialysis at high sensitivity and 
at high temporal resolution.     
2.2 Introduction 
Microdialysis has been widely employed for intracranial chemical monitoring.30,33,45,103,104 
Microdialysis probes are robust and can be used in both anesthetized and awake animals ranging 
from rodents to primates, including human patients.  They collect a broad array of small molecules 
below the molecular weight cutoff of the dialysis membrane, several varieties of which are 
available in the required hollow-fiber format.  The dialysis process produces samples that are free 
of tissue fragments, proteins, blood, and other forms of contamination.  The dialysate samples can 
either be collected, stored, and analyzed later,105-107 or analyzed in near-real time by online 
methods.67,108  Online analysis decreases the chance of sample degradation during storage and 
eliminates delays in obtaining the results.  Online analysis is often performed with liquid 
chromatography (LC)35,71,109 or capillary electrophoresis110,111 coupled to detectors employing 
laser-induced fluorescence,112,113 mass spectrometry,114,115 or electrochemistry.116-119 
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Recent progress in improving the time resolution of microdialysis sampling of 
neurotransmitters builds on earlier work.109 Developments in LC separation speed have enabled 
online collection and analysis of serotonin (5-HT) at three-72 and later two-min intervals47 on 
commercial instruments. We have used capillary LC with electrochemical detection to determine 
both dialysate DA and 5-HT (separately) in near real time at one minute intervals.76-78 Electrical 
stimulation to induce DA transients demonstrated that our approach yields an overall time 
resolution of at least one-minute.78 
While there are many studies of DA release induced by retrodialysis of high K+/low Na+ at 
modest time resolution, we are not aware of any at one-minute time resolution. It would be of 
interest to learn what information is gained by measuring at this time resolution. Thus, in this 
study, we describe the remarkable variety of dialysate dopamine transients elicited by a ten-minute 
high K+/low Na+ stimulation120 (60 mM or 100 mM K+; we denote these as “high K+” below). 
Having seen oscillations in 5-HT concentrations resulting from high K+ stimulation, we anticipated 
that DA may respond similarly. Thus, we used a 10-min stimulation to accommodate the 2-3 min 
period of the oscillations.77 Responses in awake rats were measured one- and four days after probe 
implantation. One group of animals had microdialysis probes perfused with artificial cerebrospinal 
fluid only (aCSF). A second group had microdialysis probes perfused continuously with aCSF 
containing dexamethasone87,90,121,122 via retrodialysis. We refer to the latter set of probes as “local 
dexamethasone by retrodialysis” probes (LDR probes), and the former as “control” probes. 
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2.3 Methods 
2.3.1 Chemical and Materials 
Chemicals (disodium EDTA, sodium acetate, sodium 1-octanesulfonate (SOS), 
acetonitrile, glacial acetic acid, NaCl, KCl, CaCl2, MgCl2, and NaH2PO4) were purchased from 
either Fisher Scientific (Fair Lawn, NJ) or Sigma (St. Louis, MO) and used as received. 
Dexamethasone sodium phosphate was from APP Fresenius Kabi USA, LLC, Lake Zurich IL. 
Ultra-pure water used was filtered using a Millipore Mili-Q Synthesis A10 system (Belford, MA).  
Artificial cerebrospinal fluid (aCSF: 142 mM NaCl, 1.2 mM CaCl2, 2.7 mM KCl, 1.0 mM 
MgCl2, and 2.0 mM NaH2PO4, pH 7.4) was used as the perfusion fluid for the microdialysis probes. 
The high K+ aCSF solutions were kept isotonic by lowering the Na+ concentration (60 mM K+ 
aCSF: 84.7 mM NaCl, 1.2 mM CaCl2, 60 mM KCl, 1.0 mM MgCl2, and 2.0 mM NaH2PO4. 100 
mM K+ aCSF: 44.7 mM NaCl, 1.2 mM CaCl2, 100 mM KCl, 1.0 mM MgCl2, and 2.0 mM 
NaH2PO4). Dexamethasone sodium phosphate (APP Pharmaceuticals LLC, Schaumburg, IL) and 
nomifensine maleate (Sigma-Aldrich, St. Louis, MO) were diluted in aCSF. The microdialysis 
perfusion fluids were filtered with Nalgene sterile filter units (Fisher, Pittsburgh, PA; PES 0.2 μm 
pores).  
2.3.2 Probe Construction 
Concentric-style microdialysis probes (4 mm membrane length) were built in-house (200 
μm I.D, 280 μm O.D, 13 kDa MWCO Spectra/Por hollow fiber, Spectrum Laboratories Inc. 
Rancho, Dominquez, CA) see78 for details. The probe inlet consists of 100 cm of fused silica 
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capillary (75 μm I.D., 150 μm O.D. Polymicro Technologies, Phoenix, AZ). The outlet capillary 
is of the same type but 115 cm in length. Each capillary is connected to 10 cm of 75 μm I.D., 360 
m O.D. fused silica to facilitate the connection of inlet and outlet lines to nanobore injection 
valves (described below). We estimate based on system volumes and perfusion flow rate that 
transport of a stimulant slug to the probe membrane takes 9.84 minutes, and a sample slug takes 
9.05 minutes from the probe to the injection valve. The difference is mainly due to the internal 
volume of the probe which counts towards the inlet flow path. Prior to use, the probes were soaked 
in 70% ethanol and then immersed in and flushed with filtered perfusion fluid (aCSF or aCSF with 
dexamethasone) for several hours before implantation into the rat.   
2.3.3 Surgical Procedure and Implantation 
All use of animals was approved by the University of Pittsburgh Institutional Animal Care 
and Use Committee. Prior to surgery, rats (male Sprague−Dawley, 250−350g, Charles River, 
Raleigh, NC) were acclimated overnight to a Raturn Microdialysis Bowl (MD-1404, BASI, West 
Lafayette, IN). The next day, rats were anesthetized with isoflurane (5% v/v induction, 2.5% v/v 
maintenance) and implanted with microdialysis probes using aseptic stereotaxic surgical 
techniques. Using flat skull coordinates, each probe was slowly lowered into the striatum (1.6 mm 
anterior, 2.5 mm lateral from bregma, and 7.0 mm below the dura) at 5 μm/s using a 
micropositioner (David Kopf Instruments Model 2660, Tujunga, CA). The histology of the probe 
track in the striatum using these same coordinates has been documented numerous times by our 
group.86,122 The probe was secured with bone screws and acrylic cement and the incision was 
closed with sutures. Anesthesia was removed and the animals were returned to the Raturn system 
and given free access to food and water for the duration of the experiment. Continuous perfusion 
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was maintained for the entire duration of the experiment. During procedures involving 
dexamethasone, the probe was perfused with 10 μM dexamethasone for the first 24 hours and then 
with 2 μM dexamethasone for the remainder of the experiment. 
2.3.4 Online Microdialysis-LC-EC 
The microdialysis/liquid chromatography system was similar to the one previously 
described.76 A schematic  diagram is shown in Figure 2.7-28. Perfusate was introduced using a 
syringe pump (Harvard Apparatus, Holliston, MA), running at 0.610 μL/min. The perfusate 
syringe contained 1.0 mL of perfusate and was refilled every 24 hours, at least 3 hours prior to any 
online measurement. To facilitate the introduction of a stimulant-containing solution, we used a 6-
port nanobore injection valve (electrically actuated, Valco Instruments, Houston, TX) to introduce 
solution from a 9.5 L fused silica loop (280 μm I.D., 360 m O.D, Polymicro Technologies, 
Phoenix, AZ). The valve was configured so that the loop could be loaded with stimulant-containing 
solution while perfusate flow is maintained. To introduce the stimulating solution, the valve 
position was switched from load to inject position by computer control at predetermined times for 
durations equal to the stimulus duration. So-called timed injections suffer less spreading of the 
concentration profile at the trailing edge than injections that permit the entire loop to be pushed 
into the inlet capillary. During valve position switching, flow is interrupted for 105 milliseconds. 
The stimulus reaches the probe 9.8 minutes after switching. Therefore, any DA response due to 
switching the position of the valve would be seen approximately ten minutes prior to the response 
to the stimulus. We do not see any such response to the valve position switching itself in the data. 
The outlet of the microdialysis probe carrying dialysate was connected directly to the inlet 
of the injection valve of the LC system (8-port nanobore, electrically actuated, Valco Instruments, 
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Houston, TX) so that the dialysate is loaded into one of the two 600 nL, fused-silica sample loops 
(75 μm I.D., 360 m O.D, Polymicro Technologies, Phoenix, AZ). While one sample loop is being 
loaded, the contents of other sample loop are injected into the column, separated, then detected at 
the end of the column using amperometric electrochemical detection. The dialysate flow from the 
brain to the detector is uninterrupted, except for during injection valve switching (230 
milliseconds), thus achieving in vivo, online detection of dopamine. 
For the chromatography, 4.5 cm long, 150 m ID fused silica capillary columns were 
packed in-house at 20,000 psi with 1.7 m BEH C18 reverse-phase particles (Waters, Milford, 
MA). Mobile phase was delivered using a Shimadzu LC-30DA pump with a maximum pressure 
of 18,900 psi (130 MPa) to achieve a flow rate of 7.5 L/min during experiments. Column and 
injector were heated to 40 oC.  
Separation of dopamine was achieved using ion-pairing reversed phased liquid 
chromatography with mobile phase containing 100 mM sodium acetate, 1.75 mM SOS, 0.150 mM 
EDTA, 3% v/v acetonitrile and 2% v/v acetic acid. The mobile phase was filtered and degassed 
with three passes of vacuum filtration using 0.22 m nylon filter (Osminics, Minnetonka, MN). 
Analytes were detected at 400 mV (vs. Ag/AgCl 3M NaCl) using BASi radial-style flowcell, 3-
mm glassy carbon electrode with 25 m thick gaskets, and BASi Epsilon potentiostat (West 
Lafayette, IN).  
2.3.5 Experimental Design 
Microdialysis probes were implanted and dialysate dopamine was measured in awake, 
freely moving male Sprague-Dawley rats. Each probe was either perfused continuously for four 
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days with aCSF containing dexamethasone (via retrodialysis) or aCSF alone (control). On day 1 
and day 4 after surgery (approximately 24 h and 96 h, respectively), once per hour, each rat was 
stimulated with 10-min retrodialysis of 60 mM K+ and 100 mM K+ (twice each), and 15-min 
retrodialysis of 10 M nomifensine (at the end of the experiment, when possible). Stimulant/drug 
retrodialysis times were achieved by controlling the valve position (see Figure 2.7-28).  
Dopamine transients as well as basal level dopamine in the dialysate were measured 
continuously at one-minute time resolution for the entire duration of the experiment, 
approximately six hours. Data were processed using an automated MATLAB script. For the 
purpose of principal component analysis, the 11 contiguous peaks that deviate the most from basal 
level during the K+ stimulation window were identified as the transient by the script. All 
MATLAB-identified peaks were confirmed by a human. 
2.3.6 LC-EC and Field Potential Simultaneous Measurement 
In a second set of experiments dopamine and the field potential were measured 
simultaneously during potassium stimulations. For the field potential measurements, a tungsten 
wire (50 μm diameter, 4 mm length) was glued next to the microdialysis probe so that the wire 
was parallel to the probe membrane, with approximately 0.5mm between the wire and the 
membrane (see Figure S29). A second tungsten wire was used as a reference and placed in the 
contralateral hemisphere of the brain. Both wires were attached to a larger nickel/chromium wire 
for electrical connection and protected with a plastic covering. Measurement were made using a 
Powerlab/4sp running LabChart Pro (AD Instruments). A 0.1 Hz low pass filter was used.  
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2.4 Results and Discussion 
2.4.1 One-minute Resolution Online Measurement of Dopamine 
Separation of dialysate using the online system under conditions described in the 
experimental section result in completely resolved DA peaks, with DA retention times of 
approximately 44 s (Figure 2.4-1). Chromatograms were obtained continuously, with injections 
occurring once every minute for the entire six- to eight-hour duration of the experiment. For all 
conditions, there are no other peaks in the chromatogram near the DA peak.  The DA retention 
time when measured during an online experiment is within 3% of the retention time measured 
from aqueous DA standards, as well as DA-spiked dialysate. Dialysate DA concentrations are 
calculated from average slopes and intercepts from a pair of linear calibration curves obtained prior 
to and after each day-long experiment (Figure 2.7-1). The slopes and intercepts from the two 
calibration curves were typically within 5% of each other. Figure 2.4-2 shows a DA dialysate 
concentration obtained one day after implantation of an LDR probe. The five transients are (from 
left to right) the dialysate dopamine responses to 10-min stimulations with 60 mM K+ (twice), 100 
mM K+ (twice), and a 15-min stimulation with 10 M nomifensine. Both K+ and nomifensine 
were, like the dexamethasone, delivered through the probe.  
Previous studies with K+ stimulated 5-HT47 and DA,123 using a range of K+ concentrations 
and stimulation times (25 – 120 mM K+ for 1-10 min) found that a 50-60 min recovery interval 
between stimulations is sufficient to avoid the influence of a prior stimulation on the effect of a 
following stimulation. The range of potassium concentrations and stimulation times encompasses 
our experimental conditions. Thus, during this work, we allowed a 50-min recovery time between 
each stimulus. Each of these data sets contains three measurable quantities: basal levels, transients 
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caused by 10 min K+ stimulations, and the transient caused by the 15-min nomifensine stimulation. 
These will be assessed in that order below. 
 
Figure 2.4-1. Four chromatograms of striatal dialysate by online LC-EC from a longer sequence of injections. 
Consecutive 500 nL samples of dialysate were collected under basal conditions and analyzed online at one-
min intervals. The dopamine peaks appear 44 s after each sample is injected onto the capillary column. 
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Figure 2.4-2. DA dialysate concentration measured during an experimental run (day 1, [K+] = 60 or 100 mM, 
with an LDR probe). 
The five transients seen are dopamine responses to 10-min retrodialysis of 60 mM K+ (twice), 100 mM K+ 
(twice) and 15-min retrodialysis of 10 M nomifensine. 
2.4.2 Basal 
We define basal levels as DA levels in dialysate measured at least 10 minutes and at most 
40 minutes from a transient. Figure 2.4-3 shows the frequency distributions of the one-minute 
measurements for each of the four conditions day = 1 and 4; with LDR or control probes. Consider 
first the data for control probes. These data have a skewed distribution indicating that there are 
more observations with basal levels below the mean than above the mean. The mean basal DA 
with control probes is comparable to published results from other groups as well as by our 
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group.78,86,124 The distributions obtained with LDR probes show multiple maxima with a clearly 
separate distribution on day 4. This separate distribution is a single animal’s basal data. The basal 
levels also appear to be on average higher with LDR probes, thus we did a two-way (“day” and 
“dexamethasone”) analysis of variance on the mean basal DA with and without the aforementioned 
single animal’s high basal DA data (Full ANOVA and regression output are in Table 2.7-1-Table 
2.7-3). “Day” is not significant, but “dexamethasone” is significant (p = 0.013, n = 22) when the 
aforementioned high basal DA data are included. The pattern is similar from ANOVA without the 
aforementioned high basal DA data, but the significance is higher (p = 0.0017, n = 21). A linear 
regression using the variable “dexamethasone” with values of 0 for control and 1 for LDR probes 
leads to the simple relationship: basal dialysate [DA]/nM = 10.4 + dexamethasone*4.4 (p = 0.0013, 
n = 21) without the single animal’s high basal DA data, and [DA]/nM = 10.4 + dexamethasone*6.7 
(p = 0.0097, n = 22) with those data. We conclude that the basal dialysate DA level increases in 
the presence of dexamethasone retrodialysis. 
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Figure 2.4-3. Frequency distributions of the basal concentrations measured each minute for the four 
conditions day = 1 and 4, probe = control and LDR.  
Note there are seven animals represented in day 1 control. There are five animals contributing data for the 
other three cases. The “frequency axis” represents single, one-minute measurements. 
2.4.3 Potassium Stimulations 
As mentioned above, we anticipate oscillations in DA dialysate concentrations during a 
high K+ stimulation. It is therefore important to consider what the time resolution of the entire 
microdialysis/liquid chromatography system is. Previously,77 we determined the effect of the 
transport tubing and the microdialysis probe itself on the shape of a nominally instant change in 
5-HT concentration in vitro. Importantly, we validated the use of a calculated Taylor dispersion 
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standard deviation for the spreading induced by the inlet and outlet capillaries. The individual 
contributions in the current set up are approximately 8.2, 8.7, and 8.8 s in the inlet, probe, and 
outlet, respectively. The variances add, so the overall time resolution is eroded with a standard 
deviation of 14.8 s based on spreading of the stimulus pulse on passing through the inlet/probe and 
the DA response passing through the outlet/probe. The practical result is that a perfectly sharp 
concentration step of a stimulant would be “smoothed” slightly on its way to the probe. The 
resulting DA transient would also be smoothed slightly within the probe and on the way to the 
liquid chromatograph’s injection valve. As a result, we expect to see the results of a 10-min 
stimulation as an approximately 11-min response. We can categorize the DA responses to the 88 
K+ stimulations that we observed as follows. Dialysate DA transients in response to K+ 
stimulations can be positive or negative, they can be small (less than 100 nM) with no spiking (n 
= 37), have one spike (n = 16) or have multiple spikes (n = 35).   We can also compare the average 
of the DA transients over the entire 11 minutes from a single 100 mM K+ stimulation to the basal 
level. In doing so, we see results in accord with analogous experiments using 20-min resolution 
offline microdialysis,125,126 namely dialysate DA transients of up to 50 – 60 times basal level.  
Figure 2.4-4 shows some of the dialysate DA transients we recorded from the experimental 
runs (all of them are in Figure 2.7-2 to Figure 2.7-21). While there is variability from stimulus to 
stimulus and from rat to rat, there are qualitative trends. The 100 mM K+ stimulations on day 1, 
control or LDR probe, yielded multiple (three or more) large spikes (200 nM or more, e.g., Figure 
2.4-4e).  Using similar equipment, we recently reported high-amplitude oscillations of serotonin.77 
The same group on day 4 yields mostly transients with one or two spikes on top of a 50 – 100 nM 
base, e.g., Figure 2.4-4f but similar responses may be seen on day 1 (Figure 2.4-4a). The 60 mM 
K+ transients measured with control probes on day 1 exhibit either transients similar to those in 
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Figure 2.4-4a or small spikes, with a larger spike (but small compared to those produced by 100 
mM K+) at the leading edge (Figure 2.4-4c). On day 1, responses obtained with LDR probes are 
highly variable encompassing nearly all of the transients described above. Transients induced by 
60-mM K+ on day 4 were typically small, although probes perfused with aCSF alone produced 
decreases in DA levels (Figure 2.4-4d) while LDR probes produced negligible to slightly positive 
responses with a negative transient after the cessation of the stimulations such as in Figure 2.4-4b. 
A reduction in dialysate DA in response to a 20 – 30 mM K+ stimulation 24 h post-striatal 
implantation has previously been reported in one study.127 It must be noted that, however, the 
measurements were done after 80 minutes of high K+ perfusion. Such prolonged perfusion of high 
K+ reduces DA extraction fraction128 which will alter dialysate DA concentration.  
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Figure 2.4-4. Qualitatively distinct dialysate DA responses observed during the experiments. 
Left: day 1. Right: day 4. Top: (a-d) 60 mM K+. Bottom: (e-f) 100 mM K+. The example in blue is from an 
LDR probe. The group is selected to be representative to transient characteristics, not conditions.  K+ 
stimulations are denoted by the black bar. Note the differing vertical scales. A complete set of images of all 
transients observed can be found in the Supplementary Information, Figure 2.7-2 to Figure 2.7-21. 
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2.4.3.1 Principal Component Analysis of Dopamine Transients 
There are clear qualitative differences between responses to 60 mM K+ and 100 mM K+ 
stimulations on both day 1 and day 4. However, there is also significant variability in the responses 
to each type of stimulation. Thus, we turned to principal component analysis (PCA) to help to 
classify the observed responses. All of the scatter plots of scores are in the Supplementary 
Information. Figure 2.4-5 shows such a plot for the day 4, 60 mM K+ responses from both control 
and LDR probes. The first two principal components represent more than 95% of the variance in 
the data. Importantly, the PCA scores reveal a clear separation of the responses obtained with 
control from those of LDR probes. The solid symbols in the score plots represent the mean of each 
cluster of points. Converting those mean scores to hypothetical laboratory observations leads to 
Figure 2.4-6. The result is striking – responses with LDR probes tend to show positive amplitudes 
while responses with control probes show negative amplitudes. To confirm the PCA result, we 
also show the mean responses for each of the five animals in the two categories (ten transients in 
each). The correspondence of the average and the result from the first two principal components 
gives confidence in the observation.  The PCA analysis of the analogous day 1 data shows that 
there is a greater variety of responses. There is a cluster of very similar responses (see score plot 
in Figure 2.7-22) with the same characteristics as Figure 2.4-4c, a small dialysate DA increase 
from basal level. Others are represented by Figure 2.4-4a and f, mostly small increases from basal 
levels with one or two high amplitude spikes. This level of response has been observed extensively 
in many of the microdialysis studies noted earlier (in the introduction). The short, one-min spike, 
on the other hand, would not have been observable without one-min time resolution. 
Figure 2.7-25 is the scatter plot of scores from all transients from 100 mM K+ 
stimulations. Here, it is noteworthy that the score plot shows a clustering based on “day”, but 
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not based on “dexamethasone”. We conclude from this classification that the more extreme 
perturbation of 100 mM K+ (compared to 60 mM) elicits a response mostly based on the time 
from implantation. The transients are for the most part oscillations of high magnitude.  
 
Figure 2.4-5. Scatterplot of scores of the first two principal components of all transients from day 4, 60 mM 
K+ stimulations.  
Blue circles represent data from animals with control probes, and red squares represent animals with LDR 




Figure 2.4-6. Comparison of transients from LDR (top) and control (bottom) probes on day 4 with a 60 mM 
K+ stimulation.  
Open symbols: Synthesized dopamine transients from the first two principal components. Solid symbols: 
experimental transients from averaging the responses at each minute. 
2.4.3.2 Simultaneous Measurement of Dialysate DA and Field Potential 
In two separate animals, we implanted a microdialysis probe with an attached tungsten wire 
for field potential measurements (Figure 2.7-27). Figure 2.4-7 compares the simultaneously 
measured dialysate dopamine and field potential transients recorded on day 1 with LDR probes 
and 100 mM K+ (left) and 60 mM K+ (right) stimulations. High amplitude oscillations of dialysate 
dopamine levels during 100 mM K+ stimulations correlate to the oscillations in field potential with 
the same oscillation period of roughly 3-min, while the lack of dialysate dopamine oscillations 
during 60 mM K+ stimulations correlates to similarly insignificant change in field potential.   
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Such slow oscillations in field potential are an indication of spreading depolarization.129 
which is a pathological event. Spreading depolarization and spreading depression comprise a set 
of complex processes that can originate from many irregular brain conditions and these manifest 
in several ways.129,130 The role of microglia in spreading depression is, likewise, complicated. They 
were found to promote spreading depression in one polarization (M1 microglia), and increase the 
threshold for spreading depression in another polarization (M2a microglia).131 Their presence is 
strictly required for ischemia-induced, but not for high K+-induced, spreading depression.132  
Although the effect of glia on spreading depolarization and depression is complicated, and not 
completely understood, it is nonetheless noteworthy that we see effects of dexamethasone both on 
gliosis122 and on the response in vivo to K+ stimulations. 
With day 4 60 mM K+ experiments, we observed a small increase in dialysate DA level 
from LDR probes and a small decrease in dialysate DA level for control probes. While the small 
increase, again, is expected. The small decrease is unexpected and striking as it has been seen once 
but not reproduced.123,127 We hypothesize that the decrease in dialysate DA level is a depression 
of neural electrical activity without accompanying spreading depolarization. The condition in these 
experiments, namely the proliferation of activated microglia and ischemia, is conducive129,131,132 
to spreading depression, which can lead to reduced cerebral blood flow129 and silenced synaptic 
activity,130 possibly reducing spontaneous DA release to below basal levels. 
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Figure 2.4-7. Simultaneous measurement of dialysate DA and field potential in an awake animal. 
Left: 100 mM K+ stimulation. Right: 60 mM K+ stimulation. Measurements made on day 1 with LDR probes. 
2.4.3.3 Comparison to Observations by Fast-Scan Cyclic Voltammetry 
Fast-scan cyclic voltammetry (FSCV) in combination with carbon fiber microelectrodes is 
an alternative method for monitoring extracellular DA in the brain.  A well-known application of 
FSCV is the monitoring of DA transients evoked by electrical stimulation of DA axons in the 
medial forebrain bundle (MFB).  Previously, we monitored electrically evoked DA transients with 
carbon fiber microelectrodes placed in striatal tissues in close proximity to microdialysis probes 
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and with carbon fiber electrodes positioned in the outlet of the probe.122 While a ten-minute, 
elevated K+ stimulation would not be expected to elicit the same response as a 25 s MFB 
stimulation, there are noteworthy contrasts between the responses observed during this work with 
K+ stimulation and that done previously with electrical MFB stimulation. 
First, regardless of the time point after probe implantation (4 hr, 1 day, 5 days), electrically 
evoked DA responses were not observed by FSCV in the tissue adjacent to, or at the outlet of, 
probes perfused with aCSF without dexamethasone.  These findings are difficult to interpret in 
isolation as they might either indicate an absence of DA terminals near the probe or the presence 
of DA terminals in some abnormal condition that suppresses electrically evoked DA release. 
Histology using two well-established markers for DA terminals, tyrosine hydroxylase and the 
dopamine transporter, identified DA terminals of a near-normal appearance in the tissues adjacent 
to the probes at time points beyond 4 hrs, suggesting the presence of DA terminals, albeit in some 
abnormal condition. The present results appear to support this conclusion, as 100 mM K+ 
stimulation evokes DA responses from animals with control probes on days 1 and 4.  This result 
implies the presence of terminals near the probe capable of releasing DA upon direct K+-induced 
depolarization, even though electrically evoked DA release is suppressed in the absence of 
dexamethasone.  This supports our prior conclusion that DA terminals survive the traumatic 
consequences of probe implantation, which we have called the traumatic penetration injury (TPI). 
Second, during our work using FSCV to determine the effect of dexamethasone 
retrodialysis on dopamine measurements by microdialysis, we noticed dramatic differences 
between electrically evoked DA transients on Day 5 with control probes vs LDR probes.122 As just 
mentioned, with control probes, electrically evoked responses were not observed on day 5 either 
next to or at the outlet of probes.  However, responses were normal next to LDR probes and were 
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well-above detection limits at the probe outlet.  In the current work, there is a similar dramatic 
difference in the responses from control vs. LDR probes with 60 mM K+ stimulation on day 4, 
namely there are decreases from basal with control probes,  (Figure 2.4-4d, Figure 2.4-6) and 
increases with LDR probes (Figure 2.4-4d, Figure 2.4-6).  Again, these contrasting stimulation 
responses between control and LDR probes do not correlate with the histological appearance of 
DA terminals near the probes:  The DA terminals appear normal on day 5 after probe implantation 
both with and without local dexamethasone via retrodialysis.  However, these contrasting 
stimulation responses do correlate with the histological appearance of astrocytes and microglia on 
day 5, when glial activation is robust near control probes but nearly absent near LDR probes.  Thus, 
our measurements of both electrically evoked and K+-evoked DA transients support the conclusion 
that dexamethasone facilitates the re-establishment of normal DA activity in the tissues affected 
by the TPI during probe implantation. 
In contrast to the case for 60 mM-induced transients and as deduced from the principal 
component analysis, dialysate DA responses to stimulation with 100 mM K+ on days 1 and 4 did 
not depend on the presence of dexamethasone in the perfusion fluid.  This is likely due to this high 
concentration of K+ being able to “force” the depolarization of DA terminals, possibly due to the 
induction of spreading depolarization, regardless of the presence or absence of activated glia.  
Thus, the responses to stimulation with 100-mM K+ are unique in that they appear to be the only 
ones we have recorded to date that are unaffected by activated glia. 
2.4.3.4 Comments on the Nature of the Transients 
Altering perfusate compositions can lead to changes in measured dialysate dopamine by at 
least three mechanisms. One mechanism is reverse transport via the dopamine transporter, DAT.133 
Low Na+ perfusate, 50 mM, with choline replacement and normal K+, induces dopamine efflux 
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into the extracellular space by this mechanism.134 Using low Na+ perfusate, but replacing Na+ with 
K+ rather than choline also evokes dopamine release135 even in the presence of nomifensine to 
block the first mechanism, reverse transport.134 Thus, high K+ elicits DA release by a second 
mechanism, depolarization. Finally, changes in the perfusate composition, including high K+ 128 
can lead to changes in relative recovery/extraction fraction, e.g. by altering DA uptake rates.136-138 
It is also possible for physical changes in the tissue to alter the effective diffusion coefficient, 
altering dialysis recovery.139 We have not attempted to unravel the contributions of each of these 
mechanisms to our observations. However, we have associated high amplitude oscillations during 
100 mM K+ stimulation to spreading depolarization via simultaneous field potential 
measurements.  It is interesting to speculate that some of the features that we see at high temporal 
resolution may be related to differences in the foregoing effects of high K+/low Na+ stimulation. 
Another intriguing possibility for future investigations is whether any of the variability that we see 
under the same stimulation conditions is related to the striatum’s physiological heterogeneity.140 
2.4.4 Pharmacokinetics of Nomifensine 
The DA responses to nomifensine stimulation can be modeled using a first-order model for 
rising and falling rates fitted with different time constants. Two-way ANOVA analysis of the time 
constants (Figure 2.7-26) show that neither the day of the experiment or dexamethasone treatment 
affects the nomifensine rising and falling characteristics. The maximum amplitude, however, is 
day-dependent, being lower on day 4 after implantation compared to day 1. Nomifensine is 
introduced by retrodialysis, so a significant contribution to the dynamics is the diffusion of 
nomifensine within the tissue. The results obtained indicate that the diffusion rates are not 
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significantly different among the various conditions. The rising rate constant is found to be about 
two times higher than the falling rate.  
 
Figure 2.4-8. Fitting of nomifensine response to exponential decay model. 
Time constants (min-1) Rising = 0.52 Falling = 0.20 Avg. Amplitude = 121. 
2.5 Conclusions 
In the present study, we have shown that in vivo monitoring of dopamine at one-minute 
time resolution using online microdialysis-LC-EC reveals patterns of responses to chemical 
stimulation or local drug treament by retrodialysis with considerably more information than can 
be obtained with lower resolution measurements. We find that using LDR probes increases basal 
dialysate DA levels. A high concentration of 100 mM K+ induces spreading depolarizations in the 
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striatum with control or LDR probes. This is consistent with the presence of functional DA 
terminals near the probe in both cases. Remarkably, the 60 mM K+ transients are positive after 
four days with the LDR probe while they are negative (and of a similar magnitude) with control 
probes.  
Given that spreading depolarization is a pathological condition, we are led to wonder 
whether the practice of stimulating release of neurotransmitters with K+ concentrations on the 
order of 100 mM in order to assess the experimental set up is wise. There are certainly legitimate 
reasons to use this method, but the lowest concentration of potassium ion that elicits a response is 
most likely preferred. 
We note that the dexamethasone treatment had no significant effect on an essentially 
pathological response to 100 mM K+, while it had a significant and qualitatively obvious effect on 
exposure to a lower K+ concentration. This is interesting in that it implies that the effect of 
dexamethasone is more easily discerned with less extreme perturbations of the tissue. This is 
consistent with evidence from FSCV and immunohistochemistry experiments. We infer that 
dexamethasone-induced reduction of gliosis, in combination with the higher time resolution 
microdialysis, improves the ability to observe dopamine system function when microdialysis 
probes have been chronically implanted.  
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2.7 Supplementary Information 
Additional information as noted in text. Figure 2.7-1-Figure 2.7-21 contain all dialysate 
DA concentration plots measured during experimental runs, with Figure 2.7-1 also includes pre- 
and post-calibration measurements. Figure 2.7-22-Figure 2.7-24 show scatter plots of scores of 
relevant PCA analyses. Figure 2.7-25 is a PCA comparison of 100 mM transients, including 
averaged and synthesized average from PCA analysis, of day 1 vs day 4. Figure 2.7-26 has the plot 
and ANOVA result for nomifensine fitting. Figure 2.7-27 shows the construction of microdialysis 
and field potential probes. Figure 2.7-28 contains a schematic diagram of the experimental setup. 




Figure 2.7-1. DA concentration measured during an experimental run including pre-calibration (64, 16 and 
640 nM DA respectively) and post-calibration (640 nM DA). 
 
Figure 2.7-2. DA concentration measured during an experimental run. Rat 1, Control, day 1.  
Stimulation sequence: (10 min each) 60 - 60 - 100 -100 mM K+. 
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Figure 2.7-3. DA concentration measured during an experimental run. Rat 4, Control, day 1.  
K+ stimulation sequence: (10 min each) 60 – 100 - 60 - 100 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-4. DA concentration measured during an experimental run. Rat 6, Control, day 1.  
K+ stimulation sequence: (10 min each) 60 – 100 - 100 - 60 mM.  
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Figure 2.7-5. DA concentration measured during an experimental run. Rat 7, Control, day 1.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-6. DA concentration measured during an experimental run. Rat 9, Control, day 1.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM nomifensine stimulation: 15 min 10 M. 
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Figure 2.7-7. DA concentration measured during an experimental run. Rat 11, Control, day 1.  
K+ stimulation sequence: (10 min each) 100 - 100 - 60 - 60 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-8. DA concentration measured during an experimental run. Rat 2, Control, day 4.  
K+ stimulation sequence: (10 min each) 60 - 60 - 100 - 100 mM nomifensine stimulation: 15 min 10 M.  
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Figure 2.7-9. DA concentration measured during an experimental run. Rat 4, Control, day 4.  
K+ stimulation sequence: (10 min each) 60 – 100 - 60 - 100 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-10. DA concentration measured during an experimental run. Rat 7, Control, day 4.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM.  
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Figure 2.7-11. DA concentration measured during an experimental run. Rat 9, Control, day 4.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM. 
 
Figure 2.7-12. DA concentration measured during an experimental run. Rat 11, Control, day 4.  
K+ stimulation sequence: (10 min each) 100 - 100 - 60 - 60 mM nomifensine stimulation: 15 min 10 M.  
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Figure 2.7-13. DA concentration measured during an experimental run. Rat 3, LDR probe, day 1.  
K+ stimulation sequence: (10 min each) 60 - 60 - 100 - 100 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-14. DA concentration measured during an experimental run. Rat 5, LDR probe, day 1.  
K+ stimulation sequence: (10 min each) 60 – 100 - 60 - 100 mM nomifensine stimulation: 15 min 10 M.  
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Figure 2.7-15. DA concentration measured during an experimental run. Rat 8, LDR probe, day 1.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-16. DA concentration measured during an experimental run. Rat 12, LDR probe, day 1.  

























































Figure 2.7-17. DA concentration measured during an experimental run. Rat 3, LDR probe, day 4.  
K+ stimulation sequence: (10 min each) 60 - 60 - 100 - 100 mM nomifensine stimulation: 15 min 10 M. 
 
Figure 2.7-18. DA concentration measured during an experimental run. Rat 5, LDR probe, day 4.  



























Figure 2.7-19. DA concentration measured during an experimental run. Rat 8, LDR probe, day 4.  
K+ stimulation sequence: (10 min each) 60 - 100 - 100 - 60 mM. 
 
Figure 2.7-20. DA concentration measured during an experimental run. Rat 10, LDR probe, day 4.  
K+ stimulation sequence: (10 min each) 60 - 60 - 100 - 100 mM nomifensine stimulation: 15 min 10 M.  
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Figure 2.7-21. DA concentration measured during an experimental run. Rat 12, LDR probe, day 4.  




Figure 2.7-22. PCA scatter plot of scores of all transients from day 1 60 mM K+.  




Figure 2.7-23. PCA scatter plot of scores of all transients from day 1 100 mM K+.  




Figure 2.7-24. PCA scatter plot of scores of all transients from day 4 100 mM K+. 
 Blue circles represent controls, and red squares represent LDR probe. 
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Figure 2.7-25. PCA comparison of transients 100 mM K+, both days, both probes. 
Left side: Red circle: day 4, 100 mM K+, control probe. Red triangle: day 4, 100 mM K+, LDR  probe. Blue 
circle: day 1, 100 mM K+, control probe. Blue triangle: day 1, 100 mM K+, control probe. Right side: Blue: 
day 1 Red: day 4. Dashed line: Synthesized dopamine transients from the first two principal components. 
Solid line: averaged transients. 
 52 
 
Figure 2.7-26. Average nomifensine maximum amplitude, raising and falling constant (AVG ± SEM).  
Unfilled: control probe, filled: LDR probe. In each of the three panels the day 1 data have n = 6 (control) and 
n = 4 (LDR probe) and the day 4 data have n = 3 for each bar. Amplitude, rising time constant, and falling 
time constant values were analyzed with individual 2-way ANOVA’s with day (1 and 4) and probe (control 
and LDR) as the factors. For both the rising and falling time constants neither probe, day, nor the 
interactions were significant (p > 0.05). For the overall amplitude day was a significant factor (F (1,12) = 
5.376; p < 0.05) while probe and the interaction were not significant.  
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Figure 2.7-27. A tungsten wire was glued next to the microdialysis probe.  




Figure 2.7-28. Schematic for the flow paths of the online microdialysis system.  
Perfusate/microdialysate flow path is shown in blue, bold.  The flow path starts from the perfusate reservoir, 
a 1.0-mL syringe, through switching valve A, then through the 75 m I.D. capillary into the microdialysis 
probe, through injection valve B, and finally to waste. The perfusate reservoir/syringe can last for 27 hours at 
610 nL/min flow rate. The high speed HPLC valves A and B have switching times of 105 ms and 230 ms, 
respectively. The valves are computer-controlled. Valve B switches once per minute. Valve A’s switch times 
are synchronized with valve B’s so that when A is switched, A and B switch simultaneously. 
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Table 2.7-1. ANOVA analysis of basal dopamine concentration with day and drug considered as factors. 
Outlier set excluded. 
Source Partial SS df MS F Prob > F Number of obs  = 21 
Model 101.43638         2 50.718192       6.80   0.0063 Root MSE = 2.73137     
Day .35640134           1 .35640134       0.05 0.8294 R-squared = 0.4303 
Drug 
(dex) 101.33559           1 101.33559     
13.58   0.0017 
Adj R-squared =  0.3670 
Residual 134.28685         18 7.4603806      
Total 235.72324          20 11.786162      
 
Table 2.7-2. Regression of basal dopamine concentration with drug considered as factor. 
Source SS df MS Number of obs  = 22  
Model 245.6836 1 245.6836 F(1, 20) =  8.17  
Residual 601.6788 20 30.08394 Prob > F = 0.0097  
Total 847.3624 21 40.35059 R-squared = 0.2899  
    
Adj R-squared = 0.2544 
    Root MSE = 5.4849  
mean Coef. Std. Err. t P>|t| [95% Conf. Interval] 
Drug (dex) 6.711333 2.348486 2.86 0.010 1.812476 11.61019 
_cons 10.40667 1.583349 6.57    0.000 7.103858 13.70948 
 
Table 2.7-3. Regression of basal dopamine concentration with drug considered as factor. Outlier set excluded. 
Source SS df MS Number of obs  = 21  
Model 101.079984          1 101.079984    F(1, 19) =  14.26  
Residual 134.643252         19 7.08648694    Prob > F = 0.0013  
Total 235.723235         20 11.7861618    R-squared = 0.4288  
    
Adj R-squared = 0.3987 
    Root MSE = 2.662  
mean Coef. Std. Err. t P>|t| [95% Conf. Interval] 
drug 4.433333    1.173852      3.78    0.001 1.976433     6.890233 
_cons 10.40667    .7684664     13.54    0.000 0.798248     12.01509 
 
 56 
3.0 A Rotating Operant Chamber for Use with Microdialysis 
The following chapter is reprinted (adapted) with permission from Degreef, B.; Ngo, K. 
T.; Jaquins-Gerstl, A.; Weber, S. G. J Neurosci Methods 2019, 326, 108387. Copyright© 2020 
Elsevier. 
3.1 Chapter Summary 
3.1.1 Background 
Recently, the time resolution of microdialysis followed by a chemical separation for 
quantitative analysis has improved. The advent of faster microdialysis measurements promises to 
aid in behavioral research on awake animals. However, microdialysis with awake animals 
generally employs a fluidic commutator (swivel). The swivel's volume is inimical to the time 
resolution of the measurements. 
3.1.2 New Method 
Animals can be housed in rotating cages so that the swivel is not required, but rotating 
operant chambers are not available. Here we describe the design and construction of a rotating 
operant chamber with microdialysis capability. We modified a rotating cage by adding operant 
behavior testing components to the side of the bowl-shaped cage. A modular on-board controller 
facilitates operant component/computer communication. A battery provides power to the 
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controller and the operant components. The battery and controller rotate with the cage, and the 
controller communicates with the computer wirelessly. 
3.1.3 Results 
The rotating operant chamber can be used to train a rat to retrieve a sucrose pellet following 
a cue. Microdialysis and online liquid chromatography can be used to measure dopamine at one-
minute intervals while the rat moves freely and interacts with operant behavior testing components. 
3.1.4 Comparison with Existing Method(s) 
We are not aware of one-minute dopamine measurements in awake animals in an operant 
chamber. 
3.1.5 Conclusions 
Rotating cage modifications are straightforward. One-minute observations of striatal 





Microdialysis, since its inception30 in the 1980s, has become a standard sampling method 
for animal-based biological, pharmacological, and neurochemical research. An animal with a 
microdialysis probe placed in the brain can be awake and move freely while perfusate is 
continuously pumped and dialysate collected or analyzed on-line, enabling neurochemical 
determinations during behavior141. Microdialysis is also valued for its ability to sample a broad 
array of small molecules. The recent literature shows that many different types of behavior have 
been examined while sampling the brain’s extracellular space with microdialysis: fear 
conditioning142-144, wakefulness activity145, and operant conditioning146-148. On the other hand, the 
microdialysis sampling times were relatively long - ranging from 5-30 minutes.  
Recently we and others have developed the technology to improve the time-per-
measurement in online measurements of microdialysate based on high-performance liquid 
chromatography (LC) on awake, behaving animals. We have demonstrated one-minute continuous 
measurements of striatal dopamine97 for many hours and, separately, serotonin77,78 by 
microdialysis/LC. The Andrews group made extensive two-minute striatal serotonin 
observations47. The Boutelle group has measured energy-related analytes by microdialysis with 
online continuous monitoring using sensors at 30 s per data point149. On anesthetized animals, the 
Bowser group has developed a variety of microdialysis-electrophoresis assays capable of 
simultaneous detection of as many as 16 amino acids at 12.5 – 60 s per measurement150-152. Fraction 
collection and offline analysis of segmented microdialysis flow demonstrated measurements taken 
every several seconds81,153,154. The time scale of microdialysis will never reach that of 
electrophysiology or fast-scan cyclic voltammetry, however improving the time-scale of 
microdialysis will make measurements related to behavior more meaningful.  
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It is important to understand that the overall time resolution of a microdialysis 
measurement depends on many factors, only one of which is the rate at which measurements are 
made. The other main contributor is the spreading of solute zones in the fluidic components of the 
microdialysis system: connecting tubing, the probe itself, and a swivel (if one is used). The 
spreading, or dispersion, of solutes in the fluid stream of dialysate degrades time resolution. These 
limitations define the ability of microdialysis to detect meaningful transients such as the time-
dependent response to the leading edge of a retrodialyzed plug of solution containing, e.g., a 
neurotransmitter61,155. The use of long connecting tubing and/or tubing with a large inner diameter, 
probes with large void volumes, and swivels all act to degrade time resolution or the system’s 
response time. Tubing dimensions can be optimized to provide the minimum dispersion given a 
particular dialysate flow rate and acceptable pressure156, but the use of a swivel will still cause 
significant dispersion making one-minute time resolution for the overall microdialysis system 
impossible.  
The foregoing observations present a challenge to those interested in the use of 
microdialysis in behavioral studies. The use of a swivel allows researchers to do experiments in 
operant chambers, but it also results in a time resolution that is insufficient to capture rapid 
changes. Using a rotating bowl cage permits the elimination of the swivel, but as far as we are 
aware, rotating operant chambers do not exist. Here, we describe a system for doing microdialysis 
in a rotating operant chamber (MD-ROOC) that facilitates rapid microdialysis sampling while 




3.3.1 Microdialysis Probes 
Chemicals for artificial cerebrospinal fluid (aCSF: 142 mM NaCl, 1.2 mM CaCl2, 2.7 mM 
KCl, 1.0 mM MgCl2, and 2.0 mM NaH2PO4, pH 7.4) were purchased from either Fisher Scientific 
(Fair Lawn, NJ) or Sigma (St. Louis, MO). Concentric microdialysis probes (200 m I.D, 280 m 
O.D, 4 mm length) were constructed with hollow fiber membranes (13 kDa MWCO, part # 132294, 
Specta/Por RC, Spectrum Laboratories Inc., Ranco Dominguez, CA). The inlet tubing was 
connected to a 1.0 mL gastight syringe (Hamilton 81320, Hamilton Company, Reno, NV) using 
PEEK reducer and adapter (part # P-659, F-120, P-720, IDEX Corporation, Lake Forest, IL). The 
syringe was driven by a microliter syringe pump (PHD 4400, Harvard Apparatus, Holliston, MA) 
at a rate of 0.60 μL/min. The inlet and outlet tubing were fused silica capillaries (75 μM I.D., 150 
μM O.D., 100 cm long; Polymicro Technologies, Phoenix, AZ). The aCSF used in these 
experiments contained the sodium salt of dexamethasone phosphate (APP Pharmaceuticals, 
Schaumburg, IL) to minimize tissue damage and mitigate immune response following probe 
implantation86,87. This formulation of aCSF will be referred to as “DEX”. For the first 24 h in use, 
the aCSF contained 10 μM of dexamethasone phosphate. Thereafter it contained 2 μM of 
dexamethasone phosphate. Perfusion of the probe was maintained continuously for the entire 
duration of the experiment.  
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3.3.2 Rotating Operant Chamber 
The operant behavior testing (OBT) components were obtained from Med Associates, Inc. 
(Fairfax, VT): nose poke (ENV-114AM), cue light (ENV-221M), tone generator (ENV-223AM), 
pellet dispenser (ENV-203) and pellet receptacle (ENV-200R2M). Lithium-Ion batteries (12 V, 
10 Ah Model: CR12V10Ah with BMS protection circuit) were purchased from Dakota Lithium 
Battery (Seattle, WA). An MD-ROOC uses one battery at a time. A bidirectional digital I/O 
interface (NI 9401), wireless data acquisition unit (cDAQ 9191) and interface software (LabVIEW 
2016) originated from National Instruments (Austin, TX). The wireless-LAN router (E1200 N300 
Wi-Fi Router) was from Linksys (Irvine, CA). The battery delivers the power for all OBT and 
National Instruments components. A locally constructed digital interface contains an in-house built 
printed circuit board that accepts digital inputs to control MedAssociates components as well as 
receiving signals from the nose poke. Figure 3.7-1-Figure 3.7-3.  
Ordinarily, OBT components use 28 V for both power and control signals. However, they 
can be configured, or modified, to use 12 V signals instead. Table 3.3-1 lists the modifications 
necessary to allow the OBT components to be operated at 12 V. 
Table 3.3-1. Modifications to Med-Associates devices to allow use of 12 VDC battery. 
Name Modification 
Food hopper U1 and U2 jumpered 
U9 voltage regulator replaced with a 12 VDC to 5 VDC regulator SPR01M-05 
Nose poke U3 jumpered 
Cue light Light bulb replaced with a 12 VDC LED, Dialight 586-2406-220F 
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3.3.3 Microdialysis Probe Implantation Procedure 
All procedures involving animals were approved by the Institutional Animal Care and Use 
of Committee of the University of Pittsburgh. Male Sprague-Dawley rats (250-350 g, Hilltop, 
Scottsdale, PA) were anesthetized with isoflurane (5% v/v induction, 2.5% v/v maintenance, 
Henry Schein Animal Health, Elizabethtown, PA), and 2:1 N2O:O2 (Matheson Tri-Gas, Bernards, 
NJ). Rats were wrapped in a heating blanket (37°C) and placed in a stereotaxic frame. The incisor 
bar was adjusted so the dorsal-ventral measurements at lambda and bregma were no more than 
0.01 mm apart (flat skull). A small craniotomy (3x5 mm) was made over the dorsal striatum. 
Microdialysis probes, continuously perfused, were lowered slowly into the dorsal striatum (1.6 
mm anterior and 2.5 mm lateral from bregma) or the ventral striatum (1.6 mm anterior and 1.4 mm 
lateral from bregma) over the course of approximately 30 min to final position of 7 mm or 8mm 
(respectively) below dura (Figure 3.3-1A). Probes were secured with bone screws and acrylic 
cement. Anesthesia was removed and animals were placed in a BASi Raturn chamber (MD-1404, 
Bioanalytical Systems Inc., West Lafayette, IN) for housing.  
As the goal of these animal studies was to demonstrate the MD-ROOC’s capabilities, we 
used three animals with the probe in the dorsal striatum and one animal with the probe in the 
ventral striatum. Data from one of each are shown.  
3.3.4 Online Microdialysis-LC-EC 
The microdialysis/liquid chromatography system was similar to one we previously 
described97. Perfusate was introduced using a syringe pump (Harvard Apparatus PHD 4400). The 
syringe contained 1.0 mL of perfusate and was refilled every 24 hrs at least three hours prior to 
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any online measurement. The outlet of the microdialysis probe, carrying dialysate, was connected 
directly to the inlet of the injection valve of the LC system (8-port nanobore, electrically actuated, 
C72NX-4678D, Valco Instruments, Houston, TX) so that the dialysate is loaded into one of two 
600 nL, fused-silica sample loops (75 μm I.D., 360 μm O.D, Polymicro Technologies, Phoenix, 
AZ). While one sample loop is being loaded, the contents of the other sample loop is injected onto 
the column, separated, and then detected at the end of the column using amperometric 
electrochemical detection.  
As for chromatography, 4.5 cm long, 150 μm ID fused silica capillary columns were 
packed in-house with 1.7 μm BEH C18 reversed-phase particles (Waters, Milford, MA) at 
approximately 1400 bar. Mobile phase was delivered using a Shimadzu LC-30DA pump with a 
maximum pressure of 1300 bar to achieve a flow rate of 7.5 μL/min during experiments. The 
column was heated to 40°C with a thermostatted column heater. Separation of dopamine was 
achieved with a mobile phase containing 100 mM sodium acetate, 1.75 mM SOS, 0.150 mM 
EDTA, 3.0 % v/v acetonitrile, and 2.0 % v/v acetic acid. The mobile phase was filtered and 
degassed with three passes of vacuum filtration using a 0.22 μm nylon filter (Osminics, 
Minnetonka, MN). Analytes were detected at 400 mV (vs Ag/AgCl 3 M NaCl) using a radial-style 
flowcell, 3 mm glassy carbon electrode with a 25 μm thick gasket and amperometry potentiostat 
(flowcell: MF-1091, MW-5051; potentiostat: EC Epsilon, Bioanalytical Systems Inc., West 
Lafayette, IN). Dopamine peaks from chromatograms were integrated using MATLAB and 
compared against pre- and post-run calibration curves to calculate dopamine concentration97. The 
sensitivity of the assay for DA was 0.10 ± 0.02 nA·s/nM and the limit of quantitation was 1.0 nM.  
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3.3.5 Animal Training and Observations 
3.3.5.1 Naïve Animal 
One animal was observed in an unmodified Raturn without training, from now on called a 
naive rat. This animal was placed on food restriction for 1 week (roughly 12g of Purina home chow 
per rat per day). A microdialysis probe was implanted into the ventral striatum using the surgical 
procedures described above. He was allowed to recover for 24 hours in his home cage, an 
unmodified Raturn chamber. On the day of the observation, his Raturn chamber was moved to the 
online microdialysis-LC-EC setup. After a three hour period for perfusate flowrate stabilization97, 
dialysate DA chromatograms were recorded at one-minute intervals continuously for three hours 
while the animal’s movements were recorded on video. Basal DA was established during the first 
hour. At the one-hour mark, we placed into the bowl roughly 16g of food (Purina home chow). 
The rat had free access to this food until the end of the three-hour observation.  A schematic 
representation of naive rat observations is shown in Figure 3.3-1B. 
3.3.5.2 Trained Animals 
Prior to microdialysis probe implantation, two rats were placed on a food restriction 
regimen (roughly 12g of Purina home chow per rat per day) to maintain them at approximately 
85% of their free-feeding bodyweight throughout training and testing. Reduced food intake 
ensured motivation during conditioning. Behavioral training sessions over 14 contiguous days 
lasted one hour and took place between 10:00 am and 5:00 pm in the rotating operant chamber. 
The goal was for the animals to learn to use the nose poke in order to receive a reward. During 
behavioral sessions, a cue light, mounted on the wall of the rotating operant chamber next to the 
nose poke, was turned on when the nose poke became active. If the rat triggered the nose poke 
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while it was active, a tone was generated for two seconds, at which time the pellet dispenser 
delivered a sucrose pellet (chocolate sucrose pellets, 45 mg-TestDiet, St.Louis, MO)  to the food 
receptacle as a reward. Then, the cue light was turned off and the nose poke was deactivated for 
10 s (Figure 3.3-2). The cue light is a 120 mW, 12 V LED white light. The tone generator emitted 
sound at 2900 Hz and 65 dB. 
After 14 days of training, microdialysis probes were implanted into the dorsal striatum and 
observations began 24 hours later. Initially, microdialysis-LC-EC was used to record basal 
dialysate DA concentration for two hours while the rat was in his home cage. Next, the rat was 
placed into the rotating operant chamber for one hour during which time the animal’s behavior 
was recorded (video) while one-minute DA chromatograms were obtained. Rats were then placed 
back into their home cage for another hour while the DA measurements continued (Figure 3.3-1C). 
For both training and observation, no limit was placed on the number of rewards that could be 
earned. Rats were tethered during testing but were not during training. 
3.3.6 Video Recording 
Photo/video capturing of the animals and subsequent handling of the data are approved by 
the Institutional Animal Care and Use of Committee of the University of Pittsburgh. 
We used a security video system (4 Channel Security System, SWDVK-445954, Swann 
Communications U.S.A. Inc., Santa Fe Springs, CA) to capture the behavioral experiments. There 
are two cameras which were set up orthogonally, top down from the top of the bowl and side view, 
to attempt to capture rat activity with minimal blind spots. The cameras are equipped with IR LEDs 
to enable video recording in a dark environment.  
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The cameras run on their own digital video recorder (DVR) system. The videos are time 
stamped and the DVR’s internal clock is checked daily before each experiment to ensure that the 
video’s time stamp and experimental data can be properly coordinated. Correlating microdialysis 
measurements with video data requires correcting for the time delay required for flow to take the 
sample to the loop injector. The time delay is 10.0 min for the naive observation and 12 min for 
the trained observation. 
 
Figure 3.3-1. Schematic representation of (A) microdialysis probe placements for rats in the dorsal striatum 
(gray) the ventral striatum (black). Numbers represent distance (mm) of coronal section from bregma. (B) 




Figure 3.3-2. Instrument training control logic demonstrating instrument responses to animal’s behavior.  
Here the animal is being trained to poke nose once every 12 s to retrieve a sucrose pellet. 
3.4 Results and Discussion 
3.4.1 Construction of the MD-ROOC 
3.4.1.1 Cage Modifications 
The system is based on the stand-alone Raturn System from BASi (MD-1404, 
Bioanalytical Systems Inc., West Lafayette, IN). See Figure 3.7-6 or a side-by-side comparison 
between our MD-ROOC and an unmodified Raturn. Figure 3.4-1 shows the modifications to the 
Raturn system. We did not modify the Raturn’s harness/controller or motor. We first determined 
experimentally that an unmodified Raturn can function normally without any observable slippage 
or slowdown with up to 18 kg of weight on the platform that supports the bowl. Thus, we set an 
upper limit for the total weight of the required components at 18 kg. To preserve motor drive life 
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and minimize chances for unexpected weight impact to the MD-ROOC’s performance we strove 
to add as little weight as possible to the Raturn. 
All inessential metal housing and original mounting hardware was removed from each 
operant component to save on weight as well as to make it easier to mount them on the curved 
surface of the bowl. The OBT components (Figure 3.4-1B) were added to or inserted into the side 
wall of the rat bowl 15 cm above the cage floor. The components were positioned appropriately 
for trained feeding observations (Figure 3.4-2). All wires connected to the OBT components were 
routed along the outside of the bowl and then through small openings in the base support which 
holds the on-board controller modules (Figure 3.4-1C). Details regarding the on-board controller 
modules are in a separate section below. 
To accommodate the on-board controller modules, the entire Raturn platform was raised 
18 cm. We made a circular cradle (Figure 3.4-1A.4) from polyacrylate plastic and aluminum just 
large enough to hold the desired devices. The cradle was suspended from an upper ring which rests 
on the inner edge of the rotating mechanism underneath the bottom of the bowl. This allowed the 
electronic components to rotate together with the bowl while minimizing the moment of inertia. 
The collective weight of the OBT components is an estimated 1 kg, not including food pellets. A 
counterweight of 2 kg added to the bowl opposite to the food hopper maintains balance (Figure 
3.4-1A.1). The total weight of the additions, including the cradle and on-board controller, is 
approximately 6 kg. We observed during all training sessions and experiments that the Raturn 
retains its ability to spin, stop, and change spin direction without slippage.   
The presence of the food hopper/chute outside the bowl required moving the support for 
the motion sensor/harness laterally. The motion sensor/harness arm is attached to a new support 
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(Figure 3.4-1A.2, see Figure 3.7-4 for detailed blueprint) with the same mounting points and 
mounting screws as used with the original support. 
 
Figure 3.4-1. Photographs of the ROOC.  
A. Exterior modifications: Counterweight (1), motion sensor/harness support structure (2), pellet dispenser 
(3), cradle (4). B. OBT components: Cue light (5), tone generator (6), nose poke (7), pellet receptacle (8). C. 
On-board controller: Wireless interface (9), battery (10), digital interface (11). 
 
Figure 3.4-2. Pictures depicting an operant conditioning training sequence. 
 Once a nose poke is registered, the cue light red circles) is deactivated. 
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3.4.1.2 On-board Controller 
The OBT components were powered and controlled by an on-board controller. The on-
board controller was made to be small and light and use the minimum possible power so that it can 
be attached to and spin with the Raturn without interruption for many hours. It uses Wi-Fi to 
communicate with a router attached to a computer running a LabVIEW script that can be tailored 
easily to experimental needs. Specifically, the on-board controller has three modules (Figure 
3.4-3): Module 1 (Figure 3.4-1C.10) is a 12 V, 10 Ah lithium ion rechargeable battery, module 2 
(Figure 3.4-1C.11) is a digital interface, a printed circuit board that controls the operant 
components based on instructions from the computer and also sends signals from the operant 
component back to the computer and module 3 (Figure 3.4-1C.9) is a wireless interface that 
communicates with the computer. Module 2 was designed and built in-house (see Figure 3.7-1-
Figure 3.7-3 for circuit diagrams) for instrument control functionality and to regulate the voltage 
and current from the battery to appropriate specifications with a secondary purpose of limiting 
current use as much as possible.  
Module 2, the digital interface, plays the central role in controlling and powering the OBT 
components and sending/receiving TTL signals from the wireless interface (Figure 3.4-3). The 
wireless interface handles all communications with the computer. For example, the nose poke 
powered by the 12 V battery via the digital interface. When a nose poke is registered, it sends an 
inverted 12 V signal back to the digital interface, which then generates a 5V TTL signal which is 
sent to the wireless interface and ultimately is acquired by the computer. The digital interface also 
uses the 12 V battery to create power at 5 V for the wireless interface. 
The modules are connected to operant conditioning components via ¼” TRS plugs with 
female terminals located in the cradle. The battery is also connected to the digital controller 
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(module 2) using ¼” TRS connections.  This style of connection was chosen for ease of connection 
and disconnection, so that that the battery can be swapped out with a second, fully charged one in 
a matter of seconds. We aimed for a minimum MD-ROOC usage time of 24 hrs when we selected 
the 10 Ah battery. Higher capacity lithium-Ion or lead-acid batteries are available, however the 
cost in weight and space outweighs the benefit of increased use time. Experimentally, we found 
that the entire setup can be battery-powered continuously for approximately 37 hours when the 
cue light is on continuously, tone generator is activated for 2 seconds every minute, and the food 
hopper is activated once per minute, simulating a 60 s trained feeding schedule. 
The wireless router is connected to the computer via an Ethernet cable. While it is possible 
to set up direct wireless communication between the computer and the wireless DAQ, or between 
computer and wireless router, we found that wired connection between computer and wireless 
router, then wireless router to wireless DAQ provided the most consistent connection. We 
observed no dropped connections during animal experiments with this arrangement. In contrast, 
the “all-wireless” arrangement was prone to dropping connections. It should be noted that the 
environment around the MD-ROOC has several analytical instruments and components for online 





Figure 3.4-3. Schematic overviewing OBT Components controlling scheme.  
The computer and wireless router is stationay and is powered by ordinary power sources. OBT components 
and the controller is mobile and is entirely battery powered. 
3.4.2 Observations on Animals 
3.4.2.1 Naive Animal 
We carried out measurements and observations on a naive animal in order to assure 
ourselves that the recording and microdialysis systems were functioning as expected. It turns out 
that the observations are interesting, so we present them here. Dialysate DA concentrations were 
determined with online microdialysis-LC-EC at one minute per measurement from an awake, 
freely moving rat in a Raturn. During the session, the rat was also video recorded, and the recording 
was analyzed frame-by-frame to categorize the animal’s locomotive status to six classes: sleep, 
awake but not moving, grooming, small twitch during sleep, limb movement during sleep, and 
eating. The time stamp on the video and transport time of the dialysate from the dialysis probe to 
the LC were used to correlate DA measurements with the animal’s locomotive status. Shown 
below (Figure 3.4-4) are DA concentrations in dialysate from the ventral striatum during the three-
hour naive feeding observation, where 0 minutes marks when we placed food into the bowl.  
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We measured a statistically significant difference between DA concentrations when the rat 
was actively feeding versus when it was sleeping after feeding (25.2 ± 1.0 nM, time from 1 to 14 
min vs 12.0 ± 0.3 nM, time from 15 to 120 min). We also recorded spontaneous DA release when 
the rat was sleeping and making no observable movements at -55 min, as well as when the rat was 
sleeping and there was clear limb movement at -25 min.  
 
Figure 3.4-4. Dialysate DA concentrations (nM) in the ventral striatum during observations of a naive rat 
presented with food in a Raturn. 
 The size of behavior data points represents relative amplitude of locomotor activity. Overlapping data points 
are plotted on separate y-axis positions to improve visibility. Food was presented at time zero. Trained 
animals. 
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3.4.2.2 Trained Animal 
We assessed the utility of the MD-ROOC with trained animals. During these observations, 
dorsal striatal DA was monitored with online microdialysis-LC-EC at one minute per measurement 
and the rat’s movement was video recorded while the rat was in the home cage, moved to the MD-
ROOC (see Supplementary Information Video MD-ROOC Bowl Change98,157), then moved back 
to the home cage, as described above. The rat was able to move freely and use the OBT components 
without tangling microdialysis probe tubing (see Supplementary Information Video MD-ROOC 
Operation98,158_ENREF_158), Figure 3.4-4 shows DA concentration as a function of time before, 
during (marked with a black line) and after feeding sessions. In this particular observation, two 
hours of DA concentrations were acquired prior to feeding; this is indicated from time -120 
minutes to 0. We observed a large DA release lasting 11 minutes at half height centered at -31 
minutes. Video recording showed that the rat was sleeping and was still during this time. Note that 
two spontaneous releases also occurred in the naive rat when the rat was sleeping at -50 and -25 
minutes. DA transients occurred throughout the feeding and resting phases of the experiment.  
From the data collected from the nose poke and frame-by-frame analysis of the video 
recording, we were also able to analyze the food retrieval behavior of the rat (Figure 3.4-5-Figure 
3.4-7). During the time in the MD-ROOC, feeding phase, the rat continuously used the nose poke 
to obtain sucrose pellets until it was sated and came to rest. Peak food acquisition was during the 
first 15 minutes. Also present during this time was a DA transient. After 15 minutes, food 
acquisition rate decreased with a small spike at 35 minutes and the rat remained inactive for the 




Figure 3.4-5. DA concentrations (nM) in the dorsal striatum and number of pellets eaten during a trained 
feeding session.  
Rat was moved from Raturn to ROOC at time zero, and was moved back to Raturn at 60 min.  
3.4.2.3 High Frequency DA Fluctuations Glimpsed from High Time Resolution DA 
Measurements 
We used short-time Fourier transformation (STFT) 96 to perform a spectral analysis of the 
DA concentration data shown in Figure 3.4-4 and Figure 3.4-5. The resulting spectra are shown in 
Figure 3.7-4 and Figure 3.4-6, , respectively. The STFT spectral analysis allows us to compute the 
relative power in each frequency bin plus the time dependence of the power in each frequency bin. 
A discrete Fourier transform (DFT) of an 11-minute wide section was computed and assigned to 
the central time point in the window. Frequency components are organized into bins, or frequency 
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range, according to DFT formulation 159, which are then assigned to the lowest frequency in the 
bin. The 0.091 min-1 bin or 1/11 min-1, for example, represents frequencies from 1/11 min-1 to 2/11 
min-1. And for our experiment, a signal in in this frequency bin measures a DA concentration 
change that occurs over a time interval of 5.5 to 11 minutes. We used Nuttall’s minimum 4-term 
Blackman-Harris filter 160 (“Nuttall’s window”) to reduce artificial oscillations in the spectra while 
still keeping good frequency resolution (see Supplementary Information Appendix D for 
MATLAB code). The window was moved by one minute, and the process was repeated to build 
up a picture of the relative power 161 of each frequency component at each minute. In our case, this 
relative “power” is actually a ratio of dialysate concentrations raised to the second power. Thus, 
the “power” spectral density (PSD) is plotted on a decibel scale relative to 1 nM2. Except near the 
beginning and end of the time series, individual time data points contribute to 11 spectra. The y-
axis shows a range of 0.091 to 0.45 min-1, as this is the limit of frequencies that the Fourier 
transformation can resolve with a data length of 11 data points at one-minute time resolution.  
The spectrograms share some features with the DA concentration time series. Most 
notably, there are peaks (e.g. time at -32, 73 and 100 min) in the spectrogram (Figure 3.4-6) at the 
same position as transients in the DA concentration time series (Figure 3.4-5). This is because the 
rising and falling portions of the transients represent high frequency information. However, 
spectral analysis also reveals a correlation with feeding behavior that is not apparent in the 
correlation of DA concentrations with feeding behavior. Table 3.4-1 shows Pearson correlation 
coefficients, r, between the rat’s feeding activity (quantitated as the 11-min moving average of the 
number of pellets eaten per minute) and PSD in each frequency bins as well as the 11-min moving 
average of dialysate DA concentration. It is apparent that the rat’s feeding activity does not 
correlate to dialysate DA concentration, but it does correlate to dialysate DA variation specifically 
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at the 0.45 min-1 frequency bin (Figure 3.4-7), which coincidentally is the highest frequency bin 
that our system can measure. This implies that there is measurable neurochemical information in 
the frequency domain based on a 1-min microdialysis sampling rate. 
 
Figure 3.4-6. Spectrogram using short-time Fourier transform (Nuttall’s window width of 11 minutes).  
Each narrow rectangular “point” is the PSD from the time corresponding to the point and the five point to its 
right and left (except at the time limits). The result shows the PSD at each frequency during the trained 
feeding experiment. The reference “power” is 1nM2. 
 78 
 
Figure 3.4-7. Correlation between feeding activity and high frequency DA variation.  
In blue is PSD at 0.45 min-1 and in red is 11 point moving mean of number of pellets eaten. The two time 
series have a Pearson correlation coefficient, r, of 0.31, during time 1 to 46 minutes that the animal was 
actively feeding. 
Table 3.4-1. Correlation of feeding activity with DA concentration and power spectral densities. 
Signal r 
11-point average [DA] 0.061 
PSD < 0.091 min-1 0.095 
PSD 0.091 min-1 0.084 
PSD 0.18 min-1 0.043 
PSD 0.27 min-1 0.057 
PSD 0.36 min-1 0.040 




We have demonstrated that a rotating cage suitable for fast microdialysis measurements 
can be modified easily to make a simple operant chamber. Trained rats readily use the nose poke 
to obtain food in line with their training. The fast dialysis measurements reveal transient changes 
in dialysate DA that can be correlated with behavior. Like the online microdialysis-LC-EC system, 
the MD-ROOC is built from commercially available parts with a flexible design that can be 
expanded to operant chamber components not included in this work. While we tested no biological 
hypotheses here, we have shown that one-minute DA measurements can be made simultaneously 
with either a naive rat or a trained rat using its training to acquire food according to a learned task. 
We found that there is behavioral information encoded in the 1-min time resolution DA 
measurements that is not available from traditional 10 min microdialysis.  
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3.7 Supplementary Information 
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3.7.1 Electronic Circuit and LabVIEW VI Diagram 
 




Figure 3.7-2. Electrical diagram of the power supply and digital controller. 
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Figure 3.7-3. Front and back panel of the LabVIEW VI that controls the raturn. 
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3.7.2 Raturn Component Blueprint 
 
Figure 3.7-4. Raturn replacement support arm blueprint. 
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3.7.3 Additional Figures 
 
Figure 3.7-5. Spectrogram using short-time Fourier transform (Nuttall’s window length of 11, with 10 
overlapping data point) showing spectral power density of each frequency during the naive feeding 
experiment.  
The power amplitude is in decibel, with reference power is 1 nM2. 
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Figure 3.7-6. A side-by-side comparison between a modified Raturn (left) and an unmodified Raturn (right). 
3.7.4 MATLAB Code 
load('spectrogram_data.mat'); %load data, contains vector X for DA 
concentration 
                              %and t for time 
window_width = 11; %set window width 
num_overlap = 10; %number of data point overlapped 
sample_rate = 1/60; %1 min sampling, which is 1/60 Hz  
tX = min(t)+(window_width-1)/2:1:max(t)-(window_width-1)/2; %truncate time 
axis 
%calculate spetrogram using Nuttall-defined minimum 4-term Blackman-Harris 
window  
[s,f,t,p,fc,tc] = spectrogram(X, nuttallwin(window_width), num_overlap, 
window_width, sample_rate, 'onesided', 'yaxis','psd'); 
%plot spectrogram 
figure;imagesc(f*1000,tX,10*log10(abs(p')));  




title(['Spectrogram [DA](t) Nuttalls Blackman-Harris Width' 
num2str(window_width)],'FontSize',20) 
c = colorbar; 
c.FontSize = 20; 
c.Label.String = 'Power Spectral Density (dB/Hz)'; 









4.0 Comprehensive Quantitative Microdialysis: Mathematical Method and Reconciliation 
of Preceding Theories 
4.1 Chapter Summary 
The development of one-minute or less determination of bioactive solutes in vivo (Fast 
Microdialysis) has shown that there is biologically relevant information encoded in the fluctuations 
of measured solute concentration over time. As experiments progress toward faster time resolution, 
it is appropriate to construct a framework to methodically elucidate biological (e.g. uptake rate, 
tissue morphology) and system (e.g. transport time, dispersion) information from observable 
experimental quantities. Thus, we created the Comprehensive Quantitative Microdialysis (CQM) 
which includes an approximate mathematical model for microdialysis based on earlier work, an 
experimental method, and a curve fitting method to determine sought-for parameters that affect 
time-dependent solute concentration at the detector (Cdet(t)). In this chapter, we present the 
mathematical portion of CQM which is adapted, in part, from earlier work by Chen et al. (2002) 
and Bungay et al. (2011).  The mathematical model is based on tissue and microdialysis probe 
permeabilities. An analytical expression describes Cdet(t) as a function of time resulting from a 
step concentration change of the solute at the probe inlet Cin. Notably, the model also includes 
hydrodynamic dispersion of solute during transport in the inlet/outlet capillaries of the 
microdialysis probe and the transfer function of the detector in the overall model. We also created 
a MATLAB simulation tool to demonstrate the effects of these factors to Cdet(t) to aid experimental 




Microdialysis is a sampling and delivery technique12,30,31,56 in which solutes are sampled 
or delivered via mass transport through a semipermeable membrane separating the lumen of the 
microdialysis probe and the external medium (Figure 4.2-1). Quantitative microdialysis techniques 
determine the relationship between the concentration of a solute in the dialysate sample (Cout) and 
that of in the perfusate solution (Cin) and in the external medium
55. Since the primary mechanism 
of mass flow of solutes to and across the membrane is diffusion which is driven by concentration 
gradients, the processes that affect diffusion and concentration gradients also determine Cout. These 
processes include, but are not limited to, convective flow inside (dialysate flowrate) or outside (in 
vitro stirring) the probe, chemical reactions (in the context of brain microdialysis, uptake162 and 
release163,164 of neuroactive species), and diffusion through the external medium (which, in brain 
microdialysis, is affected by tissue porosity and tortuosity165-167). Cout is therefore dependent upon 
diffusion in the extracellular space as affected by tissue morphology, and release and uptake in the 
extracellular space both at the basal conditions and as affected by exogenous agents. We note that 
quantitative microdialysis experiments54 typically operate in the steady-state domain so that Cout 
is constant during an experiment at a constant Cin. In principle, a change in Cin will result in a time-
dependent, or transient response in Cout (Cout(t)) that could be measured and would provide 
information about the parameters that affect mass transport listed just above. In fact, there are 
several theory papers, to which we return below, that describe Cout(t) resulting from a such a 
perturbation57-61,64,84. Existing experimental efforts61,168-170 to obtain mass transport information 
related to the aforementioned theories involved hours-long transients due to the poor time 
resolution of microdialysis as practiced until recently. 
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Figure 4.2-1. An illustration of the concentric microdialysis probe. 
The red circle species demonstrates a sampling process, and the blue diamond species demonstrates a 
retrodialysis (delivery) process. 
Measuring transient responses in Cout(t) will require an understanding of how the 
microdialysis/analytical instrument affects the response time of the measurement. Any attempt to 
measure microdialysis transients requires better time resolution than the typical 5 – 30 minutes per 
measurement47,171. In addition, the probe inlet and outlet are connected to long capillaries, and 
swivels may be used in awake animal work. The capillaries add hydrodynamic dispersion and the 
probe itself and swivels similarly add longitudinal dispersion, both of which degrade time 
resolution. Furthermore, in systems where periodic, discrete measurements are made, e.g., sample 
collection or liquid chromatography, a concentration averaging occurs because a single sample 
comes from an extended time period77. In systems where the outlet directs dialysate flow past a 
continuously monitoring sensor, there is a conceptually similar (but mathematically distinct) 
averaging dictated by the response time of the sensor. Pragmatic experimental needs make 
measurement of transients difficult.   
On the other hand, there has been significant progress recently on many of these issues. 
For solutes that can be determined over the long term with a sensor or selective detector, the outlet 
tubing can be connected directly to the sensor/detector for online analysis92,172. The outlet tubing 
can also be connected directly to an instrument, capillary liquid chromatography or capillary/chip 
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electrophoresis, to provide online measurements at three minutes or less per 
sample47,72,77,78,97,152,154,173-175. Offline analysis techniques are capable of measurements as fast as 
two seconds per sample80,81. This analysis time was achieved by using segmented flow to minimize 
hydrodynamic dispersion. On the inlet side, Cin can be changed rapidly by using an automated 
syringe/valve system77,97. The dispersion of solute zones in an open capillary under laminar flow, 
hydrodynamic dispersion176, is well-understood, and theory has successfully predicts 
experiments77,177. Thus, despite the difficulties involved, it is becoming possible to envision using 
microdialysis to obtain information from transient responses in Cout(t) from a perturbation in Cin 
at the minute timescale. 
The observable experimental result from a microdialysis experiment in which Cin is 
changed is not Cout(t), rather it is the time-dependent signal obtained from a quantitative analytical 
measurement from a detector, Cdet(t). Processes in the analytical system contribute to the overall 
time response of the system. Thus, a mathematical model that that seeks to describes how Cdet(t) 
is related to processes occurring in the brain must account for both the brain the analytical system. 
We have developed a technique (named Comprehensive Quantitative Microdialysis, CQM) for 
obtaining quantitative estimates related to microdialysis sampling (e.g. solute uptake and diffusion 
in tissue) and the analytical system (e.g. solute dispersion) based on the transient response in solute 
concentration experimentally measured at the detector Cdet(t) following a step change in solute 
concentration in the inlet Cin. CQM has three components: a mathematical model, an experimental 
method, and a curve-fitting method. Here, we describe the mathematical model. 
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Figure 4.2-2. Graphical illustrations of the mass transport model and key mass transport quantities.  
Top: the three regions where mass transport occurs (A1) Probe lumen, (A2) Membrane, and (A3) Tissue. The 
blue arrows indicate the direction of mass transport in a sampling experiment. Bottom: Concentrations in 
(B1) ECS volume basis (red) and (B2) Tissue volume basis pink. Rates of diffusive mass transport is affected 
by tortuosity (C1). Diffusive flux is also affected by porosity (C2). 
Microdialysis sampling relies on mass transport. It is important to acknowledge that the 
insertion of the microdialysis probe into brain tissue injures the tissue near the probe forming a so-
called trauma layer62,82,85,90,178,179 which can alter mass transport. We previously found differences 
in the steady-state dialysate DA measured in rats treated with a locally delivered anti-inflammatory 
drug compared to untreated rats97. Mathematical models65,88 in cylindrical coordinates 
incorporating a trauma layer exists for the steady-state concentration of a sought-for species (e.g. 
dopamine, DA) in microdialysis. In this model there are four volumes through which DA diffuses, 
namely, the normal tissue, the trauma layer, the membrane, and the lumen of the microdialysis 
probe. As the thickness of the trauma layer is decreased, the steady-state model’s prediction 
becomes equivalent to the prediction of steady-state models that do not incorporate a trauma layer. 
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However, as far as we are aware there is no transient theory or model that incorporates a trauma 
layer in cylindrical coordinates. Therefore, the core of the model used here is an established 
microdialysis mass transport model in which there are three physically separate media (Figure 
4.2-1) through which solutes diffuse, namely the tissue, the membrane, and the lumen of the 
microdialysis probe. Expressions for time-dependent microdialysis based on this model exist56-66, 
including closed-form analytical expressions (e.g. Amberg and Lindefors (1989) 57, Morrison et 
al. (1991) 60, Peters and Michael (1998) 62) which are the most suitable for curve-fitting. The 
existing theoretical approaches vary in both their geometries and the biological processes that 
influence mass transport. Of course, the more accurate the model is the more complex the 
mathematics are. For example, Amberg and Lindefors (1989) 57 derived an equation in cylindrical 
coordinates, but considered only diffusion, not uptake kinetics; while Peters and Michael (1998) 
62 derived an equation that includes both diffusion and uptake, but in one Cartesian spatial 
dimension. As far as we are aware, the model with the fewest assumptions is Morrison et al. (1991) 
60. It contains two source and uptake terms, one for ‘metabolism’ and one for exchange between 
brain tissue and capillary blood, but the resulting equations are very complex. Bungay and 
coworkers over the years have used the concept of the permeability61,65,84 to simplify the 
mathematics while including uptake kinetics and the cylindrical coordinate system. Based on the 
normal microdialysis probe dimensions, and for known parameters related to solute diffusion and 
uptake, we have identified the Bungay (2011) one-dimensional (radial) model61, which is adapted 
from a pair of papers58,59 from Chen and colleagues (2002), as being optimal – a balance of 
accuracy and computational burden, especially as it allow us to create a comprehensive model 
consisting solely of short, closed-form analytical expressions. Note that we will frequently refer to 
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these three identified papers as Bungay (2011) 61, Chen (2002a) 59 and Chen (2002b) 58  without a 
citation. 
In the work we describe here we describe similarities and differences in mathematical 
derivations and numerical evaluations in Bungay (2011) and Chen (2002a, b). We clarify the use 
of an “effective” or “apparent” diffusion coefficient when diffusion occurs in a porous matrix. We 
incorporate hydrodynamic dispersion in open capillaries (Taylor-Aris) and the probe, the transit 
time of solute from the probe to the detection system (which is needed to establish the time at 
which an observed change occurred in the brain), and the influence of the detection system’s 
response time. We created a MATLAB tool to aid experimental design by simulating experimental 
results from known tissue, probe, and analytical system parameters. The overarching goal of this 
two-part study is to improve quantitative microdialysis and explore future directions for 
microdialysis studies. In a second paper180, we describe an experimental and data analysis method 
to obtain quantitative estimates of parameters relating to microdialysis sampling and the detection 
system used. We also investigate the robustness of the CQM method, and microdialysis as a whole, 




Analytical-grade chemicals for dopamine standards in artificial cerebrospinal fluid 
(dopamine, L-ascorbic acid, aCSF: 142 mM NaCl, 1.2 mM CaCl2, 2.7 mM KCl, 1.0 mM MgCl2, 
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and 2.0 mM NaH2PO4, pH 7.4) and liquid chromatography mobile phases (sodium acetate, sodium 
octyl sulfonate, EDTA, acetonitrile, and acetic acid) were acquired from either Fisher Scientific 
(Fair Lawn, NJ) or Sigma (St. Louis, MO). Ascorbic acid (50 M) was added to dopamine 
standards to prevent oxidation of dopamine67.  
4.3.2 Microdialysis Probe 
Concentric microdialysis probes (280 μm diameter, 4 mm length membrane) were 
constructed with hollow fiber membranes (13 kDa MWCO, Specta/Por RC, Spectrum Laboratories 
Inc., Ranco Dominguez, CA). The inlet and outlet were fused silica capillaries (75 μM I.D., 150 
μM O.D., 110 cm long, Polymicro Technologies, Phoenix, AZ). The inlet capillary was connected 
to a 1 mL gastight syringe (Hamilton 81320, Hamilton Company, Reno, NV) with a 100-psi 
backpressure regulator and a bubble-induced dampener181. Perfusate flow was driven by a 
microliter syringe pump (PHD 4400, Harvard Apparatus, Holliston, MA) at a flowrate of 0.80 
μL/min. The outlet capillary of the microdialysis probe was connected directly to the LC system. 
4.3.3 In Vitro Online Microdialysis-HPLC 
The liquid chromatography system was similar to our previous work97,98, where the outlet 
capillary of the microdialysis probe was connected directly to the LC injector (8-port nanobore, 
electrically actuated, C72NX-4678D, Valco Instruments, Houston, TX) and dialysate was 
continuously sampled for analysis. The probe was suspended in a heated (37°C), well-stirred 
cuvette for the duration of the experiment. The LC injector had two sample loops of 0.80 μL each. 
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For every 45 s analysis cycle, one loop was is filled with dialysate from the probe and dialysate in 
the other loop was injected for separation. 
Capillary columns (7.5 cm long, 150 μm ID fused silica) were packed with 1.7 μm BEH 
C18 reversed-phase particles (Waters, Milford, MA) at approximately 1400 bar. Mobile phase was 
delivered using a Shimadzu LC-30DA pump with a maximum pressure of 1300 bar to achieve a 
flow rate of 8.5 μL/min during experiments. The column was heated to 47.5°C with a thermostatted 
column heater. Separation of dopamine was achieved with a mobile phase containing 100 mM 
sodium acetate, 1.75 mM SOS, 0.150 mM EDTA, 3.0 % v/v acetonitrile, and 2.0 % v/v acetic acid. 
The mobile phase was filtered and degassed with three passes of vacuum filtration using a 0.22 
μm nylon filter (Osminics, Minnetonka, MN).   
4.3.4 Amperometric Detection 
Dopamine was detected at 400 mV (vs Ag/AgCl 3 M NaCl) using a BASi radial-style 
flowcell, 3 mm glassy carbon electrode with a 25 μm thick gasket and BASi Epsilon potentiostat 
(West Lafayette, IN). Dopamine concentration was determined from chromatographic peak area, 
integrated using MATLAB then compared against pre- and post-run calibration curves. The 
detector sensitivity for DA was 0.106 ± 0.002 nA·s/nM (AVG±SEM) with a limit of quantitation 
of 1.0 nM (defined as RSD ≤ 10%).  
4.3.5 Time Interleaved Sampling Microdialysis 
Time interleaved sampling is a technique where multiple analog-to-digital converters are 
used to acquire discreet digital data from a single continuous analog signal, but each converter’s 
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acquisition times are offset from one another in order to increase the time resolution of the 
signal182. An array of N converters with each having its acquisition times offset from the others by 
a time that is a multiple of a fraction 1/N of the sampling interval can improve the sampling 
frequency by N times. Time interleaved sampling microdialysis is an analogous technique which 
utilizes the same principle, where instead of N detectors simultaneously measuring a single 
transient response, a single detector is used to measure N repeats of the transient response, all of 
which are assumed to be identical.   
4.3.6 MATLAB Simulation 
We wrote MATLAB scripts (MATLAB R2019a Update 2, MathWorks, Natick, MS) that 
reproduce transient calculations in published work. All MATLAB routines cited here can be found 
with embedded annotation in Supplementary Information 4.6.1. Specifically, 
Ngo2020_BungayFig2.m calculates dimensionless external medium transient permeability, as 
defined in Bungay (2011), following a step input in a no-net-flux type experiment183. This script 
replicates Bungay (2011) Fig. 2 exactly61. Ngo2020_ChenFig4.m calculates membrane resistance, 
external medium resistance and total resistance given known probe and tissue properties. This 
script replicates Chen (2002a) Fig. 4 exactly59.  
The major script, Ngo2020_simulation.m calculates the experimentally observed solute 
concentration detected at electrochemical detector given known probe construction, tissue and 
analytical system properties (Table 4.4-2). The script simulates a discrete detection system using 
chromatographic separation with a 45 s sampling time. This script also permits calculation of other 
important experimental results, such as extraction fraction or transient relaxation time. Using this 
script, one can quickly explore the effects of different experimental parameters as well as tissue 
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conditions on solute concentration profiles measured at the probe outlet, LC injector or LC detector 
and use this knowledge expeditiously to design new experiments. 
4.4 Results and Discussion 
Table 4.4-1. Experimental conditions and parameters used for simulating in vitro microdialysis sampling of a 
well-stirred solution. 
Symbol Description Value Unit Source 
L Membrane length 4.00×10-3 m Experimental 
ri Membrane inner radius 1.00×10-4 m Experimental 
ro Membrane outer radius 1.40×10-4 m Experimental 
Li Inlet capillary length 1.10 m Experimental 
Lo Oulet capillary length 1.10 m Experimental 
Q Perfusate volumetric flowrate, in vitro 1.33×10-11 m3/s Experimental 
ts LC sampling time 45 s Experimental 
ti Characteristic time of the concentration profile -24 s Calculated 
tot Hydrodynamic dispersion standard deviation 12.8 s Calculated97 
Cin Perfusate analyte concentration 1.50×10-7 M Experimental 
CECS∞ Solute concentration “ECS” (cuvette) 0 M Experimental 
D Analyte diffusion coefficient in free solution 6.0×10-10 m2/s Literature184 
λ “ECS” (cuvette) tortuosity 1 - Experimental 
ϕ “ECS” (cuvette) porosity 1 - Experimental 
k Solute uptake rate constant, first order 5×103 s-1 Nominal value 
Ews well-stirred extraction fraction, in vitro, 37°C 0.510 - Experimental 




Table 4.4-2. Nomenclature. 
Symbol Unit Name Instrument System 
C M Concentration non-specific 
D m2/s Diffusion coefficient non-specific 
λ unitless Tortuosity non-specific 
ϕ unitless Porosity non-specific 
ts s Sampling time Chromatography 
𝜎tot s Hydrodynamic dispersion 
standard deviation 
Prone and capillary 
tubing 
ti s Characteristic time of the concentration 
profile 
Microdialysis 
Q m3/s Volumetric flowrate Microdialysis 
r m Radius of probe membrane Microdialysis 
L m Membrane length Microdialysis 
S m2 Membrane surface area Microdialysis 
k s-1 Uptake rate constant External medium 
u unitless Dummy integration variable Mathematical 
variables Ed unitless Extraction fraction 
P m/s 1-D diffusive permeability 
R s/m3 1-D mass transport resistance 
Subscript Notation 
in Probe inlet 
out Probe outlet 
i Membrane inner radius 
o Membrane outer radius 
inj LC injector 
det LC detector 




4.4.1 Mathematical Model 
In this section we briefly outline a comprehensive theoretical description for quantitative 
microdialysis that accounts for the processes that contribute to an observed transient microdialysis 
response following a step-change in retrodialyzed concentration of a solute, e.g., dopamine, 
created by switching the solution being pumped through the inlet capillary to the probe. Table 
4.4-2 defines parameters and super/subscripts.  
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4.4.1.1 Diffusive Flux and Mass Balances 
In the radial dimension of a cylindrical coordinate system, the partial derivative of 
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Equation 4.4-1. Diffusive mass balance, universal volume basis. 
where C* is a concentration calculated in one of two ways, namely as moles in the ECS per total 
tissue volume, Ctissue, or moles in the ECS per total ECS volume, CECS. The two are related by 
tissue ECS
C C= where  is the tissue porosity. It can be demonstrated (see Supplementary 
Information 4.6.2.3), that as long as Equation 4.4-1 is written in a consistent volume basis, i.e. 
when all C* terms are defined as either 
*
tissue
C C= or 
*
ECS
C C= , Equation 4.4-1 is consistent with 
the literature58,61,66. Other terms are defined in Table 4.4-2. When the ECS volume basis is chosen, 
Equation 4.4-2 describes mass transport in the tissue. Note that no other ‘corrections’ to the 
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Equation 4.4-2. Diffusive mass balance, ECS volume basis. 
The following boundary conditions lead to a solution. The concentrations at the boundary between 
the membrane and the external medium are the same: 
( , ) ( , )
m o ECS o
C r r t C r r t= = =
 
Equation 4.4-3. Boundary condition, membrane-ECS mass balance. 


























=  and D is the diffusion coefficient of the solute in aqueous solution and Dm, is 
the “effective” diffusion coefficient of the solute in the membrane. The diffusion coefficients in 
the tissue and membrane are handled differently because this reflects the most well-established 
experimental results for dopamine. That is, we have not found values for m or 2m in the membrane 
materials used in the literature. However, the concentration in the membrane, Cm, is defined 
analogously to CECS. At t = 0, the concentration outside the probe is uniform, a step concentration 







Equation 4.4-5. Boundary condition, initial concentration. 









Equation 4.4-6. Boundary condition, distant concentration. 
4.4.1.2 Permeability Solutions 
Chen (2002a, b) and Bungay (2011) described a solution in one radial dimension which we 
have adopted here. There is no analytical solution for cylindrical models that include the axial 
dimension. However, for the typical microdialysis probe’s radius (100-140 nm), probe length (2-
4 mm) and uptake rate constants (10-3 to 103 s-1), the axial mass transport contribution is negligible 
(less than 5% contribution) at the time regime relevant to fast microdialysis (less than 600 s)61. 
Thus, the transient component of the response in one radial dimension can be used to obtain 
accurate mass transport information given the constraints above. The overall permeability is 
calculated from individual lumen, membrane, and external medium permeabilities. The 
permeability of the lumen of the microdialysis probe is assumed (with justification)55,58,59,61,185 to 
be so high that it does not contribute to the overall permeability. The transient membrane 
permeability reaches steady state almost instantaneously61 (Supplementary Information Figure 



















Equation 4.4-7. Analytical solution for Pm,t. 
Dm is defined above and ro and ri are outer and inner membrane radii, respectively. The external 
medium permeability is shown as Equation 4.4-8 (Bungay 2011 Eq. 20, derived from Chen 2002b 
Eq. 7. The derivation is shown in Supplementary Information 4.6.2.1 and 4.6.2.2. Terms are 
defined in Table 4.4-2). 
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Equation 4.4-8. Analytical solution for PECS(t). 
In Equation 4.4-8, Jn Yn and Kn are, respectively, Bessel functions of the first kind, the second kind, 
and a modified Bessel function of the second kind of order n. Overall permeability is then 
calculated from membrane and external medium permeabilities61 as shown in Equation 4.4-9. 
,
1 1 1
( )( ) ECS m tP t PP t → 
= +  
Equation 4.4-9. Overall permeability from individual component. 
4.4.1.3 Transient Extraction Fraction 
Extraction fraction is calculated from overall permeability61: 
(t)
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Equation 4.4-10. Transient extraction fraction from permeability 
where So is the membrane’s outer surface area through which diffusion occurs and Q is the 
microdialysate volumetric flow rate. The transient solute concentration measured at the 
microdialysis probe outlet Cout(t) resulting from a retrodialyzed step concentration change in Cin 
is61: 
( )( ) ( )out in d in ECSC t C E t C C = −  −  
Equation 4.4-11. Solute concentration at probe outlet. 
Note that the extraction fraction is time dependent. 
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This is Cout(t) the solute concentration at the probe outlet as typically described in the 
literature. However, in a practical experiment, the probe inlet and outlet are connected to inlet and 
outlet capillaries, which in turn are connected to perfusate pump and sample collector, 
respectively. The sample is then analyzed by a detector. The experimentally observable is always 
the concentration of the solute at the detector Cdet(t). The following subsections describe the 
analytical instrument’s contribution to the measured Cdet(t). 
4.4.1.4 Hydrodynamic Dispersion 
A zone of solute in laminar flow passing through each of the capillaries and the 
microdialysis probe itself is broadened by hydrodynamic dispersion. The shape of a concentration 
profile leaving the exit of a capillary, Ccap out(t),  is the convolution of the solute concentration 
profile at the entry into the capillary, Ccap in(t), with a Gaussian function whose variance is dictated 





( ) ( ) exp
22
i
cap out cap in
capcap
t t
C t C t
 
  −




Equation 4.4-12. Solute concentration at capiliary outlet. 
Here, ti is a characteristic time of the concentration profile at the outlet, the difference between this 
and the time at which a step-change in concentration occurs is the time required to transport the 
sample through the capillary. Dispersion in the capillary spreads the initial step function into an 
error function with a standard deviation cap.  
There is no simple theory for the probe itself. But, is important to point out that: (1) the 
order in which the processes altering the signal’s shape occur does not matter as long as all 
processes are linear and (2) the variances resulting from serial, linear processes add. Thus, here we 
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combined the variances from hydrodynamic dispersion into one term (“total variance”,
2
tot
 ) and 
imagine that the input to the probe is a perfect step function in concentration. The two parameters 
tot
  and ti are used with Equation 4.4-12 to model dispersion of a zone of solute caused by transport 
through the microdialysis probe, inlet and outlet capillaries, and the analytical system. For a 
chromatographic system, for example, tot  includes dispersion in the sample loop, and ti is the 
characteristic time at the end of the sample loop. In reality, the inlet capillary and some portion of 
the probe proper alter the shape of the concentration profile in the lumen of the probe. The solution 
affected by the brain suffers further spreading in the latter portion of the probe proper and the 
outlet capillary. But this difference does not affect the outcome. 
4.4.1.5 Detector Response 
There are two general types of detector, continuous and discrete. A continuous detector’s 
response to a step change is often an exponential relaxation from one steady value to another, so 
the transfer function, (t), is exponential. A discrete detector, for example using an injection loop 
as in a chromatographic determination of solute concentration, is characterized by a rectangular 
transfer function. The concentration profile of a solute at the detector is given as Equation 4.4-13 
where Cout(t) is the concentration at the outlet of the probe proper (the entrance to the outlet 
capillary), tot  is the standard deviation from dispersion in the inlet and outlet capillaries, the 
probe itself, and any fluidic connection between the outlet capillary and the detector. Cdet(t) is the 
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Equation 4.4-13. Solute concentration at detector 
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Equation 4.4-14. Exponential decay detector 
If the detector is a discrete detector with a sampling period of ts then: 
( 0) 0
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Equation 4.4-15. Discrete detector 
4.4.2 Reconciliation and Clarifications to Preceding Literature 
4.4.2.1 The Relationships Among Preceding Theories Related to Bungay 20112  
The time-dependent normalized radial concentration, U(r,t), (Chen (2002a) Eq. 6) is 
obtained by solving the partial differential equation describing mass transport in the tissue, 
Equation 4.4-2, using the boundary conditions Equation 4.4-3-Equation 4.4-6. The analytical 
solution for overall permeability (t)P  is derived from U(r,t) (Supplementary Information 4.6.2.2). 
From this analytical solution for (t)P , Chen (2002 a, b) devised two methods to evaluate overall 
permeability. The Chen analytical method calculates the (t)P  directly from its analytic expression. 
The Chen numerical method first takes the numerical limit of (t)P  as the ECS permeability 
becomes infinitely large to obtain Pm(t), then takes the numerical limit of (t)P  as the membrane 
permeability becomes infinitely large to obtain PECS(t). The overall permeability is obtained from 
the numerical solution of Equation 4.4-9 but with a time-dependent Pm(t). The Bungay analytical 
method, adapted from Chen (2002 a, b), derived an analytical solution for PECS(t) and the steady-
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state membrane permeability Pm,t→∞ from U(r,t) by making the assumptions of infinitely 
permeable membrane and infinitely permeable ECS at steady state, respectively. Intuitively, Chen 
analytical is the appropriate method and the other two are unnecessary. However, we will show 
below that it is not the case. Derivations to obtain (t)P  and PECS(t) can be found in Supplementary 
Information 4.6.2.1 and 4.6.2.2, and a step-by-step derivation summary for all three methods can 
be found in Supplementary Information 4.6.2.4. 
 
Figure 4.4-1. Comparison between (A) Chen numerical (diamond) and Bungay analytical (line) (B) Chen 
numerical (diamond) and Chen analytical (line).  
Diffusive mass transport is calculated in term of resistance (R=1/PSo). 
4.4.2.2 Chen’s Analytical and Numerical Approaches 
For clarity, in this section diffusive mass transport is compared in term of resistance 
(R=1/PSo) where P is a permeability and So is the membrane’s outer surface area through which 
the molecular flux occurs. In their 2002 papers, Chen and colleagues postulated that Chen 
analytical and Chen numerical yield identical results (Supplementary Information Figure 4.6-3A, 
which is a reproduction of Chen 2002b Fig. 4 with our MALAB code). We found that the two 
approaches are reasonably comparable (relative difference less than 0.05) at long times (longer 
than 100 s) but do not agree at short times (shorter than 100 s, Supplementary Information Figure 
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4.6-3B). The former is the time regime where traditional microdialysis operates, but the latter is 
where transient microdialysis will operate. The disagreement between the two approaches 
decreases as the solute uptake rate increases (Supplementary Information Figure 4.6-3B). 
While we do not expect microdialysis experiments to be possible, or practical, at the sub-
second time regime, we note that computation of Chen analytical completely breaks down at this 
time regime. A closer look at the data reveals that at very short time (faster than 0.01 s), the Chen 
analytical total resistance term R(t) rapidly increases (Figure 4.4-1B, dashed line), which does not 
accurately describe cylindrical transient diffusion at short time. In such a system, at very short time 
(order of milliseconds) after a concentration transient occurs, since the concentration gradient 
between tissue and probe lumen is at its highest, the flux of solute between tissue and probe lumen 
is also at its highest, thus the resistance is at its lowest. At long time, the concentration gradient 
relaxes, and the flux of solute reaches steady state. In other words, resistance is small at short time, 
and it approaches a larger, steady-state value at long time. Chen numerical exhibits this expected 
behavior (Figure 4.4-1A-B, diamond). Upon careful analysis of Chen’s work, we believe that, 
mathematically, the Chen analytical was accurately derived. From our numerical investigation, 
however, we concluded that since the Chen analytical solution does not behave correctly during 
transient conditions (100 s or faster), it should not be used for transient analysis.  
4.4.2.3 Bungay’s Analytical Approach 
Bungay’s analytical yields almost identical results to Chen’s numerical approach. In fact, 
numerical evaluation of Bungay’s analytical PECS(t) yields identical result to Chen’s numerical 
PECS(t), and Bungay’s analytical Pm, t→∞ yields identical results to Chen’s numerical Pm(t) in the 
practical experimental time regime (10 ms or longer, Supplementary Information Figure 4.6-2). 
As a result, R(t) from Bungay’s analytical and Chen’s numerical are identical in the time regime 
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of 10 ms or longer (Figure 4.4-1A). We have also carefully analyzed Bungay’s work, and we agree 
with the mathematical derivation. Thus, as Bungay’s analytical approach provides relative ease in 
computer code implementation and calculation speed (Supplementary Information 4.6.1.1), our 
method uses this approach to evaluate mass transport in transient microdialysis. Chen’s numerical 
would provide identical results at times greater than milliseconds but at a steep cost of 
mathematical complexity and computational time (Supplementary Information 4.6.1.2, therefore 
we do not recommend its use. 
 
Figure 4.4-2. MATLAB Simulation of an in vitro experiment compared to experimental results.  
(A) Transient extraction fraction Ed(t) (B) Solute concentration at probe outlet Cout(t) and (C) Solute 
concentration at injector Cinj(t) (blue), solute concentration at detector Cdet(t) (red) and in vitro experimental 
(black). 
4.4.3 MATLAB Simulation 
To demonstrate the contribution of mass transport in the tissue and in the analytical system 
thereafter to time-dependent solute concentration at the probe outlet Cout(t), injector Cinj(t) and 
detector Cdet(t), and the importance of understanding these results, we simulated an in vitro well-
stirred retrodialysis experiment. In such an experiment, the stirring creates a thin diffusion layer 
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having the effect of a high uptake rate, thus uptake rate constant k was chosen to be 5×103 s-1 with 
a tissue porosity ϕ of 1 and tortuosity λ of 1. Other simulation parameters are shown in Table 4.4-1. 
Characteristic time of the concentration profile ti was calculated from experimental time when the 
step concentration change occurs and transport time, accounting for all transport volume in the 
system, namely probe inlet capillary, probe lumen, probe outlet capillary, and the LC sample loop. 
Hydrodynamic dispersion, particularly Taylor dispersion coefficient at our flowrate (0.6-0.8 
μL/min) and capillary diameter (75 μm), was calculated from Ngo et al. 2017 97, where we 
experimentally measured an identical probe at 0.6 L/min flow rate. The dispersion coefficient is 
proportional to the square of linear velocity. From the dispersion coefficient, the dispersion 
standard deviation tot was calculated for simulation. 
Shown in Figure 4.4-2A, B are the simulation results in term of Ed(t) (Figure 4.4-2A, 
resulting from evaluation of Equation 4.4-8 to Equation 4.4-10) and Cout(t) (Figure 4.4-2B, 
resulting from evaluation of Ed(t) and Equation 4.4-11). When the uptake rate is large, diffusive 
flux rapidly establishes steady state. Therefore, Ed(t) displays a rapid transient near time = 0 but 
otherwise is constant, Cout(t) is a near perfect step with no curvature. Shown in Figure 4.4-2C are 
the simulation results for Cinj(t) (blue) from evaluation of Cout(t) and Equation 4.4-12 and Cdet(t) 
(orange) from evaluation of Cinj and Equation 4.4-13. Measurements from an in vitro well-stirred 
experiment are plotted as points in Figure 4.4-2C. The in vitro extraction fraction was measured 
at 37°C with an 18 kDa MWCO membrane, using steady-state measured concentrations from six 
replicates of 150 nM DA step concentration retrodialysis experiments. The diffusion coefficient 
of dopamine in the probe membrane was determined from the experimental in vitro well-stirred 
extraction fraction using Equation 4.4-9 and Equation 4.4-10, with the assumption of fully 
permeable ECS (PECS → ∞). There is good agreement between simulated and experimental results. 
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Simulated well-stirred steady-state extraction fraction is 0.506 and steady-state concentration is 
74.2 nM, in comparison with experimental steady-state extraction fraction and concentration of 
(AVG±SEM) 0.510±0.001 and 73.4±0.2 nM, respectively. The disagreement is due to MATLAB’s 
numerical limit in evaluating Bessel functions. Simulating with large PECS instead of large k 
produces steady-state extraction fraction and steady-state concentration equals to experimental 
results. We note that the extraction fraction was derived from eight minutes of data. 
The result above demonstrates that the model can simulate an experiment and deriving 
quantitative results from data. But this simulation is useful for experimental design as well. Here, 
it demonstrates the influence of dispersion and the detector response on the transient response, and 
thus the importance of understanding and minimizing these influences. The difference between 
Cout(t) and Cinj(t) highlights the contribution of dispersion to the transient response. Even if the 
diffusive flux establishes steady state instantaneously, and if the detector is a continuous detector 
with perfect response time (here, represented by Cinj(t)), dispersion softens the response and limits 
the time resolution of the analytical system. Minimizing dispersion (e.g. using segmented flow79) 
improves the time resolution of the analytical system. In a practical microdialysis system, the 
detector is not perfect, and the differences between Cinj(t) and Cdet(t) highlight the contribution of 
the detector to the transient response. The detector not only further softens (transform in shape) 
the response curve, lowering the time resolution, but also shifts the response curve in time. In 
principle, Cinj(t) can be calculated from Cdet(t) using deconvolution because the detector’s transfer 
function is known. However, this operation requires higher data density than microdialysis can 
realistically achieve. As shown in Figure 4.4-2C, the time shift of the curve is not straightforward. 
The top, middle, and bottom portion of the curve are time shifted by different amounts, for 
example. Thus, transport time is not obvious from a plot of the data alone. Establishing the 
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transport time is critically important in behavior studies98 for example. Fortunately, the CQM curve 
fit180 provides a quantitative estimate for transport time from a transient response in Cdet(t). 
4.4.4 Limitations of the Method 
The CQM method relies on a set of assumptions in addition to the assumptions inherent in 
the mass transport model we used. These assumptions are necessary to obtain an analytical solution 
for the mass transport model, however, they impose limitations to the method. Additionally, there 
are limitations inherent to the microdialysis technique and to the MATLAB software. The 
following section discusses these limitations.  
4.4.4.1 Trauma Layer 
Probe implantation creates a complex tissue environment surrounding the probe85, 
including a trauma layer between healthy tissue and the probe86. The trauma layer leads to the 
extraction fraction being overestimated, thus solute ECS concentration being 
underestimated55,65,88,90. At this time, there is no experimental method using microdialysis to assess 
the trauma layer, and there is no analytical solution for mathematical models describing transient 
response that incorporates the trauma layer. Thus, the CQM model does not account for the trauma 
layer. However, there are active experimental efforts to reduce implantation injury and improve 
microdialysis measurements86,87,92,97,122. 
4.4.4.2 First-order Uptake Rate 
Uptake of neurotransmitters in the extracellular space is more appropriately modeled using 









Equation 4.4-16. Michaelis-Menten kinetics 
where Vmax is the maximum velocity and KM is the concentration at which the velocity is 50% of 
Vmax. Michaelis-Menten kinetics can be approximated by a first order rate constant k = Vmax/KM if 
KM is much larger than CECS. For DA in the nucleus accumbens, for example, Km was found to be 
about 200 nM (measured with FSCV189) while the basal CECS is about 10 nM (measured with No-
Net-Flux microdialysis169) to 90 nM (measured with FSCAV52).  
4.4.4.3 One-dimensional Radial Mass Transport   
The microdialysis probe is a finite-length cylinder, thus would be more appropriately 
modeled with two-dimensional cylindrical mass transport. However, in typical experimental 
conditions, 1D and 2D calculations61 differ by less than 5%. These typical conditions include 
membrane length aspect ratio at least 12 (1.7 mm length for the typical 140 nM radius), uptake 
rate at least 10-2 s-1 (for solute in ECS with the 140 nM radius probe), and time at most 600 s. 
Uptake rate is the dominant factor, with DA uptake in the nucleus accumbens (order of 10 s-1) 
189,190, for example, the 1D solution is accurate in all practical experimental conditions.  
4.4.4.4 Numerical Precision 
Due to inherent numerical precision of MATLAB in evaluating Bessel functions, the 
simulation program is unable to simulate uptake rate outside the range of approximately 10-6 to 




In this work, we have presented the first component of the comprehensive quantitative 
microdialysis technique: a mathematical model (CQM model) based on one-dimensional radial 
mass transport for microdialysis sampling that describes the solute concentration observed at the 
detector Cdet(t) as affected by the neurochemical environment outside the probe as well as the 
analytical system that follows the probe. The mass transport model is adapted from Chen (2002) 
58,59 and Bungay (2011) 61 with appropriate corrections and clarifications to unify their analytical 
solutions, particularly at the minute timescale that is most relevant to Fast Microdialysis. Most 
notably, first-order uptake, tissue porosity, tissue tortuosity, sample transport, and detector 
response are all considered in this comprehensive model. This is the first mathematical model for 
microdialysis that illustrates an experimentally observable quantity (Cdet(t)) as affected by both 
biological and analytical system factors. Our use of only closed-form analytic expressions that are 
fully consistent with preceding literature allows data analysis, simulation, and fitting methods180 
to be accessibly built upon. 
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4.6 Supplementary Information 
4.6.1 Computer Codes 
4.6.1.1 Bungay 2011 Fig. 2 Script 
The script below reproduces Bungay (2011) Figure 2 exactly, using parameters and 
quantities defined in Bungay (2011). Notably, dimensionless ECS permeability is calculated as a 
function of a dimensionless clearance Θ and a dimensionless time τ.  
%This script simulates dimensionless ECS permeability 
%with parameters from Bungay 2011 10.1016/j.jpba.2011.01.005 
%Fig 2 in Bungay 2011 can be reproduced using this script 







Theta_array = [4 1 0.5 0.1 1e-6]; %dimensionless ECS permeability 
                        %program runs extremely slow at Theta ~ 0 
tau = logspace(-4,4,1e3); %dimensionless time axis 
%% 
P_dimensionless = zeros([length(Theta_array) length(tau)]); %preallotcate 
array 
for i = 1:length(Theta_array) 
    Theta = Theta_array(i);  
    %Define the transient part dimensionless ECS permeability 
    f_int = @(u)(((4/pi^2)*u*exp(-(u^2+Theta^2)*(tau)))/... 
        ((u^2+Theta^2)*((besselj(0,u))^2+(bessely(0,u))^2))); 
    %Evaluate the transient part of Pext(t) 
    Pext_transient = integral(f_int,0,inf,'ArrayValued',true); 
    %Evaluate the steady state part Pext(t) 
    Pext_ss = Theta*besselk(1,Theta)/besselk(0,Theta); 
    %Evaluate dimensionless Pext(t) 
    P_dimensionless(i,:) = Pext_transient+Pext_ss; 
end 
plot(tau,P_dimensionless) 
title('Bungay 2011 Fig. 2') 











title('Strital DA Response to Retrodialysis') 
xlabel('Dimensionless Time') 
ylabel('Dimensionless Permeability') 
set(gca, 'XScale', 'log','xlim', [1e-3 1],'ylim', [0 10],'FontSize',13) 
hold off 
4.6.1.2 Chen 2002b Fig. 4 Script 
%This script simulates membrane, external medium, and total resistance 
%with parameters from Chen 2002b 10.1046/j.1471-4159.2002.00793.x 
%Fig 4 in Chen 2002b can be reproduced using this script 








n = 1;  %1 negligible external medium resistance 
        %  which, calculate membrane resistance 
        %2 negligible membrane resistance 
        %  which, calculate external medium resistance 
        %3 calculate total resistance 
%kext = [1e-3 1e-4 1e-5]; %Effective uptake rate     
kext = [1e2 1e1 1e0 1e-1 1e-2 1e-3 1e-4 1e-5]; %Effective uptake rate             
L = 4e-3; %m, membrane length 
ro = 120e-6; %m, membrane outer radius 
ri = 110e-6; %m, membrane inner radius 
phi_m = 0.13; %membrane porosity  
              %Chen 2002 10.1046/j.1471-4159.2002.00793.x 
Dm = 1.5e-10; %Analyte diffusion coefficient in membrane, m^2/s 
              %Chen 2002 10.1046/j.1471-4159.2002.00793.x 
phi = 0.2; %external medium porosity 
           %Chen 2002 10.1046/j.1471-4159.2002.00793.x 
D = 2.2e-10; %m^2/s external medium  diffusion coefficient 
lambda = 1; %external medium tortuosity 
           %nominal 
switch n 
    case 1 
        D = 1; %large external medium diffusion coefficient 
        phi = 0.2; %large external medium porosity 
        kext = 1e-3; 
    case 2 
        Dm = 1; %large membrane resistance 
        phi_m = 1; %large membrane porosity 
    case 3 
end 
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De = D/lambda^2; 
Dext = De*phi; 
%% 
%Create time axis 
t = logspace(-3,5,1e4); %s, time axis 
%Dependent variables calculation 
So = 2*pi*ro*L; %m^2, membrane surface area 
Text = ro^2/De; %s, dimensionless time scaling factor 
%% 
P_dimensionless = zeros([length(kext) length(t)]); %preallotcate array 
for i = 1:length(kext(:)) 
    Theta = ro*sqrt(kext(i)/De); %dimensionless clearance 
    %Compute external medium permeability Pext(t) 
    %Define dimensionless components 
    omega = @(u)(sqrt(u.^2+Theta^2)); 
    xi = @(u)(omega(u).*sqrt(De/Dm)); 
    nu_1 = @(u)(besselj(0,xi(u)).*bessely(0,xi(u).*ri/ro)-... 
        besselj(0,xi(u).*ri/ro).*bessely(0,xi(u))); 
    nu_2 = @(u)(besselj(1,xi(u)).*bessely(0,xi(u).*ri/ro)-... 
        besselj(0,xi(u).*ri/ro).*bessely(1,xi(u))); 
    eta_1 = @(u)((phi/phi_m).*sqrt(De/Dm).*nu_1(u).*u.*besselj(1,u)-... 
        nu_2(u).*omega(u).*besselj(0,u)); 
    eta_2 = @(u)((phi/phi_m).*sqrt(De/Dm).*nu_1(u).*u.*bessely(1,u)-... 
        nu_2(u).*omega(u).*bessely(0,u)); 
    %Define the transient part of Pext(t) 
    f_int = @(u)((4/pi^2).*u.^2.*exp(-
omega(u).^2.*t/Text).*(eta_1(u).*bessely(1,u)-eta_2(u).*besselj(1,u))/... 
        (omega(u).^2.*sqrt(De/Dm).*(eta_1(u).^2+eta_2(u).^2)));     
    %Evaluate the transient part 
    P_transient = integral(f_int,0,inf,'ArrayValued',true); 
    %Evaluate the steady state part 
    P_ss = 
Theta*besselk(1,Theta)/(log(ro/ri)*(phi/phi_m)*(De/Dm)*Theta*besselk(1,Theta)
+besselk(0,Theta)); 
    %Evaluate dimensionless permeability 




P = P_dimensionless*Dext/ro; %Calculate permeability P(t) 
R = 1./(P*So); %Calculate resistance R(t) 
plot(t,R); 
if n == 1 
    title('Chen 2002b Fig. 4 R_{m}(t)') 
elseif n == 2 
    title('Chen 2002b Fig. 4 R_{e}(t)') 
    legend('k = 1\times10^{-3','k = 1\times10^{-4}','k = 1\times10^{-
5}','Location','SouthEast')      
elseif n == 3     
    title('Chen 2002b Fig. 4 R(t)') 
    legend('k = 1\times10^{-3}','k = 1\times10^{-4}','k = 1\times10^{-




set(gca,'xlim',[0 12000],'ylim',[0 3e12],'FontSize',13) 
toc 
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4.6.1.3 Simulation Script Ngo2020_simulation.m 
%We strongly recommend ti at time ~ 0 to reduce computational time. 








time_resolution = 0.01; %s, higher time accuracy produces more accurate 
integration 
Q = 0.8; %uL/min, volumetric flow rate 
Q = Q*1e-9/60; %m^3/s, volumetric flowrate  
ts = 45; %s, LC sampling time 
ti = -24; %s, time that step concentration arrives at injector 
sigma = 12.8;%s, Taylor-Aris dispersion standard deviation 
kext = 5e3; %1/s, reuptake rate 
Cin = 150; %retrodialyzed concentration 
Cinf = 0; %ECS concentration 
D = 6.0e-10; %m^2/s, free solution diffusion coefficient 
phi = 0.2; %ECS porosity 
lambda = 1.6; %ECS tortuosity  
Ews = 0.510; %well-stirred, 37 C extraction fraction 
L = 4e-3; %m, membrane length 
ro = 140e-6; %membrane outer radius, m 
ri = 100e-6; %membrane outer radius, m 
max_s = 5; %maximum simulation time, min 
max_t = max_s*1.5*60; 
t = linspace(-max_t,max_t,(2*max_t/time_resolution)+1);%s, create time axis 
%Create a step function 
step = zeros([1 length(t)]); 
for i = 1:length(t) 
    if t(i) <=0 
        step(i) = 0; 
    else 
        step(i) = 1; 
    end 
end 
%Dependent variables calculation 
So = 2*pi*ro*L; %membrane surface area 
%if Ews was measured, use the below 
Pmo = -(Q/So)*log(1-Ews); %log here is ln 
%if Dm was measured or looked up, use the below 
%Pmo = Dm/(ro*log(ro/ri)); %m/s, this log is natural log, membrane 
permeability 
De = D/lambda^2; %m^2/s, membrane diffusion coefficient 
Dext = De*phi; 
So = 2*pi*ro*L; %m^2, membrane surface area 
Text = ro^2/De; %s, dimensionless time scaling factor 
Theta = ro*sqrt(kext/De); %dimensionless clearance 
box_func = zeros([1 length(t)]); 
for i = 1:length(t) 
    if 0 <= t(i) && t(i) < ts 
        box_func(i) = time_resolution/ts; 
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    end 
end 
gauss = time_resolution*(1/(sigma*sqrt(2*pi)))*exp(-(t - ti).^2/(2*sigma^2)); 
%normalized Gaussian  
Cws = ones([1 length(t)]); 
Cws = (1-Ews)*Cws.*Cin; %well-stirred concentration 
Cin = Cin.*step; %create step function for Cin 
s_gauss = convnfft(box_func,gauss,'same'); %conv of Gaussian and box_func 
%% 
%Compute external medium permeability Pext(t) 
%Define the transient part of Pext(t) 
f_int = @(u)(((4/pi^2)*u*exp(-(u^2+Theta^2)*(t/Text)))/... 
    ((u^2+Theta^2)*((besselj(0,u))^2+(bessely(0,u))^2))); 
%Evaluate the transient part of external medium permeability Pext(t) 
Pext_transient = integral(f_int,0,inf,'ArrayValued',true); 
%Evaluate the steady state part of external medium permeability Pext(t) 
Pext_ss = Theta*besselk(1,Theta)/(besselk(0,Theta)); 
Pext_transient(isnan(Pext_transient)) = 0; %replace NaN with 0 
Pext_transient(isinf(Pext_transient)) = 0; %replace inf with 0   
%Evaluate dimensionless external medium permeability 
Pext_dimensionless = Pext_transient+Pext_ss;  
Pext_dimensionless(isnan(Pext_dimensionless)) = Pext_ss; %replace NaN with 
P_ss 
Pext_dimensionless(isinf(Pext_dimensionless)) = Pext_ss; %replace inf with 
P_ss 
                                                      %at t < 0, Pext = 
Pext_ss        
%% 
%Compute concentration at probe outlet Cout(t) 
Pext = Pext_dimensionless*Dext/ro; %Calculate external medium permeability 
Pext(t) 
P = 1./(1./Pext + 1/Pmo); %Calculate total permeability P(t) 
E = 1-exp(-So*P/Q); %Calculate extraction fraction Ed 
Cout = Cin-E.*(Cin-Cinf); %Calculate Cout(t) 
%% 
%Compute concentration arrived at injector Cinj(t) 
Cinj = (1/trapz(gauss))*convnfft(Cout,gauss,'same'); %Calculate Cinj(t) 
%% 
%Compute concentration at detector Cdet(t) 



















%title('Concentration at injector and detector','FontSize',13) 
plot(t/60,Cinj,'b'); 
plot(t/60,Cdet,'r'); 
legend('Concentration at injector',... 







function A = convnfft(A, B, shape, dims, options) 
%   KHANH T NGO KTN@PITT.EDU  
%   Adapted from: 
%https://www.mathworks.com/matlabcentral/fileexchange/24504-fft-based-
convolution 
%   Author: Bruno Luong <brunoluong@yahoo.com> 
% Copyright (c) 2009, Bruno Luong 
% All rights reserved. 
%  
% Redistribution and use in source and binary forms, with or without 
% modification, are permitted provided that the following conditions are met: 
% * Redistributions of source code must retain the above copyright notice, 
this 
%   list of conditions and the following disclaimer. 
% * Redistributions in binary form must reproduce the above copyright notice, 
%   this list of conditions and the following disclaimer in the documentation 
%   and/or other materials provided with the distribution 
% * Neither the name of FOGALE nanotech nor the names of its 
%   contributors may be used to endorse or promote products derived from this 
%   software without specific prior written permission. 
% THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" 
% AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE 
% IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE 
ARE 
% DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT OWNER OR CONTRIBUTORS BE LIABLE 
% FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL 
% DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR 
% SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER 
% CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT 
LIABILITY, 
% OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE 
USE 
% OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. 
if nargin<3 || isempty(shape) 
    shape = 'full'; 
end 
if nargin<5 || isempty(options) 
    options = struct(); 
elseif ~isstruct(options) % GPU options 
    options = struct('GPU', options); 
end 
nd = max(ndims(A),ndims(B)); 
% work on all dimensions by default 
if nargin<4 || isempty(dims) 
    dims = 1:nd; 
end 
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dims = reshape(dims, 1, []); % row (needed for for-loop index) 
% GPU enable flag 
GPU = getoption(options, 'GPU', false); 
% Check if Jacket is installed 
GPU = GPU && ~isempty(which('ginfo')); 
% IFUN function will be used later to truncate the result 
% M and N are respectively the length of A and B in some dimension 
switch lower(shape) 
    case 'full' 
        ifun = @(m,n) 1:m+n-1; 
    case 'same' 
        ifun = @(m,n) ceil((n-1)/2)+(1:m); 
    case 'valid' 
        ifun = @(m,n) n:m; 
    otherwise 
        error('convnfft: unknown shape %s', shape); 
end 
classA = class(A); 
classB = class(B); 
ABreal = isreal(A) && isreal(B); 
% Special case, empty convolution, try to follow MATLAB CONVN convention 
if any(size(A)==0) || any(size(B)==0) 
    szA = zeros(1,nd); szA(1:ndims(A))=size(A); 
    szB = zeros(1,nd); szB(1:ndims(B))=size(B); 
    % Matlab wants these: 
    szA = max(szA,1); szB = max(szB,1); 
    szC = szA; 
    for dim=dims 
        szC(dim) = length(ifun(szA(dim),szB(dim))); 
    end 
    A = zeros(szC,classA); % empty -> return zeros 
    return 
end 
power2flag = getoption(options, 'Power2Flag', true); 
if power2flag 
    % faster FFT if the dimension is power of 2 
    lfftfun = @(l) 2^nextpow2(l); 
else 
    % slower, but smaller temporary arrays 
    lfftfun = @(l) l; 
end 
if GPU % GPU/Jacket FFT 
    if isa(classA,'single') 
        A = gsingle(A); 
    else 
        A = gdouble(A); 
    end 
    if isa(classB,'single') 
        B = gsingle(B); 
    else 
        B = gdouble(B); 
    end 
    % Do the FFT 
    subs(1:ndims(A)) = {':'}; 
    for dim=dims 
        m = size(A,dim); 
        n = size(B,dim); 
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        % compute the FFT length 
        l = lfftfun(m+n-1); 
        % We need to swap dimensions because GPU FFT works along the 
        % first dimension 
        if dim~=1 % do the work when only required 
            swap = 1:nd; 
            swap([1 dim]) = swap([dim 1]); 
            A = permute(A, swap); 
            B = permute(B, swap); 
        end 
        A = fft(A,l); 
        B = fft(B,l); 
        subs{dim} = ifun(m,n); 
    end 
else % Matlab FFT 
    % Do the FFT 
    subs(1:ndims(A)) = {':'}; 
    for dim=dims 
        m = size(A,dim); 
        n = size(B,dim); 
        % compute the FFT length 
        l = lfftfun(m+n-1); 
        A = fft(A,l,dim); 
        B = fft(B,l,dim); 
        subs{dim} = ifun(m,n); 
    end 
end  
if GPU 
    A = A.*B; 
    clear B 
else 
    %inplace product to save 1/3 of the memory 
    %inplaceprod(A,B); 
    %change made by KHANH T NGO KTN6@PITT.EDU 
    %for compatibility with MATLAB 2019a WINDOWS 10 
    A = A.*B; 
end 
% Back to the non-Fourier space 
if GPU % GPU/Jacket FFT 
    for dim=dims(end:-1:1) % reverse loop 
        A = ifft(A,[]); 
        % Swap back the dimensions 
        if dim~=1 % do the work when only required 
            swap = 1:nd; 
            swap([1 dim]) = swap([dim 1]); 
            A = permute(A, swap); 
        end         
    end    
else % Matlab IFFT   
    for dim=dims 
        A = ifft(A,[],dim); 
    end 
end 
% Truncate the results 
if ABreal 
    % Make sure the result is real 
    A = real(A(subs{:})); 
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else 




    % Cast the type back 
    if isa(class(A),'gsingle') 
        A = single(A); 
    else 
        A = double(A); 
    end 
end 
end % convnfft 
%% Get default option 
function value = getoption(options, name, defaultvalue) 
% function value = getoption(options, name, defaultvalue) 
    value = defaultvalue; 
    fields = fieldnames(options); 
    found = strcmpi(name,fields); 
    if any(found) 
        i = find(found,1,'first'); 
        if ~isempty(options.(fields{i})) 
            value = options.(fields{i}); 
        end 
    end 
end 
4.6.2 Mathematical Derivation 
4.6.2.1 From Chen 2002 Eq. 7 to Bungay 2011 Eq. 20 
Chen 2002: Chen, K. C.; Hoistad, M.; Kehr, J.; Fuxe, K.; Nicholson, C. J Neurochem 2002, 
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Step 2: Using Leibniz’s integral rule, move the partial derivative inside the integration. This works 




while the integration is with respect to u 
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Step 3: Apply the partial derivative to terms that contains the variable r 
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Step 4: Change of variables 
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Step 5: Apply the following relationships d/dx K0(x) = -K1(x)    d/dx J0(x) = -J1(x)     d/dx Y0(x) = 
-Y1(x)    
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Step 7: Apply the relationship  𝐽1(𝑢)𝑌0(𝑢) − 𝑌1(𝑢)𝐽0(𝑢) = 2/(πu) 
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Step 8: Simplifies 
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4.6.2.2 From Chen 2002a Eq. 6 to Chen 2002b Eq. A6 
Chen 2002a: Chen, K. C.; Hoistad, M.; Kehr, J.; Fuxe, K.; Nicholson, C. J Neurochem 
2002, 81, 94-107. Chen 20002b: Chen, K. C.; Hoistad, M.; Kehr, J.; Fuxe, K.; Nicholson, C. J 
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Step 2: Change derivative variable appropriately and apply the following relationships d/dx K0(x) 
= -K1(x)    d/dx J0(x) = -J1(x)     d/dx Y0(x) = -Y1(x)    
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4.6.2.3 Equivalency of Volume Bases 
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Starting from the same ECS volume basis, one can derive Nicholson 2001, Chen 2002 and 
Bungay 2011’s expressions. Nicholson 2001: Nicholson, C. Rep. Prog. Phys. 2001, 64, 815-884. 
Chen 2002: Chen, K. C.; Hoistad, M.; Kehr, J.; Fuxe, K.; Nicholson, C. J Neurochem 2002, 81, 
94-107 and Chen, K. C.; Hoistad, M.; Kehr, J.; Fuxe, K.; Nicholson, C. J Neurochem 2002, 81, 
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108-121. Bungay 2011: Bungay, P. M.; Sumbria, R. K.; Bickel, U. J Pharm Biomed Anal 2011, 
55, 54-63. 
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4.6.2.4 Equivalency of Permeability Methods 
 
Figure 4.6-1. Relationship between methods to evaluate overall permeability. 
(A) The partial derivative with respective to membrane radius, evaluated at the outer radius, of 
U(r,t) is the solution for the time-dependent overall permeability ( )P t . 
(B) From U’(r,t), at large time t, the integral term drops out, and the time-dependent permeability 
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(C) Assuming a fully permeable membrane ( m → 1, and Dm >> DECS), U(r,t) simplifies to the 
time-dependent normalized radial concentration distribution function in the ECS: 
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(D) ?̂?(𝑡) is numerically evaluated with a fully permeable membrane assumption ( m = 1, and Dm 
= 1 m2/s) to obtain PECS(t). 
(E) ?̂?(𝑡) is numerically evaluated with a fully permeable ECS assumption ( ECS = 1, and DECS = 
1 m2/s) to obtain Pm(t). 
(F) ?̂?(𝑡) is numerically evaluated to obtain overall permeability. 
(G) At t >> 0.001 s, Pm, t→∞ approximates Pm(t). 
(H) The partial derivative with respective to membrane radius, evaluated at the outer radius is the 
solution for PECS(t).  
(I) PECS(t) is numerically evaluated. 
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4.6.3 Additional Figures 
 
Figure 4.6-2. Membrane permeability as a function of time across a range of uptake rate constant with 
conditions similar to Chen (2002). 
 
Figure 4.6-3. Comparison between Chen's analytical (diamond) and numerical (dashed line) method at long 
time (left) and short time (right). 
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5.0 Comprehensive Quantitative Microdialysis: Experimental Method and Data Fitting 
5.1 Chapter Summary 
The term “quantitative microdialysis” has been used to describe experimental protocols 
and associated assumptions that provide an estimate of the extracellular concentration of an 
endogenous neuroactive species like dopamine (DA) in a brain region. Most prominently, the no 
net flux method uses step-changes in concentration of the sought-for species in the microdialysis 
inlet and steady-state measurements of the concentrations in the microdialysis outlet. Here, we 
describe the use of measurements made during the transition of the concentration in the 
microdialysis outlet from initial to final steady state concentrations to infer information including 
the concentration of DA far from the microdialysis probe, CECS∞. This procedure, comprehensive 
quantitative microdialysis (CQM), includes a set of assumptions, a mathematical model, an 
experimental method, and a curve fit method that can be used to determine physiological 
parameters that affect a transient response. The model based on earlier work by Bungay et al. is in 
the previous chapter. To improve time resolution and thus the quality of the resulting parameters 
derived from the curve fit, the experiment uses time-interleaved sampling. The curve fit uses an 
adaptive simplex optimization to adjust fitting parameters to find a minimum residual sum of 
squared differences between experiment and the model. Measuring transient responses to 
retrodialysis of 50, 100, and 150 nM DA using 45 s Fast Microdialysis in the rat nucleus 
accumbens, the CQM curve fit for each of three transients yielded CECS∞ and extraction fraction 
comparable to a standard no-net-flux measurement, and an uptake rate constant comparable to 
literature values. With 15 s measurements, tissue porosity could also be determined. CQM 
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dramatically reduced the experimental time while obtaining more biologically relevant 
information compared to traditional quantitative microdialysis. 
5.2 Introduction 
Microdialysis30,192 is not only the most widely used method for brain sampling9,12,31,32,193, 
but the number of new applications and studies for it has steadily risen35,45,194. It provides a sample 
for determination of the concentrations of target analytes in the dialysate. It is a robust technique 
that can be used in both anesthetized and awake animals of sizes ranging from small rodents195,196 
to primates197, including human198,199. In recent years, breakthroughs in brain microdialysis 
techniques have improved probe response time200,201, sampling in injured tissue86,122, the time 
resolution of online analysis74,76-78, and other aspect of the technique45. This has proved to be 
immensely useful despite the difficulties inherent in inferring concentration of the analytes in the 
brain from measured concentrations in dialysate103. So called “quantitative microdialysis 
techniques”54 can provide estimates of concentrations of substances in the brain with the 
assumption that the microdialysis recovery and extraction fractions are the same55,90.  However, 
these techniques require a significant experimental time which in part is due to the low time 
resolution of typical microdialysis measurements46,47 and the fact that the analyses are based on 
steady-state measurements. 
Recent improvements in microdialysis sampling and detection speed has allowed for 
determination of neurotransmitters and metabolites at the time resolution of 1-3 minutes47,72,76-
78,152,175 with online analysis , and at the time resolution of 2 seconds80,81 with offline analysis. At 
these data acquisition rates, transient responses to chemical97 and behavioral98 stimulations have 
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been observed and analyzed, providing a brief glimpse into what could be achieved with faster 
time resolution and better theoretical and data analysis tools. Research into microdialysis theory, 
on the other hand, has entered a period of inactivity with the most recent mass transport model61 
developed by Bungay et at. in 2011. This model was based on Bungay’s previous work60,84 as well 
as on analytical solutions obtained by Chen et at.58,59. It provided an analytical solution for mass 
transport in the cylindrical coordinate system that incorporates solute uptake and diffusion in the 
extracellular space (ECS). However, there are discrepancies202 between Chen’s and Bungay’s 
mathematical descriptions (which are based on the same underlying differential equation for mass 
transport) which were clarified in the previous chapter.   
Building from Bungay’s work and previous literature for time-dependent microdialysis56-
66,84, we have developed a technique called Comprehensive Quantitative Microdialysis (CQM) that 
can be used to obtain quantitative estimates related to diffusion of solutes and solute reuptake in 
the extracellular space by analysis of a transient response in solute concentration experimentally 
measured at the detector following a step change in the solute concentration at the probe inlet. 
Note that the overall system time response includes physiological parameters as well as 
experimental parameters. Thus, to deduce the physiological parameters, the method must 
adequately account for the experimental parameters. The technique has three components: 
mathematical model and associated assumptions, experimental method, and a curve-fitting 
method. In the previous chapter, I described the mathematical model and associated assumptions, 
and demonstrated it with a simulation tool and in vitro experiments. Here, I describe the in vivo 
experiment and the curve-fitting method.  
The fitting algorithm is based on Nelder-Mead Simplex Optimization203,204 (NMS), a 
commonly used numerical method for finding a minimum of an objective function (in this case, 
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the residual sum of square differences between experiment and the model, “RSS”) in a 
multidimensional space (in this case, the fitting parameters). The general principle of our NMS 
variant is similar to the Stochastic Nelder-Mead Simplex proposed by Chang (2012)205, where 
global and local random searches are added to NMS to enhance the probability of the fit to find 
global minimum. We named our NMS variant “Adaptive Random Sampling Simplex” (ARS) for 
its main feature of performing random new searches around the current minimum, adaptively using 
said minimum as input for the search.  
Using the comprehensive quantitative microdialysis mathematical model previously 
described202, the curve fit method was able to determine microdialysis transport time, probe 
dispersion, tissue morphology and solute uptake in the extracellular space. We demonstrated this 
approach with two examples. In one, we used the curve fit to determine transport time, dispersion, 
and solute concentration and uptake rate in the rat nucleus accumbens from transient response to 
retrodialysis of DA. Quantitative estimates of solute concentration and uptake rate were compared 
with a no-net-flux experiment. In the second example, we designed the experimental method to 
improve the effective time resolution of Fast Microdialysis from 60 s to 15 s by utilizing time-
interleaved sampling182, measuring the response to identical step-changes in retrodialyzed 
concentrations of DA once every 60 s four times with each of the four offset by 15s. The CQM 
curve fit was then used to determined tissue porosity and the four physiological and system 




Chemicals, analytical-grade, to make artificial cerebrospinal fluid (aCSF: 142 mM NaCl, 
1.2 mM CaCl2, 2.7 mM KCl, 1.0 mM MgCl2, and 2.0 mM NaH2PO4, pH 7.4) and liquid 
chromatography mobile phase (sodium acetate, sodium octyl sulfonate, EDTA, acetonitrile, and 
acetic acid) were acquired from either Fisher Scientific (Fair Lawn, NJ) or Sigma (St. Louis, MO). 
Retrodialysis solution contains dopamine, aCSF and 50 M of L-ascorbic acid to prevent oxidation 
of dopamine67. Dopamine hydrochloride and L-ascorbic acid, analytical-grade or better, were 
purchased from Sigma (St. Louis, MO). 
5.3.2 Microdialysis Probe 
Concentric probes (280 μm diameter, 4 mm length membrane) were constructed from 
hollow fiber membranes (13 kDa MWCO, Spectra/Por RC, Spectrum Laboratories Inc., Rancho 
Dominguez, CA). The probe inlet and outlet were fused silica capillaries (75 μM I.D., 150 μM 
O.D., 110 cm long, Polymicro Technologies, Phoenix, AZ). The inlet capillary was connected to 
a gastight syringe (1 mL, Hamilton 81320, Hamilton Company, Reno, NV). Perfusate flow (0.60 
μL/min for 60 s sampling or 0.80 μL/min for 45 s sampling) was driven by a microliter syringe 
pump (PHD 4400, Harvard Apparatus, Holliston, MA). The outlet capillary of the probe was 
connected to the inlet port of the LC injector. A 100-psi backpressure regulator and a bubble-
induced dampener181 was added to the syringe for the time-interleaved experiment to improve flow 
accuracy and thus the quality for DA determination and of the curve fit.  
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5.3.3 Microdialysis Probe Implantation Procedure 
All procedures involving animals were approved by the Institutional Animal Care and Use 
of Committee of the University of Pittsburgh. Male Sprague-Dawley rats (250-350 g, Hilltop, 
Scottsdale, PA) were anesthetized with isoflurane (5% volume for induction, 2.5% volume for 
maintenance, Henry Schein Animal Health, Elizabethtown, PA) then wrapped in a heating blanket 
(37°C) and placed in a stereotaxic frame. Using flat skull coordinates, probes were lowered slowly 
(5 µm/sec) using a micropositioner (Model 2660, David Kopf Instruments, Tujunga, CA) into the 
nucleus accumbens (1.6 mm anterior, 1.4 mm lateral from bregma, and 8.0 mm below dura). 
Probes were secured with bone screws and acrylic cement, and the incision was closed with 
sutures. Anesthesia was removed and rats were placed in a BASi Raturn chamber (West Lafayette, 
IN) for housing with free access to food and water. Rats were allowed a recovery period of 24 hrs 
priors to any dopamine measurements.  
5.3.4 Online Microdialysis-LC-EC 
The microdialysis/liquid chromatography system was similar that used in our previous 
work97,98. The perfusate syringe was refilled every 24 hr, at least three hours prior to any dopamine 
measurement. For online experiments, the outlet capillary of the probe was connected to the LC 
injection valve (8-port nanobore, electrically actuated, C72NX-4678D, Valco Instruments, 
Houston, TX) so that the dialysate is loaded into one of two fused-silica sample loops (600 nL, 75 
μm I.D., 360 μm O.D, Polymicro Technologies, Phoenix, AZ). While one sample loop is being 
loaded from the probe, dialysate from the other loop is injected into the LC column for separation.  
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Capillary columns (7.5 cm long, 150 μm ID, Polymicro Technologies, Phoenix, AZ) were 
packed with 1.7 μm BEH C18 reversed-phase particles (Waters, Milford, MA) at a minimum 
pressure of 1400 bar. Mobile phase was delivered at a flow rate of 8.5 μL/min. (LC-30AD, 
maximum pressure of 1300 bar, Shimadzu, Columbia, MD). The column was heated to 47.5°C 
with a thermostatted heater. The mobile phase (100 mM sodium acetate, 1.75 mM SOS, 0.150 mM 
EDTA, 3.0 % v/v acetonitrile, and 2.0 % v/v acetic acid) was filtered and degassed with three 
passes of vacuum filtration using a 0.22 μm nylon filter (Osminics, Minnetonka, MN).  
5.3.5 Amperometric Detection 
Dopamine was detected at 400 mV (vs Ag/AgCl 3 M NaCl) using a BASi radial-style 
flowcell, 3 mm glassy carbon electrode with a 25 μm thick gasket and BASi Epsilon potentiostat 
(West Lafayette, IN). Dopamine peaks were integrated using MATLAB, then peak areas were 
compared against pre- and post-run calibration curves to determine dopamine concentration. The 
detector sensitivity was 0.106 ± 0.002 nA·s/nM with a limit of quantitation98,202 of 1.0 nM. 
5.4 Results and Discussion 
5.4.1 Adaptive Random Sampling Simplex Fitting 
All the processes that contribute to the shape of the resulting transient are included in the 
model202. Thus, our objective was to fit the model202 to raw experimental results (nM DA vs. time) 
from a step-change in concentration of DA in the microdialysis system. The processes/parameters 
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in the model aside from physiological parameters are the transport time from the beginning of the 
probe inlet to the end of injector loop, hydrodynamic dispersion in the microdialysis system, and 
averaging of the concentration over time due to the discrete nature of the LC analysis method (See 
Supplementary Information 5.6.1.1). The non-linear fitting algorithm, written in MATLAB 
(complete, annotated computer code is shown in Supplementary Information 5.6.2.1), fits the 
model to experimental data by adjusting parameters of the model to minimize residual sum of 
squared differences (RSS) between data and the model. The model contains the following 
parameters: characteristic time ti (characteristic time of the concentration profile at the end of 
injector loop, the difference between this and the time at which a step-change in concentration 
occurs in the microdialysis probe is the time required to transport the sample through the probe, 
inlet and outlet capillaries and injector loop), hydrodynamic dispersion standard deviation σ, ECS 
concentration CECS∞, uptake rate constant k, ECS porosity ϕ, and ECS tortuosity λ. We will refer 
to the curve fit of the four parameters ti, σ, CECS∞, and k to experimental data as a “four-dimensional 
ARS”, or 4DARS. The five-dimensional 5DARS method additionally includes the parameter 𝜙, 
and the six-dimensional 6DARS method additionally includes the parameter λ. When discussing 
the Nelder-Mead algorithm we will use analogous abbreviations:  4DNMS, 5DNMS and 6DNMS. 
The ARS fitting algorithm is based in part on Nelder-Mead Simplex Optimization203,204,206. 
In mathematics, a simplex is a generalization of a group of n + 1 points in an n-dimensional space. 
These points form a “surface” in the space where they reside and each n-dimensional point may 
be considered a “vertex”. In curve fitting applications, a simplex optimization that fits for n 
parameters uses calculations based on the n + 1 vertices. The simplex optimization calculates 
values of an “objective function” at each vertex to find the minimum (or maximum) value of the 
objective function. Typically, the objective function is the RSS and the algorithm seeks to 
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minimize it. NMS, noted for its simplicity in implementation and its speed, often provides a 
significant reduction (or improvement in a maximization problem) in the objective function with 
a relatively small number of function evaluations. However, NMS has a strong tendency to 
converge to a local minimum. Due to the presence of noises in practical experimental data, local 
minima exist which hinder the algorithm’s ability to find best-fit parameters. This a problem well-
documented59,189,207 with many proposed solutions208-211. The ARS algorithm, described below, 
was devised to improve the simplex optimization’s likelihood to find the global minimum. It is an 
improvement over NMS based on the Stochastic Nelder-Mead Simplex205, that increased the 
likelihood of finding best fit parameters.  
5.4.1.1 Minimum-Searching Algorithm 
An initialization protocol was created to generate favorable staring conditions. In the 
initialization protocol, the user must give a set of fitting parameters to use as a start point for the 
process. Another start point is created by obtaining estimation for CECS∞ from a linear regression 
of the steady-state concentrations to Bungay’s steady state microdialysis model84, for ti and  from 
a curve fit to Taylor-Aris dispersion77,97, and for k ϕ and λ from user’s input. The best of these 
starting points is augmented with small number of points (e.g. 6 for 5DARS) in the local space and 
a very large number of points (e.g. 32,000) over the entire parameter space. The n + 1 points with 
the lowest RSS are taken as the initial simplex.  
In the ARS process, in every iteration, the probability of the current simplex being in a 
local minimum is inferred through the relative standard deviation (RSD) of the objective function’s 
values at the n + 1 vertices of the simplex. The lower the RSD is, the higher the probability that 
the simplex is in a global minimum. Then, a random search is performed to find a better minimum. 
The scope of this random search is a function of the RSD (see Supplementary Information 5.6.2.3). 
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The ARS procedure is “adaptive” as it continually uses new information (RSD of RSS of the 
current simplex) as input for its next action. Complete, annotated computer code is shown in 
Supplementary Information 5.6.2.1, the minimum-searching algorithm is outlined in 
Supplementary Information 5.6.2.2, and ARS formulation is explained in Supplementary 
Information 5.6.2.3.  
5.4.1.2 Second Fitting Pass with Curvature Weight 
To further enhance sensitivity for k and 𝜙, the two most biologically relevant fitting 
parameters, a two-pass fitting strategy was developed from 5DARS, which is aptly named 
5DARS2P (complete, annotated computer code is shown in Supplementary Information 5.6.2.1). 
In 5DARS2P, the minimum found from a normal 5DARS algorithm is kept as starting point for 
the second pass. The second pass relies on the same fitting algorithm as the first past, however, 
only experimental data around the transient portion of the measurements are used for RSS 
calculation. The transient portion is defined as -4σ to +6σ (acquired from first fitting pass) from 
the midpoint defined as the DA concentration that is midway between the lowest and highest 
concentrations. The transient portion is not symmetrical because the uptake rate only affects the 
curvature after midpoint and not before.  
5.4.1.3 Sensitivity of the Curve Fit 
The curve fit optimizes a large number of parameters (4-6) to a single response, thus careful 
consideration of the effect of correlated parameters is needed. It is important to determine that the 
transient response curve has a selective and sensitive response to each of the curve fit parameters. 
Simulating a transient microdialysis response to a retrodialysis of 150 nM DA solution, using 
probe parameters from Ngo 2020a at the volumetric flowrate of 0.600 μL/min, and ti = -60 s, σ = 
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30 s, CECS∞ = 10 nM, k = 0.2 s
-1, 𝜙 = 0.2, and λ = 1.6, we investigated changes in the transient 
response curve from to changes in each of those parameters across a reasonable experimental range 
(ti = -100 to 100 s, σ = 0 to 100 s, CECS∞ = 0 to 100 nM, k = 10
-4 to 103 s-1, 𝜙 = 0.01 to 1, and λ = 
1 to 3). Figure 5.4-1 shows the curve’s responses to ti, σ, CECS∞, and k. The curve’s horizontal 
displacement is governed by ti (Figure 5.4-1A), its horizontal spread is governed by σ (Figure 
5.4-1B), its vertical displacement is governed by CECS∞ (Figure 5.4-1C), and its vertical spread by 
k (Figure 5.4-1D). While the curve’s responses to ti, σ, and CECS∞ are approximately linear, the 
curve’s response to k is roughly linear to log k. We concluded that the curve fit is sensitive to ti, σ, 
CECS∞, and k and that correlation among the parameters is low. As described below, 4DARS fitting 
of these parameters to simulated noisy data produces consistent and accurate results with narrow 
confidence intervals (C.I.) (Figure 5.4-4A). 
The curve’s response to 𝜙 and λ (Supplementary Information Figure 5.6-2) is similar to 
that of k thus these three fitting parameters are correlated. However, while they are correlated, 
useful information about k, 𝜙, and λ, thus useful biological information, can be obtained from the 
curve fit. Shown in Figure 5.4-2 is the RSS surface of an in vivo experimental data set, obtained 
by varying two (k and 𝜙, Figure 5.4-2A) or three (k, 𝜙 and λ, Figure 5.4-2B) parameters across the 
same range as above, while keeping the others constant. The RSS response to k and 𝜙 (Figure 
5.4-2A) has a very narrow and well-defined “valley” that contain RSS optima, which is centered 
around k ≈ 0.18 and 𝜙 ≈ 0.20.  A robust fitting of both k and 𝜙 to experimental or simulated data 
(5DARS or 5DARS), produces accurate quantitative estimates with a small confidence interval 
(Table 5.4-1). An uptake rate constant and tissue porosity estimation with 10-20% RSD is on par 
with contemporary measurements using established methods167,212.  
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The RSS response to k, 𝜙 and λ (Figure 5.4-2B) is a 3D sheet with a noisy RSS surface, 
however, it still has a well-defined segment that contain RSS optima, which is centered around k 
≈ 0.2, 𝜙 ≈ 0.2 and λ = 1.6.  While the RSS surface is still relatively sensitive to k and 𝜙, the RSS 
surface is not sensitive to λ, resulting a large confidence interval when 6DARS is attempted. 
Fortunately, it has been demonstrated by many research groups, using different techniques, that 
tortuosity for a certain species, measured for a certain brain region, with respective to a certain 
molecule is consistent165,167,184,213-216. Therefore, while it is possible to estimate ECS tortuosity λ 





Figure 5.4-1. Simulated microdialysis transient response to a 150 nM DA retrodialysis.  
Shown are the responses when each of the four parameter (A) ti (B) σ (C) CECS∞ and (D) k is varied while the 






Figure 5.4-2. Residual Sum of Square Surfaces (RSS), calculating by varying the two (A) two, inset: RSS 
centered about minimum, or three (B) correlated parameters to in vivo experimental data.  
The global minimum (blue) consists of a small, defined region with a narrow range of k and 𝜙 centered at k ≈ 
0.18 s-1 and 𝜙 ≈ 0.20, and a larger range of λ centered at λ ≈ 1.6. The white space regions consist of RSS above 
the maximum plotted.  
 
Figure 5.4-3. Comparison between distribution of k (A) and 𝜙 (B) from 1000 repeats of 5DNMS (blue), 
5DARS (red), 5DARS2P (orange) and 4DARS (purple). 
The probability density curve is calculated using Kernel Density Estimator with a bandwidth of 0.01 (s-1 for k, 
unitless for 𝜙). Out of 1000 repeats, the 5DNMS, 5DARS, 5DARS2P, 4DARS methods find the best fit 
parameters 61.6%, 45.8%, 80.9% and 100% of the time, respectively. 
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5.4.1.4  Confidence Interval 
The ARS fitting method is non-deterministic. Repeating the same fit to the same set of data 
multiple times using completely identical conditions (i.e. running an identical MATLAB script 
repeatedly) does not yield identical results. The NMS fitting method is deterministic; however, it 
is chaotic. Repeating the same fit to the same set of data using identical conditions yields identical 
results, however, if the starting conditions are changed then the results change in an unpredictable 
(but repeatable) manner. As demonstrated above, however, the global optimum is in a valley that 
is well defined (Figure 5.4-2). For a robust fit, even if the fit is non-deterministic, results from 
repeated fitting should be representative of the optimum on average. Figure 5.4-3 shows the 
distribution of k and 𝜙 from 1000 repeats of 5DNMS (blue), 5DARS (red), 5DARS2P (orange) 
and 4DARS (purple) to a set of in vivo experimental data. Distribution of the other fitting 
parameters is shown in Supplementary Information Figure 5.6-3. The probability density 
distribution curve is calculated using an alternative method to a histogram, the Kernel Density 
Estimator217,  to obtain a smooth and continuous probability density distribution, using a 
bandwidth of 0.01 (s-1 for k, unitless for 𝜙). Out of 1000 repeats, the 5DNMS converged 
(successfully found best-fit parameters) 65.2% of the time, while 5DARS converged 45.8% of the 
time, 5DARS2P converged 80.9% of the time, and 4DARS always converged. In term of 
distribution quality, the curve fit improves in the order 5DNMS, 5DARS, 5DARS2P, and 4DARS. 
Particularly for the distribution of k and 𝜙 as shown in Figure 5.4-3, the two methods 5DNMS and 
5DARS produce a broad distribution, while 5DARS2P and 4DARS (fixed 𝜙) yield narrow 
distributions with a bell curve resembling a Gaussian distribution. Therefore, 5DARS2P and 
4DARS are the best curve fit methods for 5D and 4D fits, respectively. The 5DNMS and 5DARS 
methods should not be used because of their poorly distributed fitting parameters. 5DARS2P 
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results in the range k of 0.02 to 0.75 (s-1) and 𝜙 of 0.11 to 0.48 (unitless), while 4DARS gives a 
narrow range of k of 0.015 to 0.22 (s-1) with a fixed 𝜙 value of 0.20 (unitless). The 4DARS 
produces a very sharp and narrow distribution for k, while the 5DARS2P produces a broader 
distribution peak for both k and 𝜙. This is because the transient response curve is sensitive to k 
when 𝜙 is fixed, and k and 𝜙 are correlated, as discussed in the previous section. Both methods 
produce good parameter distribution for ti, σ, and CECS∞ (Figure 5.6-3). Repeating the fit 1000 
times therefore provides a population of each fitted parameter representative of the global minima, 
from which a confidence interval can be calculated.  
As shown in Figure 5.4-3 and Supplementary Information Figure 5.6-3, the probability 
density distribution curves of the fitted parameters resemble Gaussian distribution. The width of 
this distribution of 1000 repeats (or any large number of repeats) can be used to estimate the error 
of the curve fit218,219. Here, we use the 95% confidence intervals (95% C.I.) of the fitted parameter 
from the repeats to estimate the 95% C.I. of the curve fit from the repeats. We compared this 
estimation with the commonly used bootstrap confidence interval220-222 (Supplementary 
Information 5.6.1.2 to 5.6.1.4). We found that both methods produce statistically identical 95% 
C.I. (F-test) for all five fitted parameters on all four curve fit methods (Table 5.6-1).  
5.4.1.5 Fit Robustness 
We simulated 16 data sets to test the robustness of the four fitting methods against changes 
in uptake rate constant, microdialysis time resolution, noise in the data, and membrane molecular 
weight cutoff (MWCO). The testing data are simulated with either a low (k = 10-2 s-1) or high (k = 
10 s-1) uptake rate constant, low (15 s) or high (1 s) sampling frequency (time-interleaved182,202 
from 60 s and 4 s microdialysis sampling interval, respectively), low (normally distributed, relative 
RSD = 1%) or high (normally distributed, relative RSD = 10%) noise in dialysate DA , and low 
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(13 kDA) or high (18 kDA) MWCO. The condition in uptake rate constant approximates the 
range for DA in rat nucleus accumbens that we and others102,189 measured. The two MWCO 
chosen are often used in microdialysis experiments, higher MWCO results in better solute 
recovery223 (higher extraction fraction for the same solute but at the same time more solutes). 
The sampling frequencies are based on work presented here and in the literature80,81, and noise 
represents a wide range of uncertainties  for such an experiment. The curve fits were repeated 
100 times. Shown in Figure 5.4-4A is a comparison of relative errors in the fitting parameter k 
for the two selected curve fit methods (4DARS and 5DARS2P). Figure 5.4-4B has relative error 
in the fitting parameter 𝜙 from 5DARS (𝜙 is fixed for 4DARS). Results for the three fitting 
parameters ti, σ, and CECS∞ are shown in Figure 5.6-4. 
Across all simulated conditions, there is no qualitative advantage between 5DARS2P and 
4DARS with respect to fitting of ti, σ, and CECS∞ (Figure 5.6-4). For fitting of k, 4DARS is the clear 
best method for k (relative error less than 36% for all data sets, 95% C.I. smaller than 6% for all 
data set) because 𝜙, which is correlated with k, is not included in the fit.  Fitting results for ti, σ, 
and CECS∞ are usually consistent and accurate (typically less than ±5% error) and have narrow 
confidence intervals (typically smaller than ±1%). Fitting results for k and 𝜙 are less accurate when 
fitting conditions are not favorable (e.g. high uptake rate of 10 s-1 or noise with relative standard 
deviation of 10%), typically underestimating k by 50-60% (with one edge case, set 10 is 
overestimated 3.5 times the actual value), and overestimate 𝜙 by 40-50%. As shown in 
Supplementary Information Figure 5.6-5 and Figure 5.6-6, even with a very high uptake rate 
constant k of 103 s-1, k can be estimated with less than 70% relative error, and 𝜙 can be estimated 
with less than 90% relative error. When k is overestimated, 𝜙 is underestimated, and vice versa. 
At ideal conditions (low uptake rate and low noise, e.g. sets 9 and 11), all four curve fit methods 
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produce accurate and precise results. There are edge cases (e.g. set 10), where k estimation from 
5DARS is inaccurate. We have not been able to identify the source of inaccuracy.  
 
 
Figure 5.4-4. Comparison between relative error of (A) k and (B) 𝜙 from 100 repeats of 5DARS2P (orange) 
and 4DARS (purple, fixed 𝜙 = 0.2) to 16 simulated data sets.  
The tables denote experimental conditions tested: Uptake rate constant k (s-1) Low = 10-2 High = 1; 
Microdialysis sampling frequency (s)  Low = 15; High = 1; Noise σ (Normally distributed) Low = 1%; High = 
10%; MWCO (kDa) Low = 13; High = 18. 5DARS2P produces no successful fit for set 16. 
5.4.2 Curve Fit of In Vivo Experimental Results 
5.4.2.1 Comparison between Quantitative Transient Microdialysis and No Net Flux 
We used 4DARS fitting of the CQM model202 to obtain quantitative estimates of ti, σ, 
CECS∞, and k from transient responses measured experimentally, in vivo online, on an awake and 
freely moving animal using 45 s microdialysis determinations of dopamine in rat nucleus 
accumbens. Tissue porosity 𝜙 (0.2) and tortuosity λ (1.6) were fixed, using literature values61 for 
the same animal and brain region. These results are compared to quantitative estimates from the 
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no net flux method, which primarily estimates steady-state extraction fraction Ed, CECS∞ 
12 and is 
seldomly used to estimate k 185. From the CQM model202, steady state extraction fractions Ed,t→∞ 
can be estimated by calculating the time-dependent extraction fraction at large time: 
 
(t)
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Equation 5.4-1. Time-dependent extraction fraction Ed(t) 
where Q (m3/s) is the flow rate of the dialysate, So (m
2) is the outer surface area of the membrane, 
and (t)P (m/s) is the time-dependent overall permeability defined in the CQM model202. These 
quantities (Ed(t) and (t)P ) are intermediate steps in the CQM model in predicting Cdet(t) from 
known and fitted parameters.  
The transient responses were induced by 30-min long retrodialysis of 50, 100, or 150 nM 
DA. The entire response curve was used for data fitting, which also includes approximately 30-
min of basal measurement before DA retrodialysis. To improve MATLAB convolution calculation 
speed, the time axis of each response was offset so that the midpoint as defined above is near zero. 
The results were then compared with the traditional quantitative technique, no net flux54,183, in 
which linear regression is performed on 45 min of basal data before the first transient and the 
steady-state values from each transient response. Identifying the steady state is non-trivial, as 
Taylor-Aris dispersion and solute uptake in the brain broadens the curve, and the in vivo 
measurements are inherently noisy. The steady state of a transient response was approximated to 
begin when the transient responses reached 95% of the average of the 30 highest measured 
concentrations. Notably, there is a periodic oscillation in DA concentration at this steady state. The 
periods of this fluctuation are different between the three retrodialysis runs. Additionally, this 
fluctuation is not present in in vitro calibration nor in in vivo measurements in this or our prior 
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work97,98. There is also no literature precedent of Fast Microdialysis measurement of steady-state 
retrodialyzed responses. We hypothesize that this oscillation could have a biological origin69 that 
we have been not able to identify.   
Shown in Figure 5.4-5A is the No-Net-Flux linear regression from basal concentrations (n 
= 55) and retrodialysis of (nM DA) 50 (n = 38), 100 (n = 36), and 150 nM (n = 32), where the 
slope of the regression is the extraction fraction Ed (0.245 ± 0.007), and the X-intercept of the 
regression is the quantitative estimate for CECS∞ (17±3 nM). This experiment was performed in 3 
hours using 45 s microdialysis. For a traditional 10-min microdialysis experiment, a full day of 
experimental work per extraction fraction determination is common102,185. In contrast, each of the 
hour-long transients at 45 s time resolution can be used for 4DARS fitting of the CQM model to 
the data. Each transient fitting gives ti, σ, CECS∞, and k, as well as Ed,t→∞. Values of CECS∞ obtained 
from the curve fits are 18.48±0.03, 15.8±0.3, 14.26±0.08 nM for the 50, 100, and 150 nM 
retrodialysis, respectively. They, as well as CECS∞ averaged from all three fits (AVG±SEM) 
(16.2±1.2 nM), are statistically identical (t-test) to ones obtained from the No-Net-Flux regression 
(17±3 nM). The extraction fractions, Ed, determined from the three transients were 0.227±0.004, 
0.256±0.005, 0.256±0.005 for 50, 100, and 150 nM retrodialysis, respectively, 0.246±0.01 
averaged from all three). These are comparable with the No-Net-Flux regression (0.245 ± 0.007). 
Finally, the uptake rate constant k (0.52±0.00, 1.15±0.00 and 1.15±0.00 s-1 for 50, 100, and 150 
nM retrodialysis, respectively, 0.94±0.21 averaged from all three) is comparable with previous 
measurements (1.9-2.9 s-1) made in the same brain region (nucleus accumbens) of rat using 
microdialysis185, but at a significant experimental time cost (2 days per k determination). The 
analytical instrument parameters ti and σ cannot be obtained from a No-Net-Flux experiment and 
are not traditionally determined in a microdialysis experiment. However, they are of immense 
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usefulness to behavior studies. The value of ti can be used to relate changes in the measured DA 
concentration to specific behavior recorded as a video98. The value of σ dictates the response time 
of a probe and the time resolution of the method.  It is important to note that microdialysis in 
operant chambers is carried out with a swivel in the microdialysis flow stream. This is inimical to 
time resolution. We earlier reported on a rotating operant chamber which allows for video 
observation of behavior and fast microdialysis98. In short, quantitative analysis using CQM 
provides more information than the traditional quantitative technique, but at a fraction of the 
experimental time cost. 
 
Figure 5.4-5. Comparison between two quantitative microdialysis techniques:  
(A) no net flux linear regression from basal concentrations (n = 55) and 50 (n = 38), 100 (n = 36), and 150 nM 
(n = 32) 30-min retrodialysis of DA, line of best fit (black) is generated from slope and intercept from the 
regression; and (B) 4DARS curve fit of 150 nM 30-min retrodialysis of DA, Blue: curve fit prediction, 
Orange: experimental measurements. 
5.4.2.2 In Vivo Quantitative Transient Microdialysis at 15 S Effective Time Resolution  
We obtained quantitative estimates of ti, σ, CECS∞, k and 𝜙 using 5DARS fitting of the CQM 
model to transient responses measured experimentally, in vivo online, on an awake and freely 
moving animal using microdialysis at 15 s effective resolution. Tissue tortuosity λ (1.6) was fixed, 
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using a literature value61. Additionally, the tissue porosity 𝜙 (0.2) was fixed for a 4DARS fitting. 
Eight transient responses to 5-min retrodialysis of 150 nM DA were measured using 60 s 
microdialysis in conjunction with time interleaved sampling (Supplementary Information 5.6.1.1) 
to determine duplicate responses with 15 s time resolution. As previously done, the time axis of 
the combined response was offset so that the middle Cdet data point of the response near zero. 
Shown in Figure 5.4-6 is a comparison between the predicted curve calculated with 5DARS and 
the in vivo experimental data.    
The fitted parameters from both the 4DARS and 5DARS2P curve fits are shown in Table 
5.6-1. The curve fits estimated comparable even if statistically different mean (t-test) and 95% C.I. 
(F-test) for the fitting parameters ti, , CECS∞ and k. We noted that both CECS∞ and k measured on 
this single animal were lower than results typically measured by our own method and published 
results, but they are in the same order of magnitude. These results are not out of the ordinary, as 
CECS∞ and k estimates in the literature have differed by one (k)102,189 to two (CECS∞)
49,52,90 orders 
of magnitudes. Lastly, tissue porosity 𝜙 determined by the curve fit (0.20±0.03) is comparable to 
literature166,184,224. All of these parameters had very narrow 95% C.I.  (±1% or less for ti, , CECS∞ 
and k; ±15% for 𝜙) because the fits were repeated 1000 times and therefore the uncertainty of the 
mean is small. These initial results in this work showed that transient microdialysis analyzed with 
CQM can greatly expand the quantitative capability of microdialysis techniques toward 
measurement regimes (e.g. tissue morphology) that are previously not accessible while 
significantly reduces experimental time cost at the same time.  
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Figure 5.4-6. 5DARS curve fit of transient response to retrodialysis of 150 nM DA at 15 s effective time 
resolution.  
Orange: in vivo experimental, Blue: curve fit. 
Table 5.4-1. Comparison between 4DARS and 5DARS curve fits (1000 repeats) of in vivo experimental data 
at 15 s effective time resolution. 
 4DARS 5DARS2P 
Transport time ti (s) -57.93±0.01 -57.95±0.01 
Dispersion standard deviations (s) 32.97±0.01 32.97±0.00 
 Tissue concentration CECS∞ (nM) 3.95±0.04 3.92±0.01 
Uptake rate constant, k (s-1) 0.18±0.00 0.19±0.00 
Tissue porosity ϕ 0.2 (fixed) 0.20±0.03 
5.4.3 Limitations of the Method 
The CQM model relies on a set of assumptions and thus poses limitations that we discussed 
in the accompanying paper202 and summarized here. The trauma layer is not considered thus 
extraction fraction is overestimated and solute concentration in the ECS is underestimated because 
extraction fraction and relative recovery are assumed to be equal. First-order uptake rate constant 
is assumed instead of Michaelis-Menten kinetics, thus is only valid for solute with high Km -
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compared to solute concentration. The model assumed one-dimensional radial mass transport and 
as a result, calculations are inaccurate202 for short probe (1.7 mm or less), and for species with very 
low uptake rate (10-2 s or less) at long time (600 s or more). Lastly, MATLAB numerical precision 
limits the range of uptake rate calculation to 10-6 to 104 s-1 for typical rates of diffusion (order of 
10-10 m2/s). In this work, the CQM experiment and curve fit methods made additional assumptions 
and therefore have additional limitations that we must recognize. 
5.4.3.1 Method Validation 
The present work was performed on a limited number of animals (n = 2), measuring a 
single neurotransmitter (DA), in a brain region specially chosen to be favorable to first-order 
uptake rate constant assumption (rat nucleus accumbens). Further experimental work, including 
validation of quantitative estimates by a separate technique (i.e. sensor), is needed to validate our 
findings. However, we note that these findings are consistent with existing literature; and the 
nature of this work focuses on developing and demonstrating the technical feasibility of a 
comprehensive mathematical, experimental and data analysis framework, rather than answering a 
biological question.  
5.4.3.2 Parameter Correlation 
We inferred from simulations that the curve fit is sensitive to ti, σ, CECS∞ and k, and k is 
correlated to 𝜙 and λ. We inferred from curve fits of synthesized data over a range of experimental 
conditions that the curve fit is robust. However, these are qualitative assessments and the curve fit 
can benefit from a quantitative analysis of parameter orthogonality, correlation, and 
insensitivity225-227. 
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5.4.3.3 Time-Interleaved Sampling  
We used a time-interleaving process to increase the time resolution of our transient 
response measurement. The success of this process depends on numerous (eight) transient 
responses from a retrodialysis of a neuroactive solute (dopamine) on an animal being identical. 
While we successfully reconstructed a single transient and elucidated useful biological 
information, the assumption may not always hold. Microdialysis measurements in the seconds 
timescale80 is feasible and will significantly improve transient response measurements.  
5.4.3.4 Parameter Space of the Curve Fit  
Even though the curve fit is robust and can determine k and 𝜙 with respectable accuracy 
and precision with k as high as 103 s-1 as discussed and shown in Supplementary Information Figure 
5.6-5 and Figure 5.6-6, the same figures also show that even with a “perfect” theoretical probe (1 
s dispersion standard deviation) and detector (0.1 s response time) with no noise, our method 
cannot determine with complete accuracy k and 𝜙 simultaneously when k is higher than 1 s-1.   
5.5 Conclusion 
In this work, we have presented the last two out of the three components of Comprehensive 
Quantitative Microdialysis (CQM): (1) a mathematical model and associate assumptions to 
describe the transient response of the solute measured at detector as affected by phycological and 
analytical system factors, (2) an experimental method to determine a transient response in solute 
concentration at the detector resulting from a step change in solute concentration at the probe inlet 
at an effective time resolution of 15 s, online, in vivo, on an awake and freely moving animal; and 
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(3) a simplex optimization method for curve fitting a model to the transient response to determine 
biological (tissue porosity, solute ECS concentration and uptake rate) and instrument (transport 
time, dispersion) factors that affect the transient response. At the time resolution of 45 s, CQM can 
determine transport time, dispersion, solute concentration, uptake rate, and extraction fraction from 
a single transient response. Extraction fraction can also be calculated. At the time resolution of 15 
s, CQM can additionally determine tissue porosity.  The solute ECS concentration and calculated 
extraction fraction from the curve fit are comparable to results from a No-Net-Flux experiment 
performed at the same time on the same rat. The measured uptake rate constant is comparable to 
literature values measured with microdialysis in the same brain region. Transient response fitting 
with CQM not only provides more information than traditional, steady-state microdialysis, but in 
addition the experimental time is also significantly reduced. These results represent a step forward 
for the microdialysis technique as a whole. This present work also shows a much-needed 
improvement in microdialysis time resolution of dopamine, which is an on-going goal in our 
laboratory and many others74,80,81,174,200,228,229. 
5.6 Supplementary Information 
5.6.1 Methods 
5.6.1.1 The Influence of Time Interleaved Sampling and Loop Averaging 
Time interleaved sampling is a technique used in signal processing182, where multiple 
analog-to-digital converters are used in parallel to digitize signal from a single continuous analog 
source at the same data acquisition rate but the timing of each converter is offset from the others 
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by a fraction of the time corresponding to the data acquisition rate, thus increasing the time 
resolution. Time interleaved sampling microdialysis is an analogous technique that uses a single 
detector is to measure N repeats of the transient response. The repeats assumed to be identical. 
Olson and Justice (1993) 168 showed that hour-long transient repeats made across multiple rats on 
multiple days are repeatable and can be used create a single response.  
It is important to account for the fact that the LC injector loop provides an average 
concentration for the volume captured by the loop when contemplating time interleaved sampling. 
Figure 5.6-1 shows a graphical representation of time interleaved sampling microdialysis where 
the effective time resolution is tripled for a chromatographic detector. For a chromatographic 
detector, the concentration determined for a sampling interval is the average of the concentrations 
sampled in the loop (Figure 5.6-1, top).  As demonstrated, even though the time interleaved 
sampling process increased the effective time resolution and the discrete measurements now better 
represent the curvature of the transient response, the response measured by a discrete detector is 
different than that measured by a continuous detector. This is because the concentration gradient 
in a loop is averaged to a single data point. The smaller the sampling loop (thus, the sampling 
time), the closer to the continuous measurement the discreet measurement is.  
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Figure 5.6-1. A graphical illustration of time interleaved sampling microdialysis which a chromatographic 
detector where the effective time resolution was tripled from 45 s (bottom, left) to 15 s (bottom, right).  
The boxes on top represent the continuous concentration gradient in the sampling loops. The solid line 
represents a transient response measured by a continuous detector, and the dots by a chromatographic 
detector. The average concentration measured from a loop is assigned to the experimental time at the 
injection time (end of loop). 
5.6.1.2 Bootstrap Confidence Interval 
The bootstrap approach220,222,230 can be used to estimate the uncertainty of the fitted 
parameters. We present this uncertainty as the 95% confidence interval (95% C.I) of the fitted 
parameters. To sample a distribution of a fitting parameter, the fitting routine is repeated N times 
to acquire N samples of the fitting parameter. The fitting routine uses completely identical 
conditions, however because it is non-deterministic, each repeat produces a different result for 
each fitting parameter. The N samples are resampled with replacement M times. The bootstrap 
principle postulates that the distribution of the M resamples approximates the distribution of the N 
samples, and for a chosen statistic (e.g. mean), the statistic computed from M resamples 
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approximates statistic computed from N samples. While repeating the fitting algorithm to obtain a 
large number of N for a well-sampled distribution is hard, resampling to create a well-sampled 
distribution is trivial, and M can be many times larger than N. The procedure is then repeated for 
the remaining fitting parameters. In practice, the fitting routine is repeated 100 to 1000 times for 
obtain fitted parameter samples, then the results are resampled 10,000 times for bootstrap 
confidence interval.  
5.6.1.3 Empirical Bootstrap 
For each parameter, the error  between a sampled mean x and true mean  is: 
 x = −  
Equation 5.6-1. Error of the sampled mean 
and the error *  between the sampled mean x  and a resampled mean 
*
x  is: 
 
* *
x x = −  
Equation 5.6-2. Error of the resampled mean 
The bootstrap principle offers that the distribution of * approximates the distribution of 
 . Since the resample count M is a very large number, the distribution of * can be found by 




* * * *
0.975
,x x  − −
 
, which approximates the 95% 
C.I. of x : 
 
0.025
* * * *
0.975 0.025 0.975
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Equation 5.6-3. Empirical 95% C.I. 
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5.6.1.4 Studentized Bootstrap 









Equation 5.6-4. Bootstrapped symmetric t-statistic 
Where *T  is the bootstrapped t-statistic of a resample, *X is the mean of the resample, X
is the mean of the sample, 
*
 is the standard deviation of the resample, and n is the size of the 














T 1- quantile of the distribution of T*, which 
approximates the 1- quantile of the distribution of T.  
5.6.2 Computer Codes 






load('invivo_6D_data'); %load data 
                        %x contains time in min 
                        %y contains nM [DA] 
%System parameters 
time_resolution = 1; %s, simulation time resolution 
Q = 0.6; %uL/min, volumetric flow rate 
Q = Q*1e-9/60; %m^3/s, volumetric flowrate 
ts = 60; %s, LC sampling time 
Cin = 150; %retrodialyzed concentration 
D = 6.0e-10; %m^2/s free solution diffusion coefficient 
lambda = 1.6; %ECS tortuosity 
Dm = 1.2734e-10; %m^2/s, membrane diffusion coefficient 
phi_m = 1; %nominal membrane porosity 
L = 4e-3; %m, membrane length 
ro = 140e-6; %m, membrane outer radius 
ri = 100e-6; %m, membrane inner radius 
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%Fitting parameters 
start_ti = -60; %s, starting value for ti, offset raw data to as close to 0 
as possible 
start_sigma = 30; %s, starting value for Taylor Aris sigma 
start_kext = 0.2; %1/s, starting value for reuptake rate constant 
start_Cinf = 5; %nM Da, starting value for Cinf 
start_phi = 0.2; %starting value for phi 
no_sample = 1000; %number of fittings, to calculate fitting statistic 
                %must be greater than or equal to 20 for bootstrap confident 
interval 
bound_ti = 200*[-1 1]; %bounds for ti 
bound_sigma = 200*[1e-6 1]; %bounds for Taylor Aris sigma 
bound_kext = [1e-4 5e3]; %bounds for uptake rate constant 
bound_Cinf = [0 25]; %bounds for Cinf 
bound_phi = [0.1 0.5]; %bounds for phi 
termination_condition = 1e-8; %test criterium, std/avg last n tests, where n 
is number of fit variables 
second_termination_condition = 1e-6; %test criterium, std/avg last n tests, 
where n is number of fit variables 
max_iter = 5000; %maximum number of iterations 
ARS_autostart = 0; %# of run before starting ARS 
alpha = 2; %ARS variable for size, cap no_extend to alpha*200 
beta = 0.2; %ARS variable for extent, must be < 1, cap size_extend to 
beta*parameter value 
RSS_threshold = 0.05; %threshold from global minimum to count as a result, 
relative 
weight_type = 1; %1. full data weight 2. curvature-centric 
%Dependent variables calculation 
start_point = [start_ti start_sigma start_kext start_Cinf start_phi]; %create 
array of starting points 
lower_bounds = [bound_ti(1) bound_sigma(1) bound_kext(1) bound_Cinf(1) 
bound_phi(1)]; 
upper_bounds = [bound_ti(2) bound_sigma(2) bound_kext(2) bound_Cinf(2) 
bound_phi(2)]; 
start_kext_log = log10(start_kext); 
bound_kext_log = log10(bound_kext); 
start_point_log = [start_ti start_sigma start_kext_log start_Cinf start_phi]; 
lower_bounds_log = [bound_ti(1) bound_sigma(1) bound_kext_log(1) 
bound_Cinf(1) bound_phi(1)]; 
upper_bounds_log = [bound_ti(2) bound_sigma(2) bound_kext_log(2) 
bound_Cinf(2) bound_phi(2)]; 
no_var = length(lower_bounds); %number of fitting variables 
no_global_random = 2^15; % number of global random starting points 
%!!!The time axis must be symmetrical for convolution to work properly 
%!!!The time axis must be centered at zero, otherwise code runs very slow 
max_t = 1.5*60*max([abs(min(x)) max(x)]); %maximum boundary to time axis, 
extended by 1.5 
                                                  %longer than time x to 
accomodate calculations  
max_t = round(max_t); %prevent a bug where t is not a whole number   
t = linspace(-max_t,max_t,(2*max_t/time_resolution)+1); %time vector 
%Create a step function 
step = zeros([1,length(t)]); %preallotcate step function 
for i = 1:length(t) 
    if t(i) <=0 
        step(i) = 0; %step is 0 at t <=0 
    else 
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        step(i) = 1;%step is 1 at t > 0 
    end 
end 
So = 2*pi*ro*L; %m^2, membrane surface area 
Pmo = phi_m*Dm/(ro*log(ro/ri)); %m/s, membrane permeability, this log is 
natural log 
Cin = Cin.*step; %create step function for Cin 
%Package the system parameters for local functions 
system_par.t = t; 
system_par.ts = ts; 
system_par.Q = Q; 
system_par.D = D; 
system_par.lambda = lambda; 
system_par.ro = ro; 
system_par.So = So; 
system_par.Pmo = Pmo; 
system_par.Cin = Cin; 
system_par.time_resolution = time_resolution; 
system_par.x = x; 
system_par.y = y; 
%% 
%Estimate starting value for ti, sigma and Cinf 
%Calculate average and standard deviation of the mean of y 
avgy = zeros([length(y(:,1)),1]); 
semy = zeros([length(y(:,1)),1]); 
for i = 1:length(y(:,1)) 
    if length(y(1,:)) > 1 
        avgy(i) = mean(y(i,:)); 
        semy(i) = std(y(i,:))/sqrt(length(y(i,:))); 
    else 
        avgy(i) = mean(y(i)); 
        semy(i) = 0; 
    end 
end 
%Approximate point of 50% rise 
midy = 0.5*(max(avgy)-min(avgy)); 
%Bottom-50% weight array 
weight_TA = zeros([length(y(:,1)),1]); 
for i = 1:length(avgy) 
    if avgy(i) < midy 
        weight_TA(i) = 1; 
        mid_index = i; 
    end 
end 
%Approximate basal concentration 
for i = 1:floor(length(avgy)/2) 
    if avgy(mid_index - i) > 0.10*(max(avgy)-min(avgy)) 
        pct_10_index = mid_index - i; 
    else 
        pct_10_index = mid_index - i; 
        break 
    end 
end 
basaly = mean(avgy(1:pct_10_index )); 
%Approximate plateau concentration 
for i = 1:floor(length(avgy)/2) 
    if avgy(mid_index + i) < 0.90*(max(avgy)-min(avgy)) 
 163 
        pct_90_index = mid_index + i; 
    else 
        pct_90_index = mid_index + i; 
        break 
    end 
end 
plateauy = mean(avgy(pct_90_index:length(avgy))); 
%Estimate Ed and Cinf 
p = polyfit([0;max(Cin)],[min(Cin)-basaly;max(Cin)-plateauy],1); 
Cinf_NNF = -p(2)/p(1); 
start_point(4) = Cinf_NNF; 
%Reformart xs, ys and weights to one column 
y_temp = zeros([length(x)*length(y(1,:)),1]); 
x_temp = zeros([length(x)*length(y(1,:)),1]); 
weighty_temp = zeros([length(x)*length(y(1,:)),1]); 
for i = 1:length(x) 
    for j = 1:length(y(1,:)) 
        y_temp(i+(j-1)*length(x)) = y(i,j); 
        x_temp(i+(j-1)*length(x)) = x(i,1); 
        weighty_temp(i+(j-1)*length(x)) = weight_TA(i,1); 
    end 
end 
y_col = y_temp; 
x_col = x_temp; 
weighty_col = weighty_temp; 
%Fitting for ti and sigma 
syms y_fit x_fit a d ti s int_ta; %define symbolic variables 
ts_TA = ts/60; %sampling interval, min 
y_fit = d+(a/2)*(1+erf((x_fit-ti/60)/(sqrt(2)*(s/60)))); %Taylor-Aris 
function 
int_ta = (int(y_fit,x_fit-ts_TA,x_fit))/ts_TA; %integrated T-A 
int_ta = char(int_ta); %convert sym to char vector 
%curve fitting core 
fo = fitoptions('Method','NonlinearLeastSquares',... %fit options 
        'DiffMinChange', 1e-15,... % Minimum change in coefficients for 
finite difference gradients 
        'MaxIter', 1e6,... % Maximum number of iterations allowed for fit  
        'MaxFunEvals', 1e6, ....%Maximum number of evaluations of model 
allowed 
        'TolFun', 1e-15,... %Termination tolerance on model value 
        'TolX', 1e-15,... %Termination tolerance on coefficient values 
        'Lower',[-inf,bound_ti(1),bound_sigma(1),-inf],... 
        'Upper',[inf,bound_ti(2),bound_sigma(2),inf],... 
        'StartPoint',[max(avgy) start_point(1) start_point(2) min(avgy)]);    
ft = fittype(int_ta,'coefficients',{'a','ti','s','d'},... 
    'independent',{'x_fit'},'dependent',{'y_fit'},'options',fo);  %execute 
fit 
[f,~,~] = fit(x_col,y_col,ft,'Weight',weighty_col); %extract fit data 
fit_coeff = coeffvalues(f).'; %extract fit coeff 
fit_confint = confint(f).'; %extract 95% confident interval 
ti_TA_fit = fit_coeff(2); %second 
sigma_TA_fit = fit_coeff(3); %second 
start_point(1) = ti_TA_fit; %set new start point 
start_point(2) = sigma_TA_fit; %set new start point 
%Calculate curvature-centric weight 
if weight_type == 1 
    weight_curve = ones([length(y(:,1)),1]); 
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elseif weight_type == 2 
    weight_curve = zeros([length(y(:,1)),1]); 
    lower_4_sigma = ti_TA_fit - 4*sigma_TA_fit; 
    upper_6_sigma = ti_TA_fit + 6*sigma_TA_fit; 
    for i = 1:length(x) 
        if x(i)*60 >= lower_4_sigma 
            lower_4_sigma_index = i; 
            break 
        end 
    end 
    for i = 1:length(x) 
        if x(i)*60 >= upper_6_sigma 
            upper_6_sigma_index = i; 
            break 
        end 
    end 
    for i = 1:length(x) 
        if lower_4_sigma_index  <= i && i <= upper_6_sigma_index 
            weight_curve(i) = 1; 
        end 





fit_result = zeros([no_sample,no_var+2]); %preallocate fit result array 
test_matrix = zeros([no_sample,3]); %preallocate test result array 
parfor k = 1:no_sample %cycle through each fitting 
    warning('off','MATLAB:integral:NonFiniteValue') 
    BPe = zeros([1,no_var]); %Preallocate array 
    BPr = zeros([1,no_var]); %same as above ^ 
    BPcr = zeros([1,no_var]) ;%same as above ^ 
    BPcw = zeros([1,no_var]); %same as above ^ 
    %Call variables for parfor loop optimization 
    lower_bounds_log; upper_bounds_log; lower_bounds; upper_bounds; 
start_point_log; 
    w = ones([1,length(x)]); %create weight array, unity 
    %Simplex 1: Calculated Start Points 
    RS1 = start_point; 
    [~, ~, ~, ~, ~, ~, RS1(no_var+1)] = fNgo2019_RSS(RS1(1),RS1(2),RS1(3),... 
                            RS1(4),RS1(5),w,system_par); 
    %Simplex 2: Ramdon Start Points 
    %Generate global random start points in log k 
    RP = zeros([no_global_random,no_var]); 
    SP = zeros([no_global_random,no_var+1]); 
    for i = 1:no_global_random 
        for j = 1:no_var 
            RP(i,j) = lower_bounds_log(j)+rand*(upper_bounds_log(j)-
lower_bounds_log(j)); 
        end 
    end 
    %Return to linear scale 
    RP(:,3) = 10.^RP(:,3); 
    for i = 1:no_global_random 
        warning('off','MATLAB:integral:NonFiniteValue') 
        RP; %call vars to reduce parfor overhead 
        [~, ~, ~, ~, ~, ~, RSS] = fNgo2019_RSS(RP(i,1),RP(i,2),RP(i,3),... 
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                                    RP(i,4),RP(i,5),w,system_par); 
        SP(i,:) = [RP(i,1) RP(i,2) RP(i,3) RP(i,4) RP(i,5) RSS]; 
    end 
    %Set random points where RSS couldn't be computed to high RSS 
    for i = 1:no_global_random 
        if SP(i,no_var+1) == 0 
            SP(i,no_var+1) = 9e5; 
        end 
    end 
    %Sort random points, select best random points, with lowest RSS 
    SP = sortrows(SP,no_var+1); 
    RS2 = SP(1,:); 
    %Compare Simplex 1 and Simplex 2 
    if RS1(no_var+1) < RS2(no_var+1) 
        RS = RS1; 
    else 
        RS = RS2; 
    end 
    %Generate Starting Simplex 
    BP = zeros([no_var+1,no_var+1]); 
    for i = 1:no_var+1 
        for j = 1:no_var 
            BP(i,j) = RS(j)*(0.95 +0.1*rand); 
        end 
        [~, ~, ~, ~, ~, ~, BP(i,no_var+1)] = 
fNgo2019_RSS(BP(i,1),BP(i,2),BP(i,3),... 
                                    BP(i,4),BP(i,5),w,system_par); 
    end 
    test = 1; %initial convergent creteria 
    run = 0; %initial interation count 
    no_extend = 0; %initial Adaptive Random Sampling count 
    disp(['Running fit for Fitting Sample ' num2str(k)])  
    %First pass 
    
%~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~    
    %Simplex loop 
    while test > termination_condition %checking convergent creterium 
    run = run+1; %run count 
    %Set points where RSS couldn't be computed to high RSS 
    for i = 1:length(BP(:,1)) 
        if BP(i,no_var+1) == 0 
            BP(i,no_var+1) = 9e5; 
        end 
    end 
    %sort points 
    BP = sortrows(BP,no_var+1); 
    %Remove worst points, leave (no of dimension+1) for Simplex  
    BP = BP(1:no_var+1,:); 
    remainder = rem(run,100); 
    %Generate Simplex optimization points 
    %Calculate coordinates of extended_reflect point 
    for i = 1:no_var 
        BPe(i) = 3*mean(BP(1:no_var,i))-2*BP(no_var+1,i);  
        if BPe(i) < lower_bounds(i) %check out of bound 
            BPe(i) = lower_bounds(i) + abs(BPe(i)-lower_bounds(i)); 
        end 
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        if BPe(i) > upper_bounds(i) %check out of bound 
            BPe(i) = upper_bounds(i) - abs(BPe(i)-upper_bounds(i)); 
        end         
    end 
    %Calculate coordiates of reflect point 
    for i = 1:no_var 
        BPr(i) = 2*mean(BP(1:no_var,i))-1*BP(no_var+1,i);  
        if BPr(i) < lower_bounds(i) %check out of bound 
            BPr(i) = lower_bounds(i)+ abs(BPr(i)-lower_bounds(i)); 
        end 
        if BPr(i) > upper_bounds(i) %check out of bound 
            BPr(i) = upper_bounds(i) - abs(BPr(i)-upper_bounds(i)); 
        end     
    end 
    %Calculate coordiates of contracted_reflect point   
    for i = 1:no_var 
        BPcr(i) = 1.5*mean(BP(1:no_var,i))-0.5*BP(no_var+1,i);  
        if BPcr(i) < lower_bounds(i) %check out of bound 
            BPcr(i) = lower_bounds(i) + abs(BPcr(i)-lower_bounds(i)); 
        end 
        if BPcr(i) > upper_bounds(i) %check out of bound 
            BPcr(i) = upper_bounds(i) - abs(BPcr(i)-upper_bounds(i)); 
        end             
    end 
    %Calculate coordiates of contracted_worst point 
    for i = 1:no_var 
        BPcw(i) = .5*mean(BP(1:no_var,i))+0.5*BP(no_var+1,i); 
        if BPcw(i) < lower_bounds(i) %check out of bound 
            BPcw(i) = lower_bounds(i) + abs(BPcw(i)-lower_bounds(i)); 
        end 
        if BPcw(i) > upper_bounds(i) %check out of bound 
            BPcw(i) = upper_bounds(i) - abs(BPcw(i)-upper_bounds(i)); 
        end             
    end 
    %Evaluate optimization points, then select new point based on evaluation 
    [~, ~, ~, ~, ~, ~, BPe(no_var+1)] = fNgo2019_RSS(BPe(1),BPe(2),BPe(3),... 
                                        BPe(4),BPe(5),w,system_par); 
    [~, ~, ~, ~, ~, ~, BPr(no_var+1)] = fNgo2019_RSS(BPr(1),BPr(2),BPr(3),... 
                                        BPr(4),BPr(5),w,system_par);                                     
    if  BPe(no_var+1) < BP(1,no_var+1) && BPr(no_var+1) < BP(1,no_var+1) 
        NP = BPe; 
    elseif  BPr(no_var+1) <= BP(floor((no_var+1)/2),no_var+1) 
        NP = BPr; 
    elseif  BPr(no_var+1) <= BP(no_var,no_var+1) %compare new RRS to RSS of 
worst point 
        NP = BPcr; 
    else 
        NP = BPcw; 
    end 
    [~, ~, ~, ~, ~, ~, NP(no_var+1)] = 
fNgo2019_RSS(NP(1),NP(2),NP(3),NP(4),... 
                                       NP(5),w,system_par); 
    if  run > ARS_autostart 
        %KTN's Adaptive Random Sampling 
        %Calculate a set of random points based on new point and weighted 
randomization     
        %no_extend increases with run and with decreasing simplex group size 
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        no_extend = 
round(alpha*(log10(test)*(100/log10(termination_condition)) + 
100*run/max_iter)); 
        %size_extend increases with number of no_extend 
        size_extend = beta*no_extend/(alpha*200);  
        NP_extend = zeros([no_extend,no_var+1]); %preallocate array 
        NP_extend_temp = zeros([no_extend,no_var+1]); %preallocate array 
        for i = 1:no_extend 
            for j = 1:no_var 
                NP_extend(i,j) = NP(j)*(1-size_extend+2*size_extend*rand); 
                if NP_extend(i,j) < lower_bounds(j) %check out of bound 
                    NP_extend(i,j) = lower_bounds(j) + abs(NP_extend(i,j)-
lower_bounds(j));                     
                elseif NP_extend(i,j) > upper_bounds(j) %check out of bound 
                    NP_extend(i,j) = upper_bounds(j) - abs(NP_extend(i,j)-
upper_bounds(j)); 
                end                  
            end 
        end 
        for i = 1:no_extend 
            warning('off','MATLAB:integral:NonFiniteValue') 
            NP_extend; 
            [~, ~, ~, ~, ~, ~, RSS] = ... 
                fNgo2019_RSS(NP_extend(i,1),NP_extend(i,2),NP_extend(i,3),... 
                NP_extend(i,4),NP_extend(i,5),w,system_par); 
            NP_extend_temp(i,:) = [NP_extend(i,1) NP_extend(i,2) 
NP_extend(i,3),... 
                NP_extend(i,4) NP_extend(i,5) RSS] 
        end 
        NP_extend = NP_extend_temp; 
        %Generate global random extend points in log k 
        RP = zeros([no_extend,no_var]); 
        for i = 1:no_extend 
            for j = 1:no_var     
                if i < no_var+2 
                    RP(i,j) = start_point_log(j)*(0.999+0.002*rand); 
                else 
                RP(i,j) = lower_bounds_log(j)+rand*(upper_bounds_log(j)-
lower_bounds_log(j)); 
                end 
            end 
        end 
        %Return to linear scale 
        RP(:,3) = 10.^RP(:,3); 
        %Evaluate RSS of random points 
        SP = zeros([no_extend,no_var+1]); 
        for i = 1:no_extend 
            warning('off','MATLAB:integral:NonFiniteValue') 
            RP; %call var to reduce parfor overhead 
            [~, ~, ~, ~, ~, ~, RSS] = 
fNgo2019_RSS(RP(i,1),RP(i,2),RP(i,3),... 
                                    RP(i,4),RP(i,5),w,system_par); 
            SP(i,:) = [RP(i,1) RP(i,2) RP(i,3) RP(i,4) RP(i,5) RSS]; 
        end 
        NP_extend_full = [NP_extend;SP]; 
        BP = [BP(1:no_var,:);NP;NP_extend_full]; %add new point(s) to Simplex 
    else 
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        BP = [BP(1:no_var,:);NP]; %add new point(s) to Simplex 
    end 
    %calculate test condition without new random points 
    if run < max_iter 
        test = std(BP(1:no_var,no_var+1))/mean(BP(1:no_var,no_var+1)); 
        test_matrix(k,:) = [k,run,test]; %store #run and convergence test 
    else 
        test = 0; 
    end  
    %replace worse point with new point, append random new points to best 
points array   
    end %end current Simplex loop     
    ti_simplex = BP(1,1); 
    sigma_simplex = BP(1,2); 
    Cinf_simplex = BP(1,4); 
    %Generate Starting Simplex 
    BP = zeros([no_var+1,no_var+1]); 
    for i = 1:no_var+1 
        BP(i,1) = ti_simplex; BP(i,2) = sigma_simplex; BP(i,4) = 
Cinf_simplex; 
        BP(i,3) = RS(3)*(0.95 +0.1*rand); BP(i,5) = RS(5)*(0.95 +0.1*rand); 
        [~, ~, ~, ~, ~, ~, BP(i,no_var+1)] = 
fNgo2019_RSS(ti_simplex,sigma_simplex,BP(i,3),... 
                                    
Cinf_simplex,BP(i,5),weight_curve,system_par); 
    end 
    %End first pass 
    
%~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~ 
    %Second pass 
    test = 1; 
    run = 0; 
    while test > second_termination_condition %checking convergent criterium 
    run = run+1; %run count 
    %Set points where RSS couldn't be computed to high RSS 
    for i = 1:length(BP(:,1)) 
        if BP(i,no_var+1) == 0 
            BP(i,no_var+1) = 9e5; 
        end 
    end 
    %sort points 
    BP = sortrows(BP,no_var+1); 
    %Remove worst points, leave (no of dimension+1) for Simplex  
    BP = BP(1:no_var+1,:); 
    %Generate Simplex optimization points 
    %Calculate coordinates of extended_reflect point 
    for i = 1:no_var 
        BPe(i) = 3*mean(BP(1:2,i))-2*BP(3,i);  
        if BPe(i) < lower_bounds(i) %check out of bound 
            BPe(i) = lower_bounds(i) + abs(BPe(i)-lower_bounds(i)); 
        end 
        if BPe(i) > upper_bounds(i) %check out of bound 
            BPe(i) = upper_bounds(i) - abs(BPe(i)-upper_bounds(i)); 
        end         
    end 
    %Calculate coordiates of reflect point 
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    for i = 1:no_var 
        BPr(i) = 2*mean(BP(1:2,i))-1*BP(3,i);  
        if BPr(i) < lower_bounds(i) %check out of bound 
            BPr(i) = lower_bounds(i)+ abs(BPr(i)-lower_bounds(i)); 
        end 
        if BPr(i) > upper_bounds(i) %check out of bound 
            BPr(i) = upper_bounds(i) - abs(BPr(i)-upper_bounds(i)); 
        end     
    end 
    %Calculate coordiates of contracted_reflect point   
    for i = 1:no_var 
        BPcr(i) = 1.5*mean(BP(1:3,i))-0.5*BP(3,i);  
        if BPcr(i) < lower_bounds(i) %check out of bound 
            BPcr(i) = lower_bounds(i) + abs(BPcr(i)-lower_bounds(i)); 
        end 
        if BPcr(i) > upper_bounds(i) %check out of bound 
            BPcr(i) = upper_bounds(i) - abs(BPcr(i)-upper_bounds(i)); 
        end             
    end 
    %Calculate coordiates of contracted_worst point 
    for i = 1:no_var 
        BPcw(i) = .5*mean(BP(2,i))+0.5*BP(3,i); 
        if BPcw(i) < lower_bounds(i) %check out of bound 
            BPcw(i) = lower_bounds(i) + abs(BPcw(i)-lower_bounds(i)); 
        end 
        if BPcw(i) > upper_bounds(i) %check out of bound 
            BPcw(i) = upper_bounds(i) - abs(BPcw(i)-upper_bounds(i)); 
        end             
    end 
    %Evaluate optimization points, then select new point based on evaluation 
    [~, ~, ~, ~, ~, ~, BPe(no_var+1)] = fNgo2019_RSS(BPe(1),BPe(2),BPe(3),... 
                                        
BPe(4),BPe(5),weight_curve,system_par); 
    [~, ~, ~, ~, ~, ~, BPr(no_var+1)] = fNgo2019_RSS(BPr(1),BPr(2),BPr(3),... 
                                        
BPr(4),BPr(5),weight_curve,system_par);                                     
    if  BPe(no_var+1) <= BP(1,no_var+1) && BPr(no_var+1) <= BP(1,no_var+1) 
        NP = BPe; 
    elseif  BPr(no_var+1) <= BP(1,no_var+1) 
        NP = BPr; 
    elseif  BPr(no_var+1) <= BP(2,no_var+1) 
        NP = BPcr; 
    else 
        NP = BPcw; 
    end 
    [~, ~, ~, ~, ~, ~, NP(no_var+1)] = 
fNgo2019_RSS(NP(1),NP(2),NP(3),NP(4),... 
                                       NP(5),weight_curve,system_par); 
    if  run > ARS_autostart 
        %KTN's Adaptive Random Sampling 
        %Calculate a set of random points based on new point and weighted 
randomization     
        %no_extend increases with run and with decreasing simplex group size 
        no_extend = 
round(alpha*(log10(test)*(100/log10(termination_condition)) + 
100*run/max_iter)); 
        %size_extend increases with number of no_extend 
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        size_extend = beta*no_extend/(alpha*200);  
        NP_extend = zeros([no_extend,no_var+1]); %preallocate array 
        NP_extend_temp = zeros([no_extend,no_var+1]); %preallocate array 
        for i = 1:no_extend 
            for j = 1:no_var 
                NP_extend(i,j) = NP(j)*(1-size_extend+2*size_extend*rand); 
                if NP_extend(i,j) < lower_bounds(j) %check out of bound 
                    NP_extend(i,j) = lower_bounds(j) + abs(NP_extend(i,j)-
lower_bounds(j));                     
                elseif NP_extend(i,j) > upper_bounds(j) %check out of bound 
                    NP_extend(i,j) = upper_bounds(j) - abs(NP_extend(i,j)-
upper_bounds(j)); 
                end                  
            end 
        end 
        for i = 1:no_extend 
            warning('off','MATLAB:integral:NonFiniteValue') 
            NP_extend; 
            [~, ~, ~, ~, ~, ~, RSS] = ... 
                fNgo2019_RSS(ti_simplex,sigma_simplex,NP_extend(i,3),... 
                Cinf_simplex,NP_extend(i,5),weight_curve,system_par); 
            NP_extend_temp(i,:) = [ti_simplex sigma_simplex 
NP_extend(i,3),... 
                Cinf_simplex NP_extend(i,5) RSS] 
        end 
        NP_extend = NP_extend_temp; 
        %Generate global random extend points in log k 
        RP = zeros([no_extend,no_var]); 
        for i = 1:no_extend 
            for j = 1:no_var     
                if i < no_var+2 
                    RP(i,j) = start_point_log(j)*(0.999+0.002*rand); 
                else 
                RP(i,j) = lower_bounds_log(j)+rand*(upper_bounds_log(j)-
lower_bounds_log(j)); 
                end 
            end 
        end 
        %Return to linear scale 
        RP(:,3) = 10.^RP(:,3); 
        %Evaluate RSS of random points 
        SP = zeros([no_extend,no_var+1]); 
        for i = 1:no_extend 
            warning('off','MATLAB:integral:NonFiniteValue') 
            RP; %call var to reduce parfor overhead 
            [~, ~, ~, ~, ~, ~, RSS] = 
fNgo2019_RSS(ti_simplex,sigma_simplex,RP(i,3),... 
                                    
Cinf_simplex,RP(i,5),weight_curve,system_par); 
            SP(i,:) = [ti_simplex sigma_simplex RP(i,3) Cinf_simplex  RP(i,5) 
RSS]; 
        end 
        NP_extend_full = [NP_extend;SP]; 
        BP = [BP(1:no_var,:);NP;NP_extend_full]; %add new point(s) to Simplex 
    else 
        BP = [BP(1:no_var,:);NP]; %add new point(s) to Simplex 
    end 
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    %calculate test condition without new random points 
    if run < max_iter 
        test = std(BP(1:no_var,no_var+1))/mean(BP(1:no_var,no_var+1)); 
        test_matrix(k,:) = [k,run,test]; %store #run and convergence test 
    else 
        test = 0; 
    end 
    end 
    %End Second pass 
    
%~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~        
    [~, ~, E, ~, ~, ~, ~] = fNgo2019_RSS(BP(1,1),BP(1,2),BP(1,3),BP(1,4),... 
                                       BP(1,5),weight_curve,system_par); 
    E_ss = E(length(t)); 
    disp_point = BP(1,:); 
    disp_point(no_var+2) = E_ss; 
    fit_result(k,:) = disp_point; %store best point 
    disp(['Fit for Fitting Sample ' num2str(k) ' finished. The parameters 
are']) 
    disp(disp_point) 
end %end fitting 
%% 
%Sort fit result, remove fit that did not converge 
fit_result(:,3) = log10(fit_result(:,3)); 
unsorted_fit_result = fit_result; %store a copy of fit_result 
unsorted_test_matrix = test_matrix; %store a copy of test_matrix 
minRSS = min(fit_result(:,no_var+1)); %calculate lowest RSS 
threshold = minRSS*(1+RSS_threshold); %calculate rejection threshold 
no_conv = no_sample; %number of convergent accepted 
for i = 1:no_sample 
    for j = 1:no_var 
        if fit_result(i,j) >= (1-RSS_threshold)*upper_bounds_log(j)... 
                || fit_result(i,j) <= (1+RSS_threshold)*lower_bounds_log(j) 
            fit_result(i,no_var+1) = 9e5; 
        end 
    end 
end 
[fit_result,I_RSSsort] = sortrows(fit_result,no_var+1); 
for i = 1:no_sample 
    test_matrix(i,:) = unsorted_test_matrix(I_RSSsort(i),:); 
end 
for i = 1:no_sample 
    if fit_result(i,no_var+1) > threshold 
        no_conv = no_conv - 1; 
    end   
end 
sorted_fit_result = zeros([no_conv,no_var+2]); 
sorted_test_matrix = zeros([no_conv,3]); 
for i = 1:no_conv 
    sorted_fit_result(i,:) = fit_result(i,:); 
    sorted_test_matrix(i,:) = test_matrix(i,:); 
end 
%Bootstrap confident interval 
no_resample = 10000; 
drs = zeros(no_resample, length(sorted_fit_result(1,:))); %preallocate delta 
resample matrix 
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student_t = zeros(no_resample, length(sorted_fit_result(1,:))); 
rs = zeros(length(sorted_fit_result(:,1))); %preallocate resample matrix 
for i = 1:length(sorted_fit_result(1,:)) %cycle through each parameter 
    for j = 1:no_resample %cycle through each resampling interation 
        for k = 1:length(sorted_fit_result(:,1)) %calculate a single resample 
            index = ceil(rand*length(sorted_fit_result(:,1))); %get random 
index 
            rs(j,k) = sorted_fit_result(index,i); %get random sample 
        end 
        student_t(j,i) = 
sqrt(length(sorted_fit_result(:,1)))*abs(mean(rs(j,:)) -... 
            mean(sorted_fit_result(:,i)))/std(rs(j,:)); 
        drs(j,i) = abs(mean(rs(j,:)) - mean(sorted_fit_result(:,i))); 
    end 
end 
%Sort delta resample for all parameters 
for i = 1:length(sorted_fit_result(1,:)) 
    student_t(:,i) = sort(student_t(:,i),'ascend'); 
    drs(:,i) = sort(drs(:,i),'ascend'); 
end 
mean_par = zeros([length(sorted_fit_result(1,:)),1]);  
CI_t = zeros([length(sorted_fit_result(1,:)),1]);  
CI_d = zeros([length(sorted_fit_result(1,:)),1]);  
CI_n = zeros([length(sorted_fit_result(1,:)),1]);  
for i = 1:length(sorted_fit_result(1,:))  
    mean_par(i) = mean(sorted_fit_result(:,i)); %calculate parameter means 
    %calculate 95% confident interval bounds, two tail symmetrical 
    CI_t(i) = 
student_t(round(0.95*no_resample),i)*std(sorted_fit_result(:,i)); 
    CI_d(i) = 
drs(round(0.95*no_resample),i)*sqrt(length(sorted_fit_result(:,1))); 




result_matrix_t = [mean_par,CI_t]; 
result_matrix_d = [mean_par,CI_d]; 
result_matrix_n = [mean_par,CI_n]; 
fit_result = unsorted_fit_result; %restore fit_result 
test_matrix = unsorted_test_matrix; %restore test_matrix 
result_matrix = result_matrix_t; 
%% 
%% 
disp('Result saved, fitting parameters and 95% CI are') 
disp(result_matrix) 
disp('Done. Fitting took') 
toc 
%% 
%RSS function is defined separately from the Cdet version for compatibility 
%with legacy code 
function [Pext, P, E, Cout, Cdet, Csample, RSS] = 
fNgo2019_RSS(ti,sigma,kext,Cinf,phi,w,system_par) 
%System variables transfer 
t = system_par.t; ts = system_par.ts; Q = system_par.Q; D = system_par.D; 
lambda = system_par.lambda; 
ro = system_par.ro; So = system_par.So; Pmo = system_par.Pmo; Cin = 
system_par.Cin; 
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time_resolution = system_par.time_resolution; x = system_par.x; y = 
system_par.y; 
%Dependent variables calculation 
De = D/lambda^2; 
Dext = De*phi; 
box_func = zeros([1 length(t)]); 
for i = 1:length(t) 
    if 0 <= t(i) && t(i) < ts 
        box_func(i) = time_resolution/ts; 
    end 
end 
gauss = time_resolution*(1/(sigma*sqrt(2*pi)))*exp(-(t - ti).^2/(2*sigma^2)); 
s_gauss = convnfft(box_func,gauss,'same'); %Sternberg Gaussian 
Theta = ro*sqrt(kext/De); %dimentionless clearance 
Text = ro^2/De; %s, dimentionless time scaling factor 
%Define the transient part of Pext(t) 
%!!! WARNING this evaluation requires symmetricat t array!!!! 
%!!! assymetrical t array will slow down evaluation significantly!!! 
f_int = @(u)(((4/pi^2)*u*exp(-(u^2+Theta^2)*(t/Text)))/... 
    ((u^2+Theta^2)*((besselj(0,u))^2+(bessely(0,u))^2))); 
%Evaluate the transient part of external medium permeability Pext(t) 
Pext_transient = integral(f_int,0,inf,'ArrayValued',true); 
%Evaluate the steady state part of external medium permeability Pext(t) 
Pext_ss = Theta*besselk(1,Theta)/(besselk(0,Theta)); 
Pext_transient(isnan(Pext_transient)) = 0; %replace NaN with 0 
Pext_transient(isinf(Pext_transient)) = 0; %replace inf with 0   
%Evaluate dimensionless external medium permeability 
Pext_dimensionless = Pext_transient+Pext_ss; %at t < 0, Pext = Pext_ss   
Pext_dimensionless(isnan(Pext_dimensionless)) = Pext_ss; %replace NaN with 
P_ss 
Pext_dimensionless(isinf(Pext_dimensionless)) = Pext_ss; %replace inf with 
P_ss                                                          
Pext = Pext_dimensionless*Dext/ro; %Calculate P1D(t) 
P = 1./(1./Pext + 1/Pmo); %Calculate P(t) 
E = 1-exp(-So*P/Q); %Calculate E(t) 
Cout = Cin-E.*(Cin-Cinf); %Calculate Cout(t) at outlet of dialysis probe 
Cdet = convnfft(Cout,s_gauss,'same'); %Compute concentration at detector 
Cdet(t) 
%Compute an array of time index where CSample will be sampled from Cdet 
t_index = zeros([1,length(x)]); 
index_offset = 1+abs(min(t)-60*min(x))/time_resolution; 
t_index(1) = index_offset; 
for i = 2:length(x) 
    t_index(i) = round(t_index(i-1)+(x(i)-x(i-1))*60/time_resolution); 
end 
%Calculate Cdet at each sampling time 
Csample = zeros([1,length(x)]); 
for i=1:length(x) 
    Csample(i) = Cdet(t_index(i)); 
end 
%Calculate RSS 
RSS = 0; 
for i = 1:length(x) 
    for j = 1:length(y(1,:)) 
        RSS = RSS+w(i)*(Csample(i) - y(i,j))^2; 




function A = convnfft(A, B, shape, dims, options) 
%   KHANH T NGO KTN@PITT.EDU  
%   Adapted from: 
%https://www.mathworks.com/matlabcentral/fileexchange/24504-fft-based-
convolution 
%   Author: Bruno Luong <brunoluong@yahoo.com> 
% Copyright (c) 2009, Bruno Luong 
% All rights reserved. 
%  
% Redistribution and use in source and binary forms, with or without 
% modification, are permitted provided that the following conditions are met: 
% * Redistributions of source code must retain the above copyright notice, 
this 
%   list of conditions and the following disclaimer. 
% * Redistributions in binary form must reproduce the above copyright notice, 
%   this list of conditions and the following disclaimer in the documentation 
%   and/or other materials provided with the distribution 
% * Neither the name of FOGALE nanotech nor the names of its 
%   contributors may be used to endorse or promote products derived from this 
%   software without specific prior written permission. 
% THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" 
% AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE 
% IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE 
ARE 
% DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT OWNER OR CONTRIBUTORS BE LIABLE 
% FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL 
% DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR 
% SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER 
% CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT 
LIABILITY, 
% OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE 
USE 
% OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. 
if nargin<3 || isempty(shape) 
    shape = 'full'; 
end 
if nargin<5 || isempty(options) 
    options = struct(); 
elseif ~isstruct(options) % GPU options 
    options = struct('GPU', options); 
end 
nd = max(ndims(A),ndims(B)); 
% work on all dimensions by default 
if nargin<4 || isempty(dims) 
    dims = 1:nd; 
end 
dims = reshape(dims, 1, []); % row (needed for for-loop index) 
% GPU enable flag 
GPU = getoption(options, 'GPU', false); 
% Check if Jacket is installed 
GPU = GPU && ~isempty(which('ginfo')); 
% IFUN function will be used later to truncate the result 
% M and N are respectively the length of A and B in some dimension 
switch lower(shape) 
    case 'full' 
        ifun = @(m,n) 1:m+n-1; 
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    case 'same' 
        ifun = @(m,n) ceil((n-1)/2)+(1:m); 
    case 'valid' 
        ifun = @(m,n) n:m; 
    otherwise 
        error('convnfft: unknown shape %s', shape); 
end 
classA = class(A); 
classB = class(B); 
ABreal = isreal(A) && isreal(B); 
% Special case, empty convolution, try to follow MATLAB CONVN convention 
if any(size(A)==0) || any(size(B)==0) 
    szA = zeros(1,nd); szA(1:ndims(A))=size(A); 
    szB = zeros(1,nd); szB(1:ndims(B))=size(B); 
    % Matlab wants these: 
    szA = max(szA,1); szB = max(szB,1); 
    szC = szA; 
    for dim=dims 
        szC(dim) = length(ifun(szA(dim),szB(dim))); 
    end 
    A = zeros(szC,classA); % empty -> return zeros 
    return 
end 
power2flag = getoption(options, 'Power2Flag', true); 
if power2flag 
    % faster FFT if the dimension is power of 2 
    lfftfun = @(l) 2^nextpow2(l); 
else 
    % slower, but smaller temporary arrays 
    lfftfun = @(l) l; 
end 
if GPU % GPU/Jacket FFT 
    if isa(classA,'single') 
        A = gsingle(A); 
    else 
        A = gdouble(A); 
    end 
    if isa(classB,'single') 
        B = gsingle(B); 
    else 
        B = gdouble(B); 
    end 
    % Do the FFT 
    subs(1:ndims(A)) = {':'}; 
    for dim=dims 
        m = size(A,dim); 
        n = size(B,dim); 
        % compute the FFT length 
        l = lfftfun(m+n-1); 
        % We need to swap dimensions because GPU FFT works along the 
        % first dimension 
        if dim~=1 % do the work when only required 
            swap = 1:nd; 
            swap([1 dim]) = swap([dim 1]); 
            A = permute(A, swap); 
            B = permute(B, swap); 
        end 
 176 
        A = fft(A,l); 
        B = fft(B,l); 
        subs{dim} = ifun(m,n); 
    end 
else % Matlab FFT 
    % Do the FFT 
    subs(1:ndims(A)) = {':'}; 
    for dim=dims 
        m = size(A,dim); 
        n = size(B,dim); 
        % compute the FFT length 
        l = lfftfun(m+n-1); 
        A = fft(A,l,dim); 
        B = fft(B,l,dim); 
        subs{dim} = ifun(m,n); 
    end 
end 
if GPU 
    A = A.*B; 
    clear B 
else 
    % inplace product to save 1/3 of the memory 
    %inplaceprod(A,B); 
    %change made by KHANH T NGO KTN6@PITT.EDU 
    %for compatibility with MATLAB 2019a WINDOWS 10 
    A = A.*B; 
end 
% Back to the non-Fourier space 
if GPU % GPU/Jacket FFT 
    for dim=dims(end:-1:1) % reverse loop 
        A = ifft(A,[]); 
        % Swap back the dimensions 
        if dim~=1 % do the work when only required 
            swap = 1:nd; 
            swap([1 dim]) = swap([dim 1]); 
            A = permute(A, swap); 
        end         
    end    
else % Matlab IFFT   
    for dim=dims 
        A = ifft(A,[],dim); 
    end 
end 
% Truncate the results 
if ABreal 
    % Make sure the result is real 
    A = real(A(subs{:})); 
else 




    % Cast the type back 
    if isa(class(A),'gsingle') 
        A = single(A); 
    else 
        A = double(A); 
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    end 
end 
end % convnfft 
%% Get default option 
function value = getoption(options, name, defaultvalue) 
% function value = getoption(options, name, defaultvalue) 
    value = defaultvalue; 
    fields = fieldnames(options); 
    found = strcmpi(name,fields); 
    if any(found) 
        i = find(found,1,'first'); 
        if ~isempty(options.(fields{i})) 
            value = options.(fields{i}); 
        end 
    end 
end 
 
5.6.2.2 Minimum-Searching Algorithm 
Our minimum-searching algorithm proceeds as follows, where n is the number of fitting 
parameters, and a point is a set of coordinates consisting of fitting parameters, and a simplex is a 
set of n+1 points: 
Step 1. Initialization: 
• Choose a starting point. 
o A guess is given (user input). 
o A routine performs a linear regression and a logistic regression to guess ti, σ and 
CECS∞. The remaining parameters are copied from the above.  
o RSS of the two above are evaluated and compared.  
o The point with lower RSS is chosen to be start point. 
• Generate a simplex around the starting point (range is ±0.5% about each coordinate). 
• Generate a large number (e.g. 2^15) of random points over the entire parameter space.  
• Evaluate RSS of the two sets above.  
• Keep n+1 points with lowest RSS (“the current simplex”). 
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Step 2.  Simplex loop 
• NMS algorithm203,204 using the current simplex to calculate direction toward local 
minimum. 
• Adaptive Random Sampling (ARS, described below). 
• Concatenate ARS result and NMS result. 
• Check termination condition. 
The simplex loop terminates when the spread of the current simplex’s RSS is very small 
(i.e. relative standard deviation of the simplex’s n+1 RSS is less than e.g. 10-8) or when a large 
number of iterations is reached (e.g. 5000). Fits that are terminated at the latter conditions are 
rejected and their results are discarded.  
Step 3. Termination 
• Keep one point with the lowest RSS.   
5.6.2.3 Adaptive Random Sampling 
The ARS step generates random points local to the simplex, as well as in the global space. 













=   +   
 
 
Equation 5.6-5. Number of ARS random point 
Where A is the current convergence criteria (defined as RSD of the simplex’s RSS), B is 
the termination convergence criteria, C is the current iteration count, and D is the termination 
iteration count.  
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The random points have a spread of p around the NMS result. The spread p is calculated 









Equation 5.6-6. ARS random point spread 
The number of ARS random points and the spread of those points is determined by the 
spread of the simplex and the extend of the run. The smaller the spread of the simplex, indicating 
that a local optimum is near, the more ARS random points are generated to find a better minimum. 
The longer the loop has been run, the more ARS random points are generated to find a minimum. 
The spread of the ARS random points is scaled to the number of ARS random points. The more 
random points there are, the more they spread out to find a better minimum.  




Figure 5.6-2. Simulated microdialysis transient response to a 150 nM retrodialysis.  
Shown are the responses when each of the six parameters ti, σ, CECS∞, k, 𝜙 and λ is varied while the others stay 





Figure 5.6-3. Comparison between distribution of ti, σ, CECS∞, k, and 𝜙 from 1000 repeats of 5DNMS (blue),  
5DARS (red), 5DARS2P  (orange) and 4DARS (purple) to in vivo experimental data.  
The probability density curve is calculated using Kernel Density Estimator with a bandwidth of 0.01. 





Figure 5.6-4. Comparison between relative error in ti, σ, CECS∞, k, and 𝜙 from 100 repeats of 5DARS2P 
(orange) and 4DARS (purple) to 16 simulated data sets.  
Simulation parameter: Uptake rate constant k (s-1) Low = 10-2; High = 1; Microdialysis time resolution (s) 
Low = 15; High = 1; Normally Distributed Noise (σ) Low = 1%; High = 10%; Probe MWCO (kDA) Low = 
13; High = 18. 5DARS2P produces no successful fit for set 16. 
 
 
Figure 5.6-5. Comparison between error in k and relative error in 𝜙 from 100 repeats of 5DARS2P  to 18 
simulated data sets with varied chromatographic sampling time (ts) and no noise, perfect probe dispersion (σ 
= 0.1 s or 1 s, σ≤ ts). 
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Figure 5.6-6. Comparison between error in k and relative error in 𝜙 from 100 repeats of 5DARS2P  to 18 
simulated data sets with varied probe dispersion (σ) and no noise, perfect chromatographic sampling time (ts 
= 1 s). 
Table 5.6-1. Comparison between mean and 95% C.I. of ti, σ, CECS∞, k, and 𝜙 from 1000 repeats of 5DNMS,  
5DARS, 5DARS2P and 4DARS to in vivo experimental data.  
Mean and 95% C.I. were calculated using both a normal distribution assumption and bootstrap-t. 
  4DARS 5DNMS 
  norm. distr. bootstrap norm. distr. bootstrap 
  mean 95% C.I. mean 95% C.I. mean 95% C.I. mean 95% C.I. 
ti -57.9342 0.006623 -57.9342 0.006665 -57.7936 0.040642 -58.2724 0.03823 
σ 32.96693 0.009483 32.96693 0.009613 32.90799 0.017089 32.90749 0.016863 
k 0.181656 0.000208 0.181656 0.000211 0.118359 0.008897 0.11831 0.008237 
CECS∞ 3.945633 0.036622 3.945633 0.036538 3.81466 0.053159 3.828314 0.054846 
𝜙         0.258807 0.008036 0.256958 0.007422 
  5DARS 5DARS2P 
  norm. distr. bootstrap norm. distr. bootstrap 
  mean 95% C.I. mean 95% C.I. mean 95% C.I. mean 95% C.I. 
ti -58.0282 0.026272 -57.9546 0.009933 -57.9546 0.009981 -57.4625 0.012624 
σ 33.13182 0.010678 32.9696 0.003392 32.9696 0.003396 32.96966 0.003159 
k 0.183122 0.012442 0.19139 0.006516 0.19139 0.006505 0.191832 0.007514 
CECS∞ 3.865465 0.036877 3.915635 0.009792 3.915635 0.010187 3.92209 0.004577 




The work in this dissertation improved many experimental and theoretical aspects of Fast 
Microdialysis to establish new applications that answer biologically relevant questions, many of 
which are infeasible with steady-state microdialysis. The experimental improvements 
comprehensively entail the entire microdialysis analytical system. They include better perfusate 
delivery to generate concentration changes for retrodialysis experiments without interrupting flow, 
rotating operant chamber to perform behavioral studies without degrading Fast Microdialysis time 
resolution, chromatographic optimization to enable hours to days long experiment, and a sampling 
technique to increase effective time resolution, to name a few. The theoretical improvements 
created a mathematical framework to describe effects of experimental conditions to experimentally 
observable quantities and applied advance data analysis techniques to elucidate biological and 
system information from experimental measurements.  
In the investigation of DEX treatment to traumatic penetration injury caused by probe 
implantation, Fast Microdialysis allowed for an unprecedented number of basal DA measurements 
in the striatum (approx. 2500 in 22 rats). Linear regression showed that DEX treatment potentiates 
(by 64%) and changes the distribution (from normal to log normal) of basal DA measurements. 
Most significantly, with the one-minute time resolution provided by Fast Microdialysis, 
retrodialysis of 100 mM K+ was found to evoke rapid, large, oscillations in DA concentration 
adjacent to the probe site. Simultaneous local field potential and DA measurements validated that 
these oscillations were spreading depolarization events, a common pathological response to 
traumatic brain injury. Principle component analysis showed that the evoked response correlated 
to both the DEX treatment and number of recovery days.  This work thus conclusively established 
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that tissue adjacent to probe site is capable of pathological response, and therefore is viable and 
has functional dopamine terminals.  
The rotating operant chamber was created to conduct behavioral study with Fast 
Microdialysis. With the rotating operant chamber, operant behavior components and their 
associated controllers, power delivery, data acquisition and wireless data transmitter all rotate with 
a raturn so that the rat can move freely during the experiment, eliminating the need for liquid 
swivel which degrades time resolution. Using the rotating operant chamber, rats were trained and 
performed learned tasks, while DA concentrations were determined with Fast Microdialysis. Rats 
were also video-recorded for behavior analysis. An animal’s untrained locomotive behaviors (e.g. 
grooming, limb movement) were found to correlate with large DA releases while the animal’s 
trained feeding behavior correlated with smaller but rapidly oscillating DA releases. This 
correlation of oscillations and behavior has not been observed by other means, demonstrating the 
unique capabilities of Fast Microdialysis. 
Comprehensive Quantitative Microdialysis (CQM) was created both as a new quantitative 
microdialysis technique that enables determination of solute concentration in the ECS; and a new 
theoretical and experimental framework that allows for determination of biological and systemic 
factors that influences the solute concentration observed at the detector, including sample transport 
time, hydrodynamic dispersion, uptake rate constant, and tissue porosity. We created a simulation 
tool and curve fit tool in MATLAB for these purposes. Analysis of transient responses on an awake 
rat using CQM found striatal tissue porosity, and striatal DA uptake rate constant comparable with 
established literature values. Extraction fraction and DA ECS concentration found were 
comparable to measurements made with traditional steady-state method (No-Net-Flux). The 
analysis also determined with high precision the time delay between a DA concentration change 
 186 
at the probe (e.g. behavior-related DA release) and measurements at the detector. It is remarkable 
that all of this information can be obtained from transient responses on an awake rat using 
microdialysis in under an hour of experimental time. Exploration of curve fit to simulated data 
showed that CQM is robust to drastic changes in experimental conditions, including high noise 
and high uptake rate constant.  
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7.0 Future Work 
From the work shown in this dissertation, particularly quantitative analysis of transient 
response using the Comprehensive Quantitative Microdialysis technique180,202, it is apparent that 
there is still a pressing need for a higher time resolution, in the order of 15 s or less, for Fast 
Microdialysis. This will eliminate the need for time-interleaved sampling to measure transient 
responses, therefore improves the quality of the measurements obtained and reduces experiment 
time. It will also bring Fast Microdialysis to parity with Fast Scan Controlled Absorption 
Voltammetry49,51 or PEDOT/functionalized carbon nanotube-coated carbon fiber microelectrodes 
with square wave voltammetry52 in term of time resolution for basal level measurements of low 
concentration (nM) neurotransmitters. We have preliminary theoretical and experimental work 
making significant progress toward higher time resolution for Fast Microdialysis of Dopamine 
(see below).  
7.1 Sub-minute Fast Microdialysis Determination of Dopamine with Online Dilution and 
Low Flow Microdialysis 
The limit to our Fast Microdialysis DA determination is the poor peak shape and low 
number of theoretical plates for DA. The separation was optimized for continuous 60 s in vivo 
online separation for up to 96 hours. Chromatographically, the separation conditions are also near 
optimal. Well-established theories231,232 predict a reduced plate height h of about 6. However, 
experimental in vivo separation of DA only achieves h of about 22 (Figure 7.1-1). Exploring 
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separation conditions, we found that the separation is better in aqueous (D.I. water) than in saline 
(aCSF or dialysate) conditions (Figure 7.1-2). The same conclusion holds true across different 
mobile phases that we tested (Figure 7.1-3). 
We hypothesized that the high ionic strength of the biological saline solutions hinders ion-
pairing, which is the retention mechanism of DA in our ion-pairing reversed-phase HPLC. Based 
on this hypothesis, we tested a number of solutions: 
• Adding ion-pairing agent during injections. Theoretically, this should aid ion-paring during 
the injection, without significantly increase the retention time. We found that this improved 
the peak shape, but it causes DA to split to two peaks.  
• Adding chelating agent during injections. Theoretically, we could chelate ions (e.g. Mg2+ 
and Ca2+) thus reduce their impact to the separation. However, as the separation is at low 
pH, chelating agents are ineffective. Theoretical calculation and experiments showed that 
added EDTA during injection did not improve the separation.  
• Working electrode surface modification. PEDOT-based coatings has been shown to 
improve selectivity to Dopamine52,233,234. By increasing DA selectivity, the separation 
could have fewer interferences from other biological solutes, thus providing an opportunity 
for better chromatographic separation. We found that the surface modification does not 
appreciably improve our chromatograms. 
• Reducing the ionic strength of the injected solution. We tested this by diluting the saline 
DA standards with DI water prior to injection, and by making saline standards with lower 
salt concentrations. This solution proved to be effective, and peak width was reduced (i.e. 
better separation) as the ionic strength of the DA standard decreased (Figure 7.1-4). 
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Dilution of samples is typically not desirable, as it reduces the concentration of solutes in 
the sample, thus worsen limit of quantitation. The limit of quantitation of our Fast Microdialysis 
method is not significantly higher than the lowest concentration of Dopamine that we have 
measured in dialysate97,98, thus a higher limit of quantitation is not acceptable. However, for a 
microdialysis experiment, dilution can be combined with lowering the flow rate of the dialysate. 
The concentration of the solute on in the dialysate is dependent to the flow rate, the lower the flow 
rate, the higher concentration of the solute recovered12,60,84,235 (Figure 7.1-5). This increased 
recovery at lower flow rate compensates for the decreases in solute concentration as the sample is 
diluted. The dilution can be done online, prior to injection  using a zero dead volume mixer236,237.  
Theoretical calculations and in vitro experiment shows that when dialysate flow rate is 
reduced and the dialysate is diluted with D.I. water prior to injection (total flowrate and injection 
volume are constant, and are identical to typical Fast Microdialysis) the peak width of the 
separation decreases (better separation) while peak height increases at the same time (Figure 
7.1-6). Leveraging this improvement in DA separation, we have obtained preliminary results 
showing improved in vivo separation (Figure 7.1-7) and feasibility of 30 s online in vivo DA 
determination using online dilution of low flow microdialysis (Figure 7.1-8).   
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Figure 7.1-1. Typical Dopamine Separation with Fast Microdialysis. Shown are four continuous 60 s 
chromatograms.  
The DA peak is indicated with an arrow. Column: 60 mm × 0.15 mm I.D, 1.7 μm BEH C18, 32.5°C. Mobile 
phase: 9 μL/min 100 mM NaOAc, 1.75 mM SOS, 0.15 mM EDTA, 3% v/v ACN, 2% v/v HOAc, pH 4.5. 
Detector: 400 mV vs Ag/AgCl (3M NaCl). 
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Figure 7.1-2. Comparison between separation of Dopamine in aqueous (red) and in saline (black) conditions. 
 Shown are four continuous 60 s chromatograms. The DA peak is indicated with an arrow. . Column: 90 mm 
× 0.15 mm I.D, 1.7 μm BEH C18, 75°C. Mobile phase: 8 μL/min 100 mM NaOAc, 1.75 mM SOS, 0.15 mM 





Figure 7.1-3. Comparison between separation of Dopamine in aqueous and in saline (black) conditions across 
different mobile phases.  
Shown are number of theoretical plate for the same column and flowrate of separations in pH 4 acetate 




Figure 7.1-4. The effect of reducing the ionic strength of the solution to separation of DA.  
The ionic strength is reduced by dilution. Dilution ratio is the ratio of final volume to starting volume. 
Separation quality is measured in peak width. 
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Figure 7.1-5. Relationship between dialysate flow rate and recovery in term of concentration (blue) and moles 
per min (orange).  
 
 
Figure 7.1-6. Comparison between in vitro experiment (left) and theoretical prediction (right) of low flow 
microdialysis with online dilution.  
Peak width (open diamond) and peak height (solid squares) are shown. 
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Figure 7.1-7. Comparison between typical Fast Microdialysis separation (blue) and separation using online 
dilution of low flow microdialysis (orange) of DA.  
The DA peak is marked with an arrow. The standard separation injected 15 fmol of DA at 10.4±0.5 nM, 
resulting a peak width (FWHM) of 3.92±0.08 s and height of 0.54±0.01 nM, giving a plate count of 800. The 
diluted separation injected 5 fmol of DA at 18.90±0.00 nM, resulting a peak width (FWHM) of 1.73±0.02 s 
and height of 0.45±0.00 nM, giving a plate count of 4300. 
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Figure 7.1-8. Online in vivo determination of DA at 30 s time resolution using Fast Microdialysis with online 
dilution and low flow microdialysis.  
The DA peak is marked with an arrow.  
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